<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN"  
  "http://www.w3.org/TR/html4/loose.dtd">  
<html > 
<head><title>Smartphone App Concept for Medical Applications.</title> 
<meta http-equiv="Content-Type" content="text/html; charset=windows-1252"> 
<meta name="generator" content="TeX4ht (http://www.tug.org/tex4ht/)"> 
<meta name="originator" content="TeX4ht (http://www.tug.org/tex4ht/)"> 
<!-- html,word,fn-in --> 
<meta name="src" content="main.tex"> 
<meta name="date" content="2016-09-06 11:17:00"> 
<link rel="stylesheet" type="text/css" href="main.css"> 
</head><body 
>
   <div class="maketitle">
                                                                  

                                                                  

<h2 class="titleHead">Smartphone App Concept for Medical
Applications.</h2>
      <div class="author" ><span 
class="ptmr7t-x-x-120">Alexander Gustafson</span>
<br /> <span 
class="ptmr7t-x-x-120">University of Applied Sciences,</span>
<br />            <span 
class="ptmr7t-x-x-120">Z</span><span 
class="ptmr7t-x-x-120">&#x00FC;rich,</span>
<br />          <span 
class="ptmr7t-x-x-120">Switzerland,</span>
<br />    <span 
class="ptmr7t-x-x-120">alex</span><span 
class="ptmr7t-x-x-120">_gustafson@yahoo.de</span></div><br />
<div class="date" ><span 
class="ptmr7t-x-x-120">September 6, 2016</span>
<span 
class="ptmr7t-x-x-120">Dozent: Reto Knaack (knaa@zhaw.ch)</span>
<span 
class="ptmr7t-x-x-120">School of Engineering, Abteilung Z</span><span 
class="ptmr7t-x-x-120">&#x00FC;rich</span>
<span 
class="ptmr7t-x-x-120">Studiengang Informatik</span>                                            </div>
                                                                  

                                                                  
   </div>
                                                                  

                                                                  
   <h2 class="likechapterHead"><a 
 id="x1-1000"></a>Abstract</h2> The market for smartphone based medical applications is a relatively new and
growing quickly. The majority of medical apps are relatively simple health management and
tracking applications that might remind a user to take his or her medicine or monitor blood
pressure and heart rate data provided by accompanying devices. However, more sophisticated
apps can directly provide diagnostic information by capturing and analysing data directly.
Several apps exist that can asses the risk of skin cancer by tracking changes in the growth of
skin lesions over time.
                                                                  

                                                                  
   <h2 class="likechapterHead"><a 
 id="x1-2000"></a>Contents</h2> <div class="tableofcontents">
   <span class="chapterToc" >1 <a 
href="#x1-30001" id="QQ2-1-3">Introduction</a></span>
<br />    <span class="sectionToc" >1.1 <a 
href="#x1-40001.1" id="QQ2-1-4">Project Description</a></span>
<br />    <span class="sectionToc" >1.2 <a 
href="#x1-50001.2" id="QQ2-1-5">Goals</a></span>
<br />    <span class="sectionToc" >1.3 <a 
href="#x1-60001.3" id="QQ2-1-6">Expected Results</a></span>
<br />   <span class="chapterToc" >2 <a 
href="#x1-70002" id="QQ2-1-7">Market Research</a></span>
<br />    <span class="sectionToc" >2.1 <a 
href="#x1-80002.1" id="QQ2-1-8">Data Gathering</a></span>
<br />     <span class="subsectionToc" >2.1.1 <a 
href="#x1-90002.1.1" id="QQ2-1-9">Gathering Data from the Apple iTunes Store</a></span>
<br />     <span class="subsectionToc" >2.1.2 <a 
href="#x1-100002.1.2" id="QQ2-1-10">Gathering App Data from the Google Play Store</a></span>
<br />    <span class="sectionToc" >2.2 <a 
href="#x1-110002.2" id="QQ2-1-11">Categorization</a></span>
<br />     <span class="subsectionToc" >2.2.1 <a 
href="#x1-120002.2.1" id="QQ2-1-12">Description of Categories</a></span>
<br />    <span class="sectionToc" >2.3 <a 
href="#x1-130002.3" id="QQ2-1-13">Results</a></span>
<br />     <span class="subsectionToc" >2.3.1 <a 
href="#x1-140002.3.1" id="QQ2-1-14">IOS Medical Apps</a></span>
<br />     <span class="subsectionToc" >2.3.2 <a 
href="#x1-150002.3.2" id="QQ2-1-16">Android Medical Apps</a></span>
<br />     <span class="subsectionToc" >2.3.3 <a 
href="#x1-160002.3.3" id="QQ2-1-18">Dermatology Apps 2013 vs 2016</a></span>
<br />     <span class="subsectionToc" >2.3.4 <a 
href="#x1-170002.3.4" id="QQ2-1-21">Dermatological Apps with Automatic Risk Assesment</a></span>
<br />   <span class="chapterToc" >3 <a 
href="#x1-180003" id="QQ2-1-22">Image Data Sources</a></span>
<br />    <span class="sectionToc" >3.1 <a 
href="#x1-190003.1" id="QQ2-1-23">Dermofit</a></span>
<br />    <span class="sectionToc" >3.2 <a 
href="#x1-200003.2" id="QQ2-1-25">DermQuest</a></span>
<br />    <span class="sectionToc" >3.3 <a 
href="#x1-210003.3" id="QQ2-1-27">PH2Dataset</a></span>
<br />   <span class="chapterToc" >4 <a 
href="#x1-220004" id="QQ2-1-29">Image Feature Extraction</a></span>
<br />    <span class="sectionToc" >4.1 <a 
href="#x1-230004.1" id="QQ2-1-30">Preprocessing</a></span>
<br />     <span class="subsectionToc" >4.1.1 <a 
href="#x1-240004.1.1" id="QQ2-1-31">Equalization</a></span>
<br />     <span class="subsectionToc" >4.1.2 <a 
href="#x1-250004.1.2" id="QQ2-1-32">Median Blur</a></span>
<br />     <span class="subsectionToc" >4.1.3 <a 
href="#x1-260004.1.3" id="QQ2-1-33">Gaussian Blur</a></span>
<br />    <span class="sectionToc" >4.2 <a 
href="#x1-270004.2" id="QQ2-1-34">Segmentation</a></span>
<br />     <span class="subsectionToc" >4.2.1 <a 
href="#x1-280004.2.1" id="QQ2-1-35">Iterative Thresholding</a></span>
<br />     <span class="subsectionToc" >4.2.2 <a 
href="#x1-290004.2.2" id="QQ2-1-36">Region Selection</a></span>
<br />    <span class="sectionToc" >4.3 <a 
href="#x1-300004.3" id="QQ2-1-37">Image Feature Extraction</a></span>
<br />   <span class="chapterToc" >5 <a 
href="#x1-310005" id="QQ2-1-38">TDS Algorithm</a></span>
<br />    <span class="sectionToc" >5.1 <a 
href="#x1-320005.1" id="QQ2-1-39">Description of the Algorithm</a></span>
<br />     <span class="subsectionToc" >5.1.1 <a 
href="#x1-330005.1.1" id="QQ2-1-41">Adaptation for use in a smart phone application</a></span>
<br />    <span class="sectionToc" >5.2 <a 
href="#x1-340005.2" id="QQ2-1-43">Automatic Calculation of ABCD Values</a></span>
<br />     <span class="subsectionToc" >5.2.1 <a 
href="#x1-350005.2.1" id="QQ2-1-44">Asymmetry</a></span>
<br />     <span class="subsectionToc" >5.2.2 <a 
href="#x1-360005.2.2" id="QQ2-1-47">Border</a></span>
<br />     <span class="subsectionToc" >5.2.3 <a 
href="#x1-370005.2.3" id="QQ2-1-52">Color</a></span>
<br />     <span class="subsectionToc" >5.2.4 <a 
href="#x1-380005.2.4" id="QQ2-1-57">Differential</a></span>
                                                                  

                                                                  
<br />    <span class="sectionToc" >5.3 <a 
href="#x1-390005.3" id="QQ2-1-58">Two Examples</a></span>
<br />     <span class="subsectionToc" >5.3.1 <a 
href="#x1-400005.3.1" id="QQ2-1-59">Postitiv Example</a></span>
<br />     <span class="subsectionToc" >5.3.2 <a 
href="#x1-410005.3.2" id="QQ2-1-60">False Example</a></span>
<br />    <span class="sectionToc" >5.4 <a 
href="#x1-420005.4" id="QQ2-1-61">Results of Algorithm</a></span>
<br />    <span class="sectionToc" >5.5 <a 
href="#x1-430005.5" id="QQ2-1-64">Performance Evaluation</a></span>
<br />   <span class="chapterToc" >6 <a 
href="#x1-440006" id="QQ2-1-65">Machine Learning</a></span>
<br />    <span class="sectionToc" >6.1 <a 
href="#x1-450006.1" id="QQ2-1-66">Section Title</a></span>
<br />    <span class="sectionToc" >6.2 <a 
href="#x1-460006.2" id="QQ2-1-67">Results of Algorithm</a></span>
<br />   <span class="chapterToc" >7 <a 
href="#x1-470007" id="QQ2-1-68">Implementaion of the Algorithm</a></span>
<br />    <span class="sectionToc" >7.1 <a 
href="#x1-480007.1" id="QQ2-1-69">Section Title</a></span>
<br />   <span class="chapterToc" >8 <a 
href="#x1-490008" id="QQ2-1-70">Requirements</a></span>
<br />    <span class="sectionToc" >8.1 <a 
href="#x1-500008.1" id="QQ2-1-71">Use Cases</a></span>
<br />    <span class="sectionToc" >8.2 <a 
href="#x1-510008.2" id="QQ2-1-80">Prioritisation</a></span>
<br />    <span class="sectionToc" >8.3 <a 
href="#x1-520008.3" id="QQ2-1-81">Requirements</a></span>
<br />    <span class="sectionToc" >8.4 <a 
href="#x1-530008.4" id="QQ2-1-82">Prioritized Requirements</a></span>
<br />   <span class="chapterToc" >9 <a 
href="#x1-540009" id="QQ2-1-95">Architecture Design</a></span>
<br />    <span class="sectionToc" >9.1 <a 
href="#x1-550009.1" id="QQ2-1-96">User Interface</a></span>
<br />    <span class="sectionToc" >9.2 <a 
href="#x1-560009.2" id="QQ2-1-103">Data Structure</a></span>
<br />     <span class="subsectionToc" >9.2.1 <a 
href="#x1-570009.2.1" id="QQ2-1-104">Server Data Structure</a></span>
<br />     <span class="subsectionToc" >9.2.2 <a 
href="#x1-580009.2.2" id="QQ2-1-106">Client Data Structure</a></span>
<br />    <span class="sectionToc" >9.3 <a 
href="#x1-590009.3" id="QQ2-1-107">Software Architecture</a></span>
<br />     <span class="subsectionToc" >9.3.1 <a 
href="#x1-600009.3.1" id="QQ2-1-108">MVC</a></span>
<br />     <span class="subsectionToc" >9.3.2 <a 
href="#x1-610009.3.2" id="QQ2-1-110">Modern MVC</a></span>
<br />     <span class="subsectionToc" >9.3.3 <a 
href="#x1-620009.3.3" id="QQ2-1-112">MVC Derivatives</a></span>
<br />     <span class="subsectionToc" >9.3.4 <a 
href="#x1-630009.3.4" id="QQ2-1-114">MVC and Smart Phone Applications</a></span>
<br />     <span class="subsectionToc" >9.3.5 <a 
href="#x1-640009.3.5" id="QQ2-1-115">Considerations</a></span>
<br />     <span class="subsectionToc" >9.3.6 <a 
href="#x1-650009.3.6" id="QQ2-1-116">VIPER</a></span>
<br />    <span class="sectionToc" >9.4 <a 
href="#x1-660009.4" id="QQ2-1-118">Mobile Development Strategies</a></span>
<br />     <span class="subsectionToc" >9.4.1 <a 
href="#x1-670009.4.1" id="QQ2-1-119">Pure Native vs Hybrid Native vs Hybrid vs Web Apps</a></span>
<br />   <span class="chapterToc" >10 <a 
href="#x1-6800010" id="QQ2-1-121">Testing</a></span>
<br />    <span class="sectionToc" >10.1 <a 
href="#x1-6900010.1" id="QQ2-1-122">Section Title</a></span>
<br />   <span class="chapterToc" >11 <a 
href="#x1-7000011" id="QQ2-1-123">Application Implementation</a></span>
<br />    <span class="sectionToc" >11.1 <a 
href="#x1-7100011.1" id="QQ2-1-124">Language and Libraries</a></span>
<br />     <span class="subsectionToc" >11.1.1 <a 
href="#x1-7200011.1.1" id="QQ2-1-125">Server</a></span>
<br />     <span class="subsectionToc" >11.1.2 <a 
href="#x1-7300011.1.2" id="QQ2-1-126">Mobile Client</a></span>
<br />   <span class="chapterToc" >12 <a 
href="#x1-7400012" id="QQ2-1-127">Conclusions</a></span>
<br />    <span class="sectionToc" >12.1 <a 
href="#x1-7500012.1" id="QQ2-1-128">Section Title</a></span>
<br />   <span class="chapterToc" >13 <a 
href="#x1-7700013" id="QQ2-1-130">Appendix</a></span>
<br />    <span class="sectionToc" >13.1 <a 
href="#x1-7800013.1" id="QQ2-1-131">Optimizations</a></span>
<br />     <span class="subsectionToc" >13.1.1 <a 
href="#x1-7900013.1.1" id="QQ2-1-132">Border Extraction</a></span>
<br />     <span class="subsectionToc" >13.1.2 <a 
href="#x1-8000013.1.2" id="QQ2-1-133">SFA Threshold</a></span>
<br />     <span class="subsectionToc" >13.1.3 <a 
href="#x1-8100013.1.3" id="QQ2-1-134">TDS Evaluation</a></span>
   </div>
                                                                  

                                                                  
   <h2 class="chapterHead"><span class="titlemark">Chapter 1</span><br /><a 
 id="x1-30001"></a>Introduction</h2>
<!--l. 2--><p class="noindent" >TODO: Medical Apps / future promise and benefits / communication with experts / fast
diagnosis
<!--l. 4--><p class="indent" >   TODO: Fields that can benefit from Medical Apps on smart phones
<!--l. 6--><p class="indent" >   TODO: What is cancerous melanoma? danger? importance of early detection.
   <h3 class="sectionHead"><span class="titlemark">1.1    </span> <a 
 id="x1-40001.1"></a>Project Description</h3>
<!--l. 11--><p class="noindent" >This bachelor project will investigate the following questions:
<!--l. 13--><p class="noindent" >
     <ul class="itemize1">
     <li class="itemize">What smartphone based medical apps are available that can track and assess the
     risk of skin lesions?
     </li>
     <li class="itemize">What methods and algorithms can be employed by mobile phones to calculate
     the risk?
     </li>
     <li class="itemize">What is necessary to build a mobile app that can provide a risk assessment of
     skin cancer melanoma from captured images?
     </li></ul>
<!--l. 21--><p class="noindent" >
   <h3 class="sectionHead"><span class="titlemark">1.2    </span> <a 
 id="x1-50001.2"></a>Goals</h3>
<!--l. 23--><p class="noindent" >
     <dl class="enumerate-enumitem"><dt class="enumerate-enumitem">
  1. </dt><dd 
class="enumerate-enumitem">Research the medical app market to gain an overview of areas of development,
     what apps are available, what trends are discernible. Of special interest are apps
     that use internal sensors ( e.g., camera ) and mathematical algorithms to detect
     skin cancer melanoma.
     </dd><dt class="enumerate-enumitem">
  2. </dt><dd 
class="enumerate-enumitem">Gain  familiarity  with  machine  learning  and  image  recognition  algorithms.
     Describe the basic principles of these algorithms.
     </dd><dt class="enumerate-enumitem">
  3. </dt><dd 
class="enumerate-enumitem">Research and compare available data and algorithms (e.g. in computer vision
     / machine learning). Define the relevant attributes that can be used to train the
     algorithm. This can also include changes in size over time.
     </dd><dt class="enumerate-enumitem">
  4. </dt><dd 
class="enumerate-enumitem">Based on the research and comparison choose a specific algorithm and data with which
     to proceed. The algorithm must be able to
                                                                  

                                                                  
         <dl class="enumerate-enumitem"><dt class="enumerate-enumitem">
      (a) </dt><dd 
class="enumerate-enumitem">identify the skin lesion correctly,
         </dd><dt class="enumerate-enumitem">
      (b) </dt><dd 
class="enumerate-enumitem">compute the relevant attributes,
         </dd><dt class="enumerate-enumitem">
      (c) </dt><dd 
class="enumerate-enumitem">use  these  attributes  to  classify  the  skin  lesions  whether  it  is  possibly
         cancerous or not</dd></dl>
     </dd><dt class="enumerate-enumitem">
  5. </dt><dd 
class="enumerate-enumitem">Implement the algorithm as a prototype ( using Python for example ). Using images of
     a skin lesion as input, the algorithm will provide a risk assessment as output.
     Implement tests that can calculate the accuracy of the algorithm. Compare the
     implemented algorithm with at least one other algorithm.
     </dd><dt class="enumerate-enumitem">
  6. </dt><dd 
class="enumerate-enumitem">Create a concept for a medical mobile app that can utilise the features of modern
     smartphones to provide a risk assessment of skin cancer melanoma based on captured
     images. This includes a full requirements analysis, i.e. use cases, functional /
     non-functional requirements, architecture.
     </dd><dt class="enumerate-enumitem">
  7. </dt><dd 
class="enumerate-enumitem">Implement as proof of concept specific aspects of the medical mobile app.
     </dd></dl>
<!--l. 44--><p class="noindent" >
   <h3 class="sectionHead"><span class="titlemark">1.3    </span> <a 
 id="x1-60001.3"></a>Expected Results</h3>
<!--l. 46--><p class="noindent" >
     <dl class="enumerate-enumitem"><dt class="enumerate-enumitem">
  1. </dt><dd 
class="enumerate-enumitem">Results of the medical app market research including graphical presentation of
     trends and statistics.
     </dd><dt class="enumerate-enumitem">
  2. </dt><dd 
class="enumerate-enumitem">Documentation  of  the  available  data  and  algorithms  including  high  level
     excursion  into  the  theory  behind  machine  learning  and  image  recognition
     algorithms.
     </dd><dt class="enumerate-enumitem">
  3. </dt><dd 
class="enumerate-enumitem">Comparison of available data and algorithms. Definition of relevant attributes.
     </dd><dt class="enumerate-enumitem">
  4. </dt><dd 
class="enumerate-enumitem">Decision, which algorithm to use.
     </dd><dt class="enumerate-enumitem">
  5. </dt><dd 
class="enumerate-enumitem">Documentation   of   the   implementation   of   the   algorithm,   including   tests,
     evaluation and comparison with at least one other algorithm.
                                                                  

                                                                  
     </dd><dt class="enumerate-enumitem">
  6. </dt><dd 
class="enumerate-enumitem">Documentation  of  a  concept  for  a  medial  app,  including  defined  use  cases,
     requirements, architecture and implemented design patterns.
     </dd><dt class="enumerate-enumitem">
  7. </dt><dd 
class="enumerate-enumitem">Proof of Concept: implementation of specific aspects of the medical mobile app.</dd></dl>
                                                                  

                                                                  
   <h2 class="chapterHead"><span class="titlemark">Chapter 2</span><br /><a 
 id="x1-70002"></a>Market Research</h2>
   <h3 class="sectionHead"><span class="titlemark">2.1    </span> <a 
 id="x1-80002.1"></a>Data Gathering</h3>
<!--l. 3--><p class="noindent" >
   <h4 class="subsectionHead"><span class="titlemark">2.1.1    </span> <a 
 id="x1-90002.1.1"></a>Gathering Data from the Apple iTunes Store</h4>
<!--l. 5--><p class="noindent" >Searching the Apple iTunes store is typically done manually via the iTunes Application from
which text and data cannot be automatically extracted. Therefore, searching for and gathering
data about IOS Applications is not easy. However, Apple does provide an rss feed that can be
used to list Apps in specific categories and ordered according to how new, or how popular
they are and if they are free or not. The rss feed is limited to 100 items per category. The data
provided by the rss feed is minimal, not much more than title and a text description of the
app. There are no sub-genres or tags than can be used to further differentiate the
apps.
<!--l. 7--><p class="indent" >   Using a python script data was gathered from the following rss feeds:
<!--l. 9--><p class="indent" >   Top 100 Free Medical Apps Top 100 Grossing Medical Apps Top 100 Paid Medical Apps
This combined results included data about 255 IOS apps. The title and description fields were
imported into a database. Other information from the data such as price, right, or image link
were ignored.
<!--l. 15--><p class="noindent" >
   <h4 class="subsectionHead"><span class="titlemark">2.1.2    </span> <a 
 id="x1-100002.1.2"></a>Gathering App Data from the Google Play Store</h4>
<!--l. 17--><p class="noindent" >In order to gather data from the Goole app store a script was programmed that could extract
lists of apps from a specific url. The following urls were scanned:
     <ul class="itemize1">
     <li class="itemize">Top Paid Medical Apps : https://play.google.com/store/apps/category/MEDICAL/collection/topselling_paid
     </li>
     <li class="itemize">Top Free Medical Apps : https://play.google.com/store/apps/category/MEDICAL/collection/topselling_free</li></ul>
<!--l. 25--><p class="indent" >   For each app listed the script would extract the url of the apps detail page. From the
detail page more imformation would be gathered and stored in a database. The data set is
similar to that of the itunes rss feed. The title and description text were imported, other fields
such as pricing and copyright were ignored.
<!--l. 27--><p class="indent" >   Data on 480 Medical Apps for Android was imported. However a significant percentage
of the apps could not be classified because the description text was in a language other than
English, German, or French.
<!--l. 1--><p class="noindent" >
   <h3 class="sectionHead"><span class="titlemark">2.2    </span> <a 
 id="x1-110002.2"></a>Categorization</h3>
                                                                  

                                                                  
<!--l. 3--><p class="noindent" >The term Medical App is broad and neither the iTunes nor Google app stores offer any kind
of sub categorization. In order to get a better overview of what sort of Medical Apps are
available it was necessary to manually browse the gathered data and assign categories to the
apps.
<!--l. 5--><p class="indent" >   A database management tool was created using the python based Django Web
Framework. Django provides many tools that makes constructing and interacting with
databases very easy. The built-in backend administration tool can be configured to browse,
edit, and filter data.
<!--l. 7--><p class="indent" >   In order to quickly browse through and categorize over 700 apps. The Django backend
admin was configured so apps could be categorized one after the other with a minimum of
clicks or scrolling. The user was presented a list of uncategorized apps. The first one is
clicked. The user is then presented with a page displaying the title and summary text of
the app and a field from which a category can be selected. Once saved, the app is
no longer presented on the list, the user can select the next app at the top of the
list.
<!--l. 9--><p class="noindent" >
   <h4 class="subsectionHead"><span class="titlemark">2.2.1    </span> <a 
 id="x1-120002.2.1"></a>Description of Categories</h4>
<!--l. 10--><p class="noindent" >
     <ul class="itemize1">
     <li class="itemize"><span 
class="ptmb7t-">Community </span>- provides some soft of social networking service through which
     the user can share data with her family or with a network of people suffering
     from similar disorders.
     </li>
     <li class="itemize"><span 
class="ptmb7t-">Fun / Entertainment </span>- These apps have to real medical purpose. They are for
     enjoyment only.
     </li>
     <li class="itemize"><span 
class="ptmb7t-">Alert / First Response </span>- Apps that assist first responders or that help users alert
     first responders that help is needed.
     </li>
     <li class="itemize"><span 
class="ptmb7t-">Health / Lifestyle </span>- Relaxation and meditation apps, or ovulation and fertility
     reminders
     </li>
     <li class="itemize"><span 
class="ptmb7t-">Resource Finder </span>- Apps that locate resources in the vicinitly, nearby pharmacies
     or care providers.
     </li>
     <li class="itemize"><span 
class="ptmb7t-">Reminder </span>- Apps with timer or calendar functionality that might remind a user
     of an appointment or manage medince consumption.
                                                                  

                                                                  
     </li>
     <li class="itemize"><span 
class="ptmb7t-">Algorithmic / Diagnostic </span>- These are apps that provide some sort of diagnositc
     information based on data that as been gathered by sensors or entered by the user.
     Examples are seizure detection apps, or stroke severity evalutaion apps.
     </li>
     <li class="itemize"><span 
class="ptmb7t-">Learning / Educational / Reference </span>- By far the largest category, this includes
     apps that provide reference information about diseases or education material like
     anatomy apps for example.
     </li>
     <li class="itemize"><span 
class="ptmb7t-">Organisational </span>- Apps in this category might help a user or practitioner organise,
     share or track data and documents. Examples are apps that help users track the
     status  of  their  blood  pressure  or  blood  sugar  levels,  create  health  diaries,  or
     manage clinical data and images.</li></ul>
<!--l. 1--><p class="noindent" >
   <h3 class="sectionHead"><span class="titlemark">2.3    </span> <a 
 id="x1-130002.3"></a>Results</h3>
<!--l. 4--><p class="noindent" >
   <h4 class="subsectionHead"><span class="titlemark">2.3.1    </span> <a 
 id="x1-140002.3.1"></a>IOS Medical Apps</h4>
<!--l. 6--><p class="noindent" ><hr class="figure"><div class="figure" 
>
                                                                  

                                                                  
<a 
 id="x1-14001r1"></a>
                                                                  

                                                                  

<!--l. 8--><p class="noindent" ><img 
src="assets/market_research/apple_chart1.png" alt="PIC"  
>
<br /> <div class="caption" 
><span class="id">Figure 2.1: </span><span  
class="content">Medical Apps on the iTunes Apple Store, Search conducted on 17.05.2016</span></div><!--tex4ht:label?: x1-14001r1 -->
                                                                  

                                                                  
<!--l. 11--><p class="noindent" ></div><hr class="endfigure">
   <h4 class="subsectionHead"><span class="titlemark">2.3.2    </span> <a 
 id="x1-150002.3.2"></a>Android Medical Apps</h4>
<!--l. 16--><p class="noindent" ><hr class="figure"><div class="figure" 
>
                                                                  

                                                                  
<a 
 id="x1-15001r2"></a>
                                                                  

                                                                  

<!--l. 18--><p class="noindent" ><img 
src="assets/market_research/android_chart.png" alt="PIC"  
>
<br /> <div class="caption" 
><span class="id">Figure 2.2: </span><span  
class="content">Medical Apps on the Goolge Play Store, Search conducted on 17.05.2016</span></div><!--tex4ht:label?: x1-15001r2 -->
                                                                  

                                                                  
<!--l. 21--><p class="noindent" ></div><hr class="endfigure">
   <h4 class="subsectionHead"><span class="titlemark">2.3.3    </span> <a 
 id="x1-160002.3.3"></a>Dermatology Apps 2013 vs 2016</h4>
<!--l. 25--><p class="noindent" >Mobile apps are an especially good fit for dermatology-related care. Most dermatological
conditions are by nature visible. The initial diagnosis and follow up monitoring is mostly
done visually. A mobile device with a camera can aid patients and practitioners in the
diagnosis of a dermatological condition and tracking its development. The article Mobile
Applications in Dermatology<span class="cite"> [<a 
href="#XBrewer_2013">5</a>]</span> in 2013 identified 229 dermatology-related apps across 5
app platforms ( Android, Apple, Blackberry, Nokia, and Windows ). These were grouped into
categories based on their primary functionality. The Self-surveillance/diagnosis category
was the second largest on the Android and Apple platforms, with 13 and 24 apps
respectively.
<!--l. 27--><p class="indent" >   <hr class="figure"><div class="figure" 
>
                                                                  

                                                                  
<a 
 id="x1-16001r3"></a>
                                                                  

                                                                  

<!--l. 29--><p class="noindent" ><img 
src="assets/market_research/brewer.png" alt="PIC"  
>
<br /> <div class="caption" 
><span class="id">Figure 2.3: </span><span  
class="content">Total Applications, Brewer 2013</span></div><!--tex4ht:label?: x1-16001r3 -->
                                                                  

                                                                  
<!--l. 32--><p class="indent" >   </div><hr class="endfigure">
<!--l. 34--><p class="indent" >   Using the same search criteria and categories from the article above indicates that the
availability of dermatological apps is growing. Today there are 33 dermatological apps on the
Apple platform that can be identified as having Self-surveillance/diagnostic features. With
the exception of the Reference category, all other categories show significantly higher
numbers of available apps.
<!--l. 37--><p class="indent" >   <hr class="figure"><div class="figure" 
>
                                                                  

                                                                  
<a 
 id="x1-16002r4"></a>
                                                                  

                                                                  

<!--l. 39--><p class="noindent" ><img 
src="assets/market_research/apple2013vs2016.png" alt="PIC"  
>
<br /> <div class="caption" 
><span class="id">Figure 2.4: </span><span  
class="content">Demotological Apps by Category, July 2013(Brewer 2013) vs May 2016</span></div><!--tex4ht:label?: x1-16002r4 -->
                                                                  

                                                                  
<!--l. 42--><p class="indent" >   </div><hr class="endfigure">
<!--l. 44--><p class="indent" >   It is important to note that the categories listed above are not defined in the stores. The
apps must be manually assigned to a category based on an interpretation of the
description text in the store and information obtainable on related websites. It is possible
therefore that apps that were originally designated to the Reference category
might have been interpreted in this paper as a Educational aid app for example.
The interpretation of the functionality of an app is fuzzy in many cases, and many
apps have some crossover functionality. An app developed for self-surveillance
will often contain information pertaining to symptoms and treatment ( reference
).
   <h4 class="subsectionHead"><span class="titlemark">2.3.4    </span> <a 
 id="x1-170002.3.4"></a>Dermatological Apps with Automatic Risk Assesment</h4>
<!--l. 48--><p class="noindent" >Of the 55 apps identified belonging to the Self-surveillance/diagnosis category,
only 2 provided risk assesment features based on automatic analysis of captured
images.
<!--l. 50--><p class="noindent" >
     <ul class="itemize1">
     <li class="itemize">SkinVision : https://skinvision.com
     </li>
     <li class="itemize">mSkin                                                                                                          Doctor
     https://play.google.com/store/apps/details?id=com.maleemtaufiq.mSkinDoctor</li></ul>
                                                                  

                                                                  
   <h2 class="chapterHead"><span class="titlemark">Chapter 3</span><br /><a 
 id="x1-180003"></a>Image Data Sources</h2>
   <h3 class="sectionHead"><span class="titlemark">3.1    </span> <a 
 id="x1-190003.1"></a>Dermofit</h3>
<!--l. 3--><p class="noindent" >High quality clinical images with corresponding masks. Great for training and testing.
   <div class="table">
                                                                  

                                                                  
<!--l. 5--><p class="indent" >   <a 
 id="x1-19001r1"></a><hr class="float"><div class="float" 
>
                                                                  

                                                                  
<div class="tabular"> <table id="TBL-2" class="tabular" 
cellspacing="0" cellpadding="0" rules="groups" 
><colgroup id="TBL-2-1g"><col 
id="TBL-2-1"></colgroup><colgroup id="TBL-2-2g"><col 
id="TBL-2-2"></colgroup><colgroup id="TBL-2-3g"><col 
id="TBL-2-3"></colgroup><colgroup id="TBL-2-4g"><col 
id="TBL-2-4"></colgroup><tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-2-1-"><td  style="white-space:nowrap; text-align:left;" id="TBL-2-1-1"  
class="td11"> <span 
class="ptmr7t-x-x-90">Image Type                          </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-2-1-2"  
class="td11"> <!--l. 9--><p class="noindent" ><span 
class="ptmr7t-x-x-90">Description</span>                            </td><td  style="white-space:nowrap; text-align:left;" id="TBL-2-1-3"  
class="td11"> <span 
class="ptmr7t-x-x-90">Amount   </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-2-1-4"  
class="td11"> <!--l. 9--><p class="noindent" ><span 
class="ptmr7t-x-x-90">Comment</span>                               </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-2-2-"><td  style="white-space:nowrap; text-align:left;" id="TBL-2-2-1"  
class="td11"> <span 
class="ptmr7t-x-x-90">Actinic Keratosis                  </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-2-2-2"  
class="td11"> <!--l. 10--><p class="noindent" ><span 
class="ptmr7t-x-x-90">Pre-cancerous          patches</span>
   <span 
class="ptmr7t-x-x-90">of   flakey   or   crusty   skin,</span>
   <span 
class="ptmr7t-x-x-90">can develop into Squamous</span>
   <span 
class="ptmr7t-x-x-90">Cell Carcinoma</span>                      </td><td  style="white-space:nowrap; text-align:left;" id="TBL-2-2-3"  
class="td11"> <span 
class="ptmr7t-x-x-90">45            </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-2-2-4"  
class="td11"> <!--l. 11--><p class="noindent" ><span 
class="ptmr7t-x-x-90">Not  useful  as  comparison</span>
   <span 
class="ptmr7t-x-x-90">against melanoma</span>                  </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-2-3-"><td  style="white-space:nowrap; text-align:left;" id="TBL-2-3-1"  
class="td11"> <span 
class="ptmr7t-x-x-90">Basal Cell Carcinoma          </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-2-3-2"  
class="td11"> <!--l. 12--><p class="noindent" ><span 
class="ptmr7t-x-x-90">Abnormal,</span>
   <span 
class="ptmr7t-x-x-90">uncontrolled growths of the</span>
   <span 
class="ptmr7t-x-x-90">skins basal cells.</span>                   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-2-3-3"  
class="td11"> <span 
class="ptmr7t-x-x-90">239          </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-2-3-4"  
class="td11"> <!--l. 13--><p class="noindent" ><span 
class="ptmr7t-x-x-90">Not  useful  as  comparison</span>
   <span 
class="ptmr7t-x-x-90">against melanoma</span>                  </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-2-4-"><td  style="white-space:nowrap; text-align:left;" id="TBL-2-4-1"  
class="td11"> <span 
class="ptmr7t-x-x-90">Dermatofibroma                   </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-2-4-2"  
class="td11"> <!--l. 14--><p class="noindent" ><span 
class="ptmr7t-x-x-90">Common  and  benign  skin</span>
   <span 
class="ptmr7t-x-x-90">tumour.</span>                                   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-2-4-3"  
class="td11"> <span 
class="ptmr7t-x-x-90">65            </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-2-4-4"  
class="td11"> <!--l. 15--><p class="noindent" ><span 
class="ptmr7t-x-x-90">Useful                              as</span>
   <span 
class="ptmr7t-x-x-90">comparison,  some  extreme</span>
   <span 
class="ptmr7t-x-x-90">cases might have to be left</span>
   <span 
class="ptmr7t-x-x-90">out of the training set.</span>            </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-2-5-"><td  style="white-space:nowrap; text-align:left;" id="TBL-2-5-1"  
class="td11"> <span 
class="ptmr7t-x-x-90">Haemangioma                      </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-2-5-2"  
class="td11"> <!--l. 16--><p class="noindent" ><span 
class="ptmr7t-x-x-90">A collection of small blood</span>
   <span 
class="ptmr7t-x-x-90">vessels  that  form  a  lump</span>
   <span 
class="ptmr7t-x-x-90">under the skin.</span>                       </td><td  style="white-space:nowrap; text-align:left;" id="TBL-2-5-3"  
class="td11"> <span 
class="ptmr7t-x-x-90">97            </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-2-5-4"  
class="td11"> <!--l. 17--><p class="noindent" ><span 
class="ptmr7t-x-x-90">Useful                              as</span>
   <span 
class="ptmr7t-x-x-90">comparison,  some  extreme</span>
   <span 
class="ptmr7t-x-x-90">cases might have to be left</span>
   <span 
class="ptmr7t-x-x-90">out of the training set</span>             </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-2-6-"><td  style="white-space:nowrap; text-align:left;" id="TBL-2-6-1"  
class="td11"> <span 
class="ptmr7t-x-x-90">Intraepithelial Carcinoma     </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-2-6-2"  
class="td11"> <!--l. 18--><p class="noindent" ><span 
class="ptmr7t-x-x-90">A  type  of  squamous  cell</span>
   <span 
class="ptmr7t-x-x-90">skin  cancer  limited  to  the</span>
   <span 
class="ptmr7t-x-x-90">upper layer of the skin.</span>          </td><td  style="white-space:nowrap; text-align:left;" id="TBL-2-6-3"  
class="td11"> <span 
class="ptmr7t-x-x-90">97            </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-2-6-4"  
class="td11"> <!--l. 19--><p class="noindent" ><span 
class="ptmr7t-x-x-90">Not useful</span>                              </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-2-7-"><td  style="white-space:nowrap; text-align:left;" id="TBL-2-7-1"  
class="td11"> <span 
class="ptmr7t-x-x-90">Malignant Melanoma           </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-2-7-2"  
class="td11"> <!--l. 20--><p class="noindent" ><span 
class="ptmr7t-x-x-90">A    type    of    cancer    that</span>
   <span 
class="ptmr7t-x-x-90">develops         from         the</span>
   <span 
class="ptmr7t-x-x-90">pigment-containing      cells</span>
   <span 
class="ptmr7t-x-x-90">known as melanocytes.</span>          </td><td  style="white-space:nowrap; text-align:left;" id="TBL-2-7-3"  
class="td11"> <span 
class="ptmr7t-x-x-90">76            </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-2-7-4"  
class="td11"> <!--l. 21--><p class="noindent" ><span 
class="ptmr7t-x-x-90">This is our baseline set, half</span>
   <span 
class="ptmr7t-x-x-90">will be used for training, the</span>
   <span 
class="ptmr7t-x-x-90">other half for testing</span>              </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-2-8-"><td  style="white-space:nowrap; text-align:left;" id="TBL-2-8-1"  
class="td11"> <span 
class="ptmr7t-x-x-90">Melanocytic Nevus              </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-2-8-2"  
class="td11"> <!--l. 22--><p class="noindent" ><span 
class="ptmr7t-x-x-90">Typical mole, benign.</span>            </td><td  style="white-space:nowrap; text-align:left;" id="TBL-2-8-3"  
class="td11"> <span 
class="ptmr7t-x-x-90">331          </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-2-8-4"  
class="td11"> <!--l. 23--><p class="noindent" ><span 
class="ptmr7t-x-x-90">Very usefull as comparison</span>
   <span 
class="ptmr7t-x-x-90">to Melanoma</span>                          </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-2-9-"><td  style="white-space:nowrap; text-align:left;" id="TBL-2-9-1"  
class="td11"> <span 
class="ptmr7t-x-x-90">Pyogenic Granuloma            </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-2-9-2"  
class="td11"> <!--l. 24--><p class="noindent" ><span 
class="ptmr7t-x-x-90">Common</span>
   <span 
class="ptmr7t-x-x-90">skin  growth,  small,  round</span>
   <span 
class="ptmr7t-x-x-90">and red in color due to large</span>
   <span 
class="ptmr7t-x-x-90">number of blood vessels.</span>       </td><td  style="white-space:nowrap; text-align:left;" id="TBL-2-9-3"  
class="td11"> <span 
class="ptmr7t-x-x-90">24            </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-2-9-4"  
class="td11"> <!--l. 25--><p class="noindent" ><span 
class="ptmr7t-x-x-90">Not usefull</span>                             </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-2-10-"><td  style="white-space:nowrap; text-align:left;" id="TBL-2-10-1"  
class="td11"> <span 
class="ptmr7t-x-x-90">Seborrhoeic Keratosis          </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-2-10-2"  
class="td11"> <!--l. 26--><p class="noindent" ><span 
class="ptmr7t-x-x-90">Common      non-cancerous</span>
   <span 
class="ptmr7t-x-x-90">skin growth.</span>                           </td><td  style="white-space:nowrap; text-align:left;" id="TBL-2-10-3"  
class="td11"> <span 
class="ptmr7t-x-x-90">257          </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-2-10-4"  
class="td11"> <!--l. 27--><p class="noindent" ><span 
class="ptmr7t-x-x-90">Maybe usefull</span>                        </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-2-11-"><td  style="white-space:nowrap; text-align:left;" id="TBL-2-11-1"  
class="td11"> <span 
class="ptmr7t-x-x-90">Squamous Cell Carcinoma   </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-2-11-2"  
class="td11"> <!--l. 28--><p class="noindent" ><span 
class="ptmr7t-x-x-90">Abnormal and uncontrolled</span>
   <span 
class="ptmr7t-x-x-90">growth of squamous cells in</span>
   <span 
class="ptmr7t-x-x-90">the epidermis.</span>                        </td><td  style="white-space:nowrap; text-align:left;" id="TBL-2-11-3"  
class="td11"> <span 
class="ptmr7t-x-x-90">88            </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-2-11-4"  
class="td11"> <!--l. 29--><p class="noindent" ><span 
class="ptmr7t-x-x-90">Not usefull</span>                             </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-2-12-"><td  style="white-space:nowrap; text-align:left;" id="TBL-2-12-1"  
class="td11">                    </td></tr></table></div>
<br /><div class="caption" 
><span class="id">Table 3.1: </span><span  
class="content">Dermofit Image Categories</span></div><!--tex4ht:label?: x1-19001r1 -->
                                                                  

                                                                  
   </div><hr class="endfloat" />
   </div>
   <h3 class="sectionHead"><span class="titlemark">3.2    </span> <a 
 id="x1-200003.2"></a>DermQuest</h3>
<!--l. 40--><p class="noindent" >Online teaching and learning resource with large image database.
<!--l. 42--><p class="indent" >   Image were selected based on their usefullness for this project. Usefullness is based on
quality and type of image. Dermoscopic images were not selected. Instead images were taken
that appeared to be taken with a standard camera. The images only contained the mole to be
examined and the surrounding skin area. No other details like eyelids, ears, or dark
shadows.
<!--l. 44--><p class="indent" >   Subgroups of Melanocytic Nevus were chosen. Dysplastic and Intradermal
Nevus for the non-cancerous cases, and Malignant Melanoma as the cancerous
cases.
   <div class="table">
                                                                  

                                                                  
<!--l. 46--><p class="indent" >   <a 
 id="x1-20001r2"></a><hr class="float"><div class="float" 
>
                                                                  

                                                                  
<div class="tabular"> <table id="TBL-3" class="tabular" 
cellspacing="0" cellpadding="0" rules="groups" 
><colgroup id="TBL-3-1g"><col 
id="TBL-3-1"></colgroup><colgroup id="TBL-3-2g"><col 
id="TBL-3-2"></colgroup><colgroup id="TBL-3-3g"><col 
id="TBL-3-3"></colgroup><colgroup id="TBL-3-4g"><col 
id="TBL-3-4"></colgroup><tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-3-1-"><td  style="white-space:nowrap; text-align:left;" id="TBL-3-1-1"  
class="td11"> <span 
class="ptmr7t-x-x-90">Image Type                 </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-3-1-2"  
class="td11"> <!--l. 50--><p class="noindent" ><span 
class="ptmr7t-x-x-90">Description</span>                            </td><td  style="white-space:nowrap; text-align:left;" id="TBL-3-1-3"  
class="td11"> <span 
class="ptmr7t-x-x-90">Amount   </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-3-1-4"  
class="td11"> <!--l. 50--><p class="noindent" ><span 
class="ptmr7t-x-x-90">Comment</span>                               </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-3-2-"><td  style="white-space:nowrap; text-align:left;" id="TBL-3-2-1"  
class="td11"> <span 
class="ptmr7t-x-x-90">Benign Keratosis          </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-3-2-2"  
class="td11"> <!--l. 52--><p class="noindent" >                    </td><td  style="white-space:nowrap; text-align:left;" id="TBL-3-2-3"  
class="td11"> <span 
class="ptmr7t-x-x-90">5              </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-3-2-4"  
class="td11"> <!--l. 52--><p class="noindent" >                    </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-3-3-"><td  style="white-space:nowrap; text-align:left;" id="TBL-3-3-1"  
class="td11"> <span 
class="ptmr7t-x-x-90">Malignant Melanoma   </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-3-3-2"  
class="td11"> <!--l. 53--><p class="noindent" ><span 
class="ptmr7t-x-x-90">A    type    of    cancer    that</span>
   <span 
class="ptmr7t-x-x-90">develops         from         the</span>
   <span 
class="ptmr7t-x-x-90">pigment-containing      cells</span>
   <span 
class="ptmr7t-x-x-90">known as melanocytes.</span>          </td><td  style="white-space:nowrap; text-align:left;" id="TBL-3-3-3"  
class="td11"> <span 
class="ptmr7t-x-x-90">39            </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-3-3-4"  
class="td11"> <!--l. 54--><p class="noindent" ><span 
class="ptmr7t-x-x-90">This is our baseline set, half</span>
   <span 
class="ptmr7t-x-x-90">will be used for training, the</span>
   <span 
class="ptmr7t-x-x-90">other half for testing</span>              </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-3-4-"><td  style="white-space:nowrap; text-align:left;" id="TBL-3-4-1"  
class="td11"> <span 
class="ptmr7t-x-x-90">Melanocytic Nevus      </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-3-4-2"  
class="td11"> <!--l. 55--><p class="noindent" ><span 
class="ptmr7t-x-x-90">Typical mole, benign.</span>            </td><td  style="white-space:nowrap; text-align:left;" id="TBL-3-4-3"  
class="td11"> <span 
class="ptmr7t-x-x-90">51            </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-3-4-4"  
class="td11"> <!--l. 56--><p class="noindent" ><span 
class="ptmr7t-x-x-90">Very usefull as comparison</span>
   <span 
class="ptmr7t-x-x-90">to Melanoma</span>                          </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-3-5-"><td  style="white-space:nowrap; text-align:left;" id="TBL-3-5-1"  
class="td11">                 </td></tr></table></div>
<br /><div class="caption" 
><span class="id">Table 3.2: </span><span  
class="content">DermQuest Image Categories</span></div><!--tex4ht:label?: x1-20001r2 -->
                                                                  

                                                                  
   </div><hr class="endfloat" />
   </div>
   <h3 class="sectionHead"><span class="titlemark">3.3    </span> <a 
 id="x1-210003.3"></a>PH2Dataset</h3>
<!--l. 67--><p class="noindent" >Demascopic Images
<!--l. 69--><p class="indent" >   Many of the mole images extend almost to or even beyond the image border. This makes
some of the processing difficult. However the images include an excel spreadsheet which
clearly designates what type of mole, including some scoring info such as Asymmetry and
Color information. Includes border mask images.
   <div class="table">
                                                                  

                                                                  
<!--l. 72--><p class="indent" >   <a 
 id="x1-21001r3"></a><hr class="float"><div class="float" 
>
                                                                  

                                                                  
<div class="tabular"> <table id="TBL-4" class="tabular" 
cellspacing="0" cellpadding="0" rules="groups" 
><colgroup id="TBL-4-1g"><col 
id="TBL-4-1"></colgroup><colgroup id="TBL-4-2g"><col 
id="TBL-4-2"></colgroup><colgroup id="TBL-4-3g"><col 
id="TBL-4-3"></colgroup><colgroup id="TBL-4-4g"><col 
id="TBL-4-4"></colgroup><tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-4-1-"><td  style="white-space:nowrap; text-align:left;" id="TBL-4-1-1"  
class="td11"> <span 
class="ptmr7t-x-x-90">Image Type         </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-4-1-2"  
class="td11"> <!--l. 76--><p class="noindent" ><span 
class="ptmr7t-x-x-90">Description</span>                            </td><td  style="white-space:nowrap; text-align:left;" id="TBL-4-1-3"  
class="td11"> <span 
class="ptmr7t-x-x-90">Amount   </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-4-1-4"  
class="td11"> <!--l. 76--><p class="noindent" ><span 
class="ptmr7t-x-x-90">Comment</span>                               </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-4-2-"><td  style="white-space:nowrap; text-align:left;" id="TBL-4-2-1"  
class="td11"> <span 
class="ptmr7t-x-x-90">Common Nevus   </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-4-2-2"  
class="td11"> <!--l. 78--><p class="noindent" >                    </td><td  style="white-space:nowrap; text-align:left;" id="TBL-4-2-3"  
class="td11"> <span 
class="ptmr7t-x-x-90">79            </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-4-2-4"  
class="td11"> <!--l. 78--><p class="noindent" >                    </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-4-3-"><td  style="white-space:nowrap; text-align:left;" id="TBL-4-3-1"  
class="td11"> <span 
class="ptmr7t-x-x-90">Atypical Nevus    </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-4-3-2"  
class="td11"> <!--l. 80--><p class="noindent" >                    </td><td  style="white-space:nowrap; text-align:left;" id="TBL-4-3-3"  
class="td11"> <span 
class="ptmr7t-x-x-90">79            </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-4-3-4"  
class="td11"> <!--l. 80--><p class="noindent" >                    </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-4-4-"><td  style="white-space:nowrap; text-align:left;" id="TBL-4-4-1"  
class="td11"> <span 
class="ptmr7t-x-x-90">Melanoma            </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-4-4-2"  
class="td11"> <!--l. 82--><p class="noindent" >                    </td><td  style="white-space:nowrap; text-align:left;" id="TBL-4-4-3"  
class="td11"> <span 
class="ptmr7t-x-x-90">39            </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-4-4-4"  
class="td11"> <!--l. 82--><p class="noindent" ><span 
class="ptmr7t-x-x-90">Baseline set for training</span>         </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-4-5-"><td  style="white-space:nowrap; text-align:left;" id="TBL-4-5-1"  
class="td11">             </td></tr></table></div>
<br /><div class="caption" 
><span class="id">Table 3.3: </span><span  
class="content">PH2 Image Categories</span></div><!--tex4ht:label?: x1-21001r3 -->
                                                                  

                                                                  
   </div><hr class="endfloat" />
   </div>
                                                                  

                                                                  
   <h2 class="chapterHead"><span class="titlemark">Chapter 4</span><br /><a 
 id="x1-220004"></a>Image Feature Extraction</h2>
<!--l. 1--><p class="noindent" >A digital image is a matrix of pixels that contain color information, typically comprised of the
3 color channels red, green, and blue. A person can look at an image and quickly make
statements about its content. For instance, someone might look at an image of a street
scene and be able to easily say This is an image of a street in a town, there is one
automobile, three people and a building in this scene. A person would easily be able to
draw outlines around the objects and be able to differentiate between areas in each
object.
<!--l. 3--><p class="indent" >   For a computer to be able to make statements about the contents of an image it must use
algorithms to group together and differentiate between objects in an image. The grouping
together and differentiating of areas in an image is known as <span 
class="ptmri7t-">segmentation</span>. The statements
that a computer can make about the content of an image are usually of statistical
nature and are refered to as <span 
class="ptmri7t-">feature extraction</span>. Before segmentation an image is goes
through a <span 
class="ptmri7t-">preprocessing </span>stage in order to remove or reduce irrelevant information or
noise.
<!--l. 5--><p class="indent" >   There are no universal algorithms for preprocessing, segmentation, or feature extraction.
The algorithms employed depend on the context of the images to be analyed and the type of
information that one is looking for.
   <h3 class="sectionHead"><span class="titlemark">4.1    </span> <a 
 id="x1-230004.1"></a>Preprocessing</h3>
<!--l. 3--><p class="noindent" >
   <h4 class="subsectionHead"><span class="titlemark">4.1.1    </span> <a 
 id="x1-240004.1.1"></a>Equalization</h4>
<!--l. 4--><p class="noindent" >
   <h4 class="subsectionHead"><span class="titlemark">4.1.2    </span> <a 
 id="x1-250004.1.2"></a>Median Blur</h4>
<!--l. 5--><p class="noindent" >
   <h4 class="subsectionHead"><span class="titlemark">4.1.3    </span> <a 
 id="x1-260004.1.3"></a>Gaussian Blur</h4>
<!--l. 1--><p class="noindent" >
   <h3 class="sectionHead"><span class="titlemark">4.2    </span> <a 
 id="x1-270004.2"></a>Segmentation</h3>
<!--l. 3--><p class="noindent" >
   <h4 class="subsectionHead"><span class="titlemark">4.2.1    </span> <a 
 id="x1-280004.2.1"></a>Iterative Thresholding</h4>
                                                                  

                                                                  
<!--l. 4--><p class="noindent" >
   <h4 class="subsectionHead"><span class="titlemark">4.2.2    </span> <a 
 id="x1-290004.2.2"></a>Region Selection</h4>
<!--l. 1--><p class="noindent" >
   <h3 class="sectionHead"><span class="titlemark">4.3    </span> <a 
 id="x1-300004.3"></a>Image Feature Extraction</h3>
                                                                  

                                                                  
   <h2 class="chapterHead"><span class="titlemark">Chapter 5</span><br /><a 
 id="x1-310005"></a>TDS Algorithm</h2>
   <h3 class="sectionHead"><span class="titlemark">5.1    </span> <a 
 id="x1-320005.1"></a>Description of the Algorithm</h3>
<!--l. 3--><p class="noindent" >Early detection of melanoma greatly increases the chances of successful treatment. A biopsy
can be performed in order to gain a definitive diagnosis. However, biopsies are invasive,
painful and take time. There are also visual markers Dermatologists look for in order to make
a risk assessment. The ABCD Rule, also known as Stokes or TDS Calculation, looks
for 4 sets of features. Based on the features the Total Dermoscopy Score (TDS) is
calculated.
<!--l. 5--><p class="indent" >   The 4 sets of features are Asymmetry (A), Border Irregularity (B), Color (C) and
Differential Structure or Diameter (D).
<!--l. 7--><p class="indent" >   Asymmetry can have a value of 0, 1 or 2 depending on the symmetry of the lesion. Where
0 is symmetric and 2 is asymmetric. A value of 1 indicates at least one axis was found across
which symmetry exists. The Border score is an integer value from 0 to 8 indicating the
presence of border irregularities in 8 regions. Color is an integer value from 1 to 6 indicating
the presence of one to six specific colors. Similarly, the value for D indicates the presence of
one to five distinct structures or textures. Alternatively, in some literature<span class="cite"> [<a 
href="#XSiddiq_2015">11</a>]</span> D is defined as
Diameter, where a diameter greater than 6mm results in a value of 5, otherwise
1.
<!--l. 9--><p class="indent" >   The final TDS Score is the weighted sum of the ABCD Values and is in the range 1.0 to
8.9.
   <table 
class="equation"><tr><td>
   <center class="math-display" >
<img 
src="main0x.png" alt="T DS = A *1.3+ B *0.1+ C *0.5+ D * 0.5
" class="math-display" ><a 
 id="x1-32001r1"></a></center></td><td class="equation-label">(5.1)</td></tr></table>
<!--l. 14--><p class="nopar" >
<!--l. 16--><p class="indent" >   A diagnosis can be made based on the TDS Score according to the following
table:
   <div class="table">
                                                                  

                                                                  
<!--l. 18--><p class="indent" >   <a 
 id="x1-32002r1"></a><hr class="float"><div class="float" 
>
                                                                  

                                                                  
<div class="tabular"> <table id="TBL-5" class="tabular" 
cellspacing="0" cellpadding="0" rules="groups" 
><colgroup id="TBL-5-1g"><col 
id="TBL-5-1"></colgroup><colgroup id="TBL-5-2g"><col 
id="TBL-5-2"></colgroup><colgroup id="TBL-5-3g"><col 
id="TBL-5-3"></colgroup><colgroup id="TBL-5-4g"><col 
id="TBL-5-4"></colgroup><tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-5-1-"><td  style="white-space:nowrap; text-align:left;" id="TBL-5-1-1"  
class="td11"> <span 
class="ptmr7t-x-x-90">Evaluation   </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-5-1-2"  
class="td11"> <!--l. 23--><p class="noindent" ><span 
class="ptmr7t-x-x-90">TDS Score</span>                             </td></tr><tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-5-2-"><td  style="white-space:nowrap; text-align:left;" id="TBL-5-2-1"  
class="td11"> <span 
class="ptmr7t-x-x-90">Benign </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-5-2-2"  
class="td11"> <!--l. 24--><p class="noindent" ><span 
class="cmmi-9">&#x003C;</span><span 
class="ptmr7t-x-x-90">4.75</span></td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-5-3-"><td  style="white-space:nowrap; text-align:left;" id="TBL-5-3-1"  
class="td11"> <span 
class="ptmr7t-x-x-90">Suspicious    </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-5-3-2"  
class="td11"> <!--l. 25--><p class="noindent" ><span 
class="ptmr7t-x-x-90">4.75 to 5.45</span>                            </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-5-4-"><td  style="white-space:nowrap; text-align:left;" id="TBL-5-4-1"  
class="td11"> <span 
class="ptmr7t-x-x-90">Malignant    </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-5-4-2"  
class="td11"> <!--l. 26--><p class="noindent" ><span 
class="cmmi-9">&#x003E;</span><span 
class="ptmr7t-x-x-90">5.45</span>                                     </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-5-5-"><td  style="white-space:nowrap; text-align:left;" id="TBL-5-5-1"  
class="td11">          </td></tr></table></div>
<br /><div class="caption" 
><span class="id">Table 5.1: </span><span  
class="content">TDS Evaluation<span class="cite"> [<a 
href="#XWeigert_2012">13</a>]</span></span></div><!--tex4ht:label?: x1-32002r1 -->
                                                                  

                                                                  
   </div><hr class="endfloat" />
   </div>
   <h4 class="subsectionHead"><span class="titlemark">5.1.1    </span> <a 
 id="x1-330005.1.1"></a>Adaptation for use in a smart phone application</h4>
<!--l. 37--><p class="noindent" >The ABCD Rule, also known as the Total <span 
class="ptmbi7t-">Dermoscopy </span>Score, is really only applicable to
images captured using a dermatoscope. Especially the differential structures are
only visible on dermatoscopic images where the subsurface structures are made
visible<span class="cite"> [<a 
href="#XFernandez_Alcon_2009">3</a>]</span>.
<!--l. 39--><p class="indent" >   Since the D component is not applicable to images captured with a smart phone this
project will use a modified TDS without the D component. The original TDS formula <a 
href="#x1-32001r1">5.1<!--tex4ht:ref: eq:tds_formula --></a> can
have values ranging from 1 to 8.9 and D can be 0.5 to 2.5. Without D the TDS can have
values between 0.5 and 6.4.
   <table 
class="equation"><tr><td>
   <center class="math-display" >
<img 
src="main1x.png" alt="TDSmod  = A* 1.3 + B * 0.1 + C *0.5
" class="math-display" ><a 
 id="x1-33001r2"></a></center></td><td class="equation-label">(5.2)</td></tr></table>
<!--l. 44--><p class="nopar" >
<!--l. 46--><p class="indent" >   This results in a bening cuttoff score of 3.2 and malignagnt cuttoff of 3.7.
   <div class="table">
                                                                  

                                                                  
<!--l. 48--><p class="indent" >   <a 
 id="x1-33002r2"></a><hr class="float"><div class="float" 
>
                                                                  

                                                                  
<div class="tabular"> <table id="TBL-6" class="tabular" 
cellspacing="0" cellpadding="0" rules="groups" 
><colgroup id="TBL-6-1g"><col 
id="TBL-6-1"></colgroup><colgroup id="TBL-6-2g"><col 
id="TBL-6-2"></colgroup><colgroup id="TBL-6-3g"><col 
id="TBL-6-3"></colgroup><colgroup id="TBL-6-4g"><col 
id="TBL-6-4"></colgroup><tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-6-1-"><td  style="white-space:nowrap; text-align:left;" id="TBL-6-1-1"  
class="td11"> <span 
class="ptmr7t-x-x-90">Evaluation   </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-6-1-2"  
class="td11"> <!--l. 53--><p class="noindent" ><span 
class="ptmr7t-x-x-90">Score</span>                                      </td></tr><tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-6-2-"><td  style="white-space:nowrap; text-align:left;" id="TBL-6-2-1"  
class="td11"> <span 
class="ptmr7t-x-x-90">Benign </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-6-2-2"  
class="td11"> <!--l. 54--><p class="noindent" ><span 
class="cmmi-9">&#x003C;</span><span 
class="ptmr7t-x-x-90">3.20</span></td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-6-3-"><td  style="white-space:nowrap; text-align:left;" id="TBL-6-3-1"  
class="td11"> <span 
class="ptmr7t-x-x-90">Suspicious    </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-6-3-2"  
class="td11"> <!--l. 55--><p class="noindent" ><span 
class="ptmr7t-x-x-90">3.20 to 3.7</span>                              </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-6-4-"><td  style="white-space:nowrap; text-align:left;" id="TBL-6-4-1"  
class="td11"> <span 
class="ptmr7t-x-x-90">Malignant    </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-6-4-2"  
class="td11"> <!--l. 56--><p class="noindent" ><span 
class="cmmi-9">&#x003E;</span><span 
class="ptmr7t-x-x-90">3.7</span>                                       </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-6-5-"><td  style="white-space:nowrap; text-align:left;" id="TBL-6-5-1"  
class="td11">          </td></tr></table></div>
<br /><div class="caption" 
><span class="id">Table 5.2: </span><span  
class="content">Adapted TDS Evaluation</span></div><!--tex4ht:label?: x1-33002r2 -->
                                                                  

                                                                  
   </div><hr class="endfloat" />
   </div>
   <h3 class="sectionHead"><span class="titlemark">5.2    </span> <a 
 id="x1-340005.2"></a>Automatic Calculation of ABCD Values</h3>
<!--l. 68--><p class="noindent" >The ABCD Rule is used by Dermatologists to differentiate benign from malignant
melanocytic tumors. It is a clearly defined rule based on easily recognizable visual features.
Clinicians with limited dermoscopy experience achieve better results using the ABCD rule
than other methods <span class="cite"> [<a 
href="#XWeigert_2012">13</a>]</span>. The following sections detail methods to automate the calculation
of the ABCD scores.
<!--l. 70--><p class="noindent" >
   <h4 class="subsectionHead"><span class="titlemark">5.2.1    </span> <a 
 id="x1-350005.2.1"></a>Asymmetry</h4>
<!--l. 1--><p class="noindent" >The Center of mass method of measuring asymmetry is relatively easy to calculate and is
more accurate compared to other complex algorithms <span class="cite"> [<a 
href="#XPremaladha_2014">9</a>]</span>.
<!--l. 3--><p class="indent" >   This algorithm begins by calculating an array of radii from the lesions center of mass to
border for each of 360 degrees. The coordinates for the center of mass are calculated from the
sum of all x and y coordinates of pixels within the lesions border each divided by the sum of
pixels.
<!--l. 5--><p class="indent" >   For each of the 360 radii <span 
class="cmmi-10">r</span><sub><span 
class="cmmi-7">i</span></sub> a score is calculated by comparing the lengths of pairs of radii
that are symmetric across <span 
class="cmmi-10">r</span><sub><span 
class="cmmi-7">i</span></sub>. If the lengths of the pair of symmetric radii have a difference of
less than 10% then a point is given. The sum of points is the <span 
class="cmmi-10">SFA</span><sub><span 
class="cmmi-7">i</span></sub> (Score For Axis) for
<span 
class="cmmi-10">r</span><sub><span 
class="cmmi-7">i</span></sub>.
<!--l. 7--><p class="indent" >   <hr class="figure"><div class="figure" 
>
                                                                  

                                                                  
<a 
 id="x1-35001r1"></a>
                                                                  

                                                                  
<!--l. 9--><p class="noindent" ><img 
src="main2x.png" alt="PIC" class="graphics"><!--tex4ht:graphics  
name="main2x.png" src="assets/assymertry/asymmetry_01.pdf"  
-->
<br /> <div class="caption" 
><span class="id">Figure 5.1: </span><span  
class="content">Calculate SFA for <span 
class="cmmi-10">r</span><sub><span 
class="cmmi-7">i</span></sub></span></div><!--tex4ht:label?: x1-35001r1 -->
                                                                  

                                                                  
<!--l. 12--><p class="indent" >   </div><hr class="endfigure">
<!--l. 15--><p class="indent" >   The radius with the maximum SFA score is defined as the major axis of symmetry. The
SFA of the major axis as well as the perpendicular are stored. The Asymmetry score is
evaluated as follows:
   <div class="table">
                                                                  

                                                                  
<!--l. 18--><p class="indent" >   <a 
 id="x1-35002r3"></a><hr class="float"><div class="float" 
>
                                                                  

                                                                  
<div class="tabular"> <table id="TBL-7" class="tabular" 
cellspacing="0" cellpadding="0" rules="groups" 
><colgroup id="TBL-7-1g"><col 
id="TBL-7-1"></colgroup><colgroup id="TBL-7-2g"><col 
id="TBL-7-2"></colgroup><colgroup id="TBL-7-3g"><col 
id="TBL-7-3"></colgroup><colgroup id="TBL-7-4g"><col 
id="TBL-7-4"></colgroup><tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-7-1-"><td  style="white-space:nowrap; text-align:left;" id="TBL-7-1-1"  
class="td11"> <span 
class="ptmr7t-x-x-90">SFA Results                                                                                                                                       </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-7-1-2"  
class="td11"> <!--l. 23--><p class="noindent" ><span 
class="ptmr7t-x-x-90">Description</span>                            </td><td  style="white-space:nowrap; text-align:left;" id="TBL-7-1-3"  
class="td11"> <span 
class="ptmr7t-x-x-90">Asymmetry Score   </span></td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-7-2-"><td  style="white-space:nowrap; text-align:left;" id="TBL-7-2-1"  
class="td11"> <!--tex4ht:inline--><div class="tabular"><table id="TBL-8" class="tabular" 
cellspacing="0" cellpadding="0"  
><colgroup id="TBL-8-1g"><col 
id="TBL-8-1"></colgroup><tr  
 style="vertical-align:baseline;" id="TBL-8-1-"><td  style="white-space:nowrap; text-align:center;" id="TBL-8-1-1"  
class="td00"><span 
class="ptmr7t-x-x-90">major axis </span><span 
class="cmsy-9"><font face="Symbol">³</font> </span><span 
class="ptmr7t-x-x-90">140</span></td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-8-2-"><td  style="white-space:nowrap; text-align:center;" id="TBL-8-2-1"  
class="td00"><span 
class="ptmr7t-x-x-90">minor axis </span><span 
class="cmsy-9"><font face="Symbol">³</font> </span><span 
class="ptmr7t-x-x-90">140</span></td></tr></table>                                                                                                                        </div>   </td><td  style="white-space:wrap; text-align:left;" id="TBL-7-2-2"  
class="td11"> <!--l. 24--><p class="noindent" ><span 
class="ptmr7t-x-x-90">Symmetric across both axis</span>   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-7-2-3"  
class="td11"> <span 
class="ptmr7t-x-x-90">0                              </span></td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-7-3-"><td  style="white-space:nowrap; text-align:left;" id="TBL-7-3-1"  
class="td11"> <!--tex4ht:inline--><div class="tabular"><table id="TBL-9" class="tabular" 
cellspacing="0" cellpadding="0"  
><colgroup id="TBL-9-1g"><col 
id="TBL-9-1"></colgroup><tr  
 style="vertical-align:baseline;" id="TBL-9-1-"><td  style="white-space:nowrap; text-align:center;" id="TBL-9-1-1"  
class="td00"><span 
class="ptmr7t-x-x-90">major axis </span><span 
class="cmsy-9"><font face="Symbol">³</font> </span><span 
class="ptmr7t-x-x-90">140</span></td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-9-2-"><td  style="white-space:nowrap; text-align:center;" id="TBL-9-2-1"  
class="td00"><span 
class="ptmr7t-x-x-90">minor axis</span> <span 
class="cmmi-9">&#x003C;</span> <span 
class="ptmr7t-x-x-90">140</span></td></tr></table>                                                                                                                        </div>   </td><td  style="white-space:wrap; text-align:left;" id="TBL-7-3-2"  
class="td11"> <!--l. 25--><p class="noindent" ><span 
class="ptmr7t-x-x-90">Symmetric across one axis</span>    </td><td  style="white-space:nowrap; text-align:left;" id="TBL-7-3-3"  
class="td11"> <span 
class="ptmr7t-x-x-90">1                              </span></td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-7-4-"><td  style="white-space:nowrap; text-align:left;" id="TBL-7-4-1"  
class="td11"> <!--tex4ht:inline--><div class="tabular"><table id="TBL-10" class="tabular" 
cellspacing="0" cellpadding="0"  
><colgroup id="TBL-10-1g"><col 
id="TBL-10-1"></colgroup><tr  
 style="vertical-align:baseline;" id="TBL-10-1-"><td  style="white-space:nowrap; text-align:center;" id="TBL-10-1-1"  
class="td00"><span 
class="ptmr7t-x-x-90">major axis </span><span 
class="cmmi-9">&#x003C;</span><span 
class="ptmr7t-x-x-90">140</span></td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-10-2-"><td  style="white-space:nowrap; text-align:center;" id="TBL-10-2-1"  
class="td00"><span 
class="ptmr7t-x-x-90">minor axis </span><span 
class="cmmi-9">&#x003C;</span><span 
class="ptmr7t-x-x-90">140</span></td></tr></table>                                                                                                                         </div>   </td><td  style="white-space:wrap; text-align:left;" id="TBL-7-4-2"  
class="td11"> <!--l. 26--><p class="noindent" ><span 
class="ptmr7t-x-x-90">Asymmetric</span>                           </td><td  style="white-space:nowrap; text-align:left;" id="TBL-7-4-3"  
class="td11"> <span 
class="ptmr7t-x-x-90">2                              </span></td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-7-5-"><td  style="white-space:nowrap; text-align:left;" id="TBL-7-5-1"  
class="td11">                                                                  </td></tr></table>
</div>
<br /><div class="caption" 
><span class="id">Table 5.3: </span><span  
class="content">TDS Evaluation<span class="cite"> [<a 
href="#XWeigert_2012">13</a>]</span></span></div><!--tex4ht:label?: x1-35002r3 -->
                                                                  

                                                                  
   </div><hr class="endfloat" />
   </div>
   <h4 class="subsectionHead"><span class="titlemark">5.2.2    </span> <a 
 id="x1-360005.2.2"></a>Border</h4>
<!--l. 1--><p class="noindent" >An image is generated where only the pixels at the border or the lesion are visible, the rest of
the image is black. The pixels are gathered sequentially into an array starting at any arbitrary
border pixel and traversing the border continually. Its important that the sequential order of
the pixels be maintained since the change in angle and distance to the lesions center will be
measured.
<!--l. 3--><p class="indent" >   <hr class="figure"><div class="figure" 
>
                                                                  

                                                                  
<a 
 id="x1-36001r2"></a>
                                                                  

                                                                  
<!--l. 5--><p class="noindent" ><img 
src="main3x.png" alt="PIC" class="graphics"><!--tex4ht:graphics  
name="main3x.png" src="assets/border/travers_grid.pdf"  
-->
<br /> <div class="caption" 
><span class="id">Figure 5.2: </span><span  
class="content">Traverse the border sequentially</span></div><!--tex4ht:label?: x1-36001r2 -->
                                                                  

                                                                  
<!--l. 8--><p class="indent" >   </div><hr class="endfigure">
<!--l. 10--><p class="indent" >   An algorithm was developed that finds an arbitrary border pixel in an image that is
otherwise black by iterating though pixels starting at the top left corner. When it has found a
pixel that is not black it tests neighboring pixels, starting with the upper left neighbor
and traversing the pixels row by row starting from the left most pixel in a row, as
illustrated by the numbered pixels in figure <a 
href="#x1-36001r2">5.2<!--tex4ht:ref: fig:tra_border --></a>. The center pixel, pixel number 5, is
skipped.
<!--l. 12--><p class="indent" >   When a non black pixel is detected it is compared to a a list or previously detected pixels.
If it has not been previously detected, it is added to the list and becomes the new center. The
algorithm is repeated.
<!--l. 14--><p class="indent" >   If no new non-black pixel is detected the outter range is expanded by one pixel at each
edge and the pixels at the edge of a 5 x 5 area are tested. This is repeated until a new pixel is
found. This prevents the algorithm from halting if there are discontinuities in the
border.
<!--l. 16--><p class="indent" >   When the algorithm reaches the starting pixels it ends. The list of pixels now contains a
sequential list of pixels that are in sequential order.
<!--l. 18--><p class="indent" >   For each pixel the distance and angle from the lesions center of mass is calculated. If a
lesions border is irregular the measure of distance and angle from the center will
be erratic, whereas is the border is relatively circular and smooth the measure of
distance and the difference in angle will not change abruptly between neighboring
pixels.
<!--l. 20--><p class="indent" >   The distance function is averaged around the distance of the start pixel (set to zero) in
order to reduce discontinueities. A gaussian lowpass filter is used to reduce noise and aliasing
artifacts due to pixelization.
<!--l. 22--><p class="indent" >   From the smoothed distance function the first derivative is calucalated. From the angle
function the difference from neighboring pixels is calculated. The resulting two functions are
split into 8 equal segments. Each segment is analysed for strong variations in distance and
sign changes in the difference of the angles. A sign change would indicate a very strong
change in direction of the border function. For each segment in which strong variations are
detected a point in the B score is added.
<!--l. 24--><p class="indent" >   A lesion with strong variations in one segment, but otherwise smooth border function
would have a B score of 1, whereas a lesion with variation is each of the 8 segments would
have a B score of 8.
<!--l. 26--><p class="indent" >   <hr class="figure"><div class="figure" 
>
                                                                  

                                                                  
<a 
 id="x1-36002r3"></a>
                                                                  

                                                                  

<!--l. 27--><p class="noindent" ><img 
src="assets/border/examples/border_0/border.png" alt="PIC"  
> <img 
src="assets/border/examples/border_0/figure_1.png" alt="PIC"  
>
<br /> <div class="caption" 
><span class="id">Figure 5.3: </span><span  
class="content">Example of border score 0</span></div><!--tex4ht:label?: x1-36002r3 -->
                                                                  

                                                                  
<!--l. 31--><p class="indent" >   </div><hr class="endfigure">
<!--l. 32--><p class="indent" >   <hr class="figure"><div class="figure" 
>
                                                                  

                                                                  
<a 
 id="x1-36003r4"></a>
                                                                  

                                                                  

<!--l. 33--><p class="noindent" ><img 
src="assets/border/examples/border_4/border.png" alt="PIC"  
> <img 
src="assets/border/examples/border_4/figure_1.png" alt="PIC"  
>
<br /> <div class="caption" 
><span class="id">Figure 5.4: </span><span  
class="content">Example of border score 4</span></div><!--tex4ht:label?: x1-36003r4 -->
                                                                  

                                                                  
<!--l. 37--><p class="indent" >   </div><hr class="endfigure">
<!--l. 38--><p class="indent" >   <hr class="figure"><div class="figure" 
>
                                                                  

                                                                  
<a 
 id="x1-36004r5"></a>
                                                                  

                                                                  

<!--l. 39--><p class="noindent" ><img 
src="assets/border/examples/border_8/border.png" alt="PIC"  
> <img 
src="assets/border/examples/border_8/figure_1.png" alt="PIC"  
>
<br /> <div class="caption" 
><span class="id">Figure 5.5: </span><span  
class="content">Example of border score 8</span></div><!--tex4ht:label?: x1-36004r5 -->
                                                                  

                                                                  
<!--l. 43--><p class="indent" >   </div><hr class="endfigure">
   <h4 class="subsectionHead"><span class="titlemark">5.2.3    </span> <a 
 id="x1-370005.2.3"></a>Color</h4>
<!--l. 1--><p class="noindent" >In order to calculate the color score the <span 
class="ptmri7t-">Quantification of Color</span><span class="cite"> [<a 
href="#XFernandez_Alcon_2009">3</a>]</span> algorithm was
implemented in which the distance of each pixel to a defined set of colors is evaluated.
<!--l. 3--><p class="indent" >   The original image is first filtered using a low pass Gaussian filter in order to reduce
noise. Then for for each pixel with the lesion area the euclidean distance from 6 RGB values
is calculated. The 6 RGB values, as shown in table <a 
href="#x1-37001r4">5.4<!--tex4ht:ref: fig:tds_color --></a>, represent the colors that are relevent
to the TDS calculation.
   <div class="table">
                                                                  

                                                                  
<!--l. 5--><p class="indent" >   <a 
 id="x1-37001r4"></a><hr class="float"><div class="float" 
>
                                                                  

                                                                  
<div class="tabular"> <table id="TBL-11" class="tabular" 
cellspacing="0" cellpadding="0" rules="groups" 
><colgroup id="TBL-11-1g"><col 
id="TBL-11-1"></colgroup><colgroup id="TBL-11-2g"><col 
id="TBL-11-2"></colgroup><colgroup id="TBL-11-3g"><col 
id="TBL-11-3"></colgroup><colgroup id="TBL-11-4g"><col 
id="TBL-11-4"></colgroup><tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-11-1-"><td  style="white-space:nowrap; text-align:left;" id="TBL-11-1-1"  
class="td11"> <span 
class="ptmr7t-x-x-90">Color             </span></td><td  style="white-space:nowrap; text-align:left;" id="TBL-11-1-2"  
class="td11"> <span 
class="ptmr7t-x-x-90">R      </span></td><td  style="white-space:nowrap; text-align:left;" id="TBL-11-1-3"  
class="td11"> <span 
class="ptmr7t-x-x-90">G      </span></td><td  style="white-space:nowrap; text-align:left;" id="TBL-11-1-4"  
class="td11"> <span 
class="ptmr7t-x-x-90">B      </span></td></tr><tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-11-2-"><td  style="white-space:nowrap; text-align:left;" id="TBL-11-2-1"  
class="td11"> <span 
class="ptmr7t-x-x-90">White </span></td><td  style="white-space:nowrap; text-align:left;" id="TBL-11-2-2"  
class="td11"> <span 
class="ptmr7t-x-x-90">255 </span></td><td  style="white-space:nowrap; text-align:left;" id="TBL-11-2-3"  
class="td11"> <span 
class="ptmr7t-x-x-90">255 </span></td><td  style="white-space:nowrap; text-align:left;" id="TBL-11-2-4"  
class="td11"> <span 
class="ptmr7t-x-x-90">255</span></td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-11-3-"><td  style="white-space:nowrap; text-align:left;" id="TBL-11-3-1"  
class="td11"> <span 
class="ptmr7t-x-x-90">Red                 </span></td><td  style="white-space:nowrap; text-align:left;" id="TBL-11-3-2"  
class="td11"> <span 
class="ptmr7t-x-x-90">204   </span></td><td  style="white-space:nowrap; text-align:left;" id="TBL-11-3-3"  
class="td11"> <span 
class="ptmr7t-x-x-90">51     </span></td><td  style="white-space:nowrap; text-align:left;" id="TBL-11-3-4"  
class="td11"> <span 
class="ptmr7t-x-x-90">51     </span></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-11-4-"><td  style="white-space:nowrap; text-align:left;" id="TBL-11-4-1"  
class="td11"> <span 
class="ptmr7t-x-x-90">Light Brown </span></td><td  style="white-space:nowrap; text-align:left;" id="TBL-11-4-2"  
class="td11"> <span 
class="ptmr7t-x-x-90">153 </span></td><td  style="white-space:nowrap; text-align:left;" id="TBL-11-4-3"  
class="td11"> <span 
class="ptmr7t-x-x-90">102 </span></td><td  style="white-space:nowrap; text-align:left;" id="TBL-11-4-4"  
class="td11"> <span 
class="ptmr7t-x-x-90">0</span></td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-11-5-"><td  style="white-space:nowrap; text-align:left;" id="TBL-11-5-1"  
class="td11"> <span 
class="ptmr7t-x-x-90">Dark Brown   </span></td><td  style="white-space:nowrap; text-align:left;" id="TBL-11-5-2"  
class="td11"> <span 
class="ptmr7t-x-x-90">51     </span></td><td  style="white-space:nowrap; text-align:left;" id="TBL-11-5-3"  
class="td11"> <span 
class="ptmr7t-x-x-90">0       </span></td><td  style="white-space:nowrap; text-align:left;" id="TBL-11-5-4"  
class="td11"> <span 
class="ptmr7t-x-x-90">0       </span></td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-11-6-"><td  style="white-space:nowrap; text-align:left;" id="TBL-11-6-1"  
class="td11"> <span 
class="ptmr7t-x-x-90">Blue Gray       </span></td><td  style="white-space:nowrap; text-align:left;" id="TBL-11-6-2"  
class="td11"> <span 
class="ptmr7t-x-x-90">51     </span></td><td  style="white-space:nowrap; text-align:left;" id="TBL-11-6-3"  
class="td11"> <span 
class="ptmr7t-x-x-90">153   </span></td><td  style="white-space:nowrap; text-align:left;" id="TBL-11-6-4"  
class="td11"> <span 
class="ptmr7t-x-x-90">255   </span></td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-11-7-"><td  style="white-space:nowrap; text-align:left;" id="TBL-11-7-1"  
class="td11"> <span 
class="ptmr7t-x-x-90">Black              </span></td><td  style="white-space:nowrap; text-align:left;" id="TBL-11-7-2"  
class="td11"> <span 
class="ptmr7t-x-x-90">0       </span></td><td  style="white-space:nowrap; text-align:left;" id="TBL-11-7-3"  
class="td11"> <span 
class="ptmr7t-x-x-90">0       </span></td><td  style="white-space:nowrap; text-align:left;" id="TBL-11-7-4"  
class="td11"> <span 
class="ptmr7t-x-x-90">0       </span></td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-11-8-"><td  style="white-space:nowrap; text-align:left;" id="TBL-11-8-1"  
class="td11">           </td></tr></table></div>
<br /><div class="caption" 
><span class="id">Table 5.4: </span><span  
class="content">RGB values of the six possible TDS-relevent colors<span class="cite"> [<a 
href="#XFernandez_Alcon_2009">3</a>]</span></span></div><!--tex4ht:label?: x1-37001r4 -->
                                                                  

                                                                  
   </div><hr class="endfloat" />
   </div>
<!--l. 25--><p class="indent" >   For each color a counter is incremented when a pixel is found that is closest to
it. The end results are divided by the total number of pixels within the lesions
boundaries. For each color with a value greater than 0.01 a point is given to the TDS C
score.
<!--l. 27--><p class="indent" >   <hr class="figure"><div class="figure" 
>
                                                                  

                                                                  
<a 
 id="x1-37002r6"></a>
                                                                  

                                                                  

<!--l. 28--><p class="noindent" ><img 
src="assets/color/examples/color_1.png" alt="PIC"  
>
<br /> <div class="caption" 
><span class="id">Figure 5.6: </span><span  
class="content">Example of color score 1</span></div><!--tex4ht:label?: x1-37002r6 -->
                                                                  

                                                                  
<!--l. 31--><p class="indent" >   </div><hr class="endfigure">
<!--l. 32--><p class="indent" >   <hr class="figure"><div class="figure" 
>
                                                                  

                                                                  
<a 
 id="x1-37003r7"></a>
                                                                  

                                                                  

<!--l. 33--><p class="noindent" ><img 
src="assets/color/examples/color_3.png" alt="PIC"  
>
<br /> <div class="caption" 
><span class="id">Figure 5.7: </span><span  
class="content">Example of color score 3</span></div><!--tex4ht:label?: x1-37003r7 -->
                                                                  

                                                                  
<!--l. 36--><p class="indent" >   </div><hr class="endfigure">
<!--l. 37--><p class="indent" >   <hr class="figure"><div class="figure" 
>
                                                                  

                                                                  
<a 
 id="x1-37004r8"></a>
                                                                  

                                                                  

<!--l. 38--><p class="noindent" ><img 
src="assets/color/examples/color_4.png" alt="PIC"  
>
<br /> <div class="caption" 
><span class="id">Figure 5.8: </span><span  
class="content">Example of color score 4</span></div><!--tex4ht:label?: x1-37004r8 -->
                                                                  

                                                                  
<!--l. 41--><p class="indent" >   </div><hr class="endfigure">
   <h4 class="subsectionHead"><span class="titlemark">5.2.4    </span> <a 
 id="x1-380005.2.4"></a>Differential</h4>
<!--l. 81--><p class="noindent" >
   <h3 class="sectionHead"><span class="titlemark">5.3    </span> <a 
 id="x1-390005.3"></a>Two Examples</h3>
<!--l. 82--><p class="noindent" >
   <h4 class="subsectionHead"><span class="titlemark">5.3.1    </span> <a 
 id="x1-400005.3.1"></a>Postitiv Example</h4>
<!--l. 84--><p class="noindent" >
   <h4 class="subsectionHead"><span class="titlemark">5.3.2    </span> <a 
 id="x1-410005.3.2"></a>False Example</h4>
<!--l. 86--><p class="noindent" >TDS Values were calculated but classification result was false.
<!--l. 88--><p class="noindent" >
   <h3 class="sectionHead"><span class="titlemark">5.4    </span> <a 
 id="x1-420005.4"></a>Results of Algorithm</h3>
<a 
 id="x1-42001r5"></a>
   <!--l. 3--><div class="longtable"> <table id="TBL-12" class="longtable" 
cellspacing="0" cellpadding="0" rules="groups" 
><colgroup id="TBL-12-1g"><col 
id="TBL-12-1"></colgroup><colgroup id="TBL-12-2g"><col 
id="TBL-12-2"></colgroup><colgroup id="TBL-12-3g"><col 
id="TBL-12-3"></colgroup><colgroup id="TBL-12-4g"><col 
id="TBL-12-4"></colgroup><colgroup id="TBL-12-5g"><col 
id="TBL-12-5"></colgroup>
<tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-12-1-"><td  style="white-space:nowrap; text-align:left;" id="TBL-12-1-1"  
class="td11"> Source         </td><td  style="white-space:nowrap; text-align:left;" id="TBL-12-1-2"  
class="td11"> False Positives  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-12-1-3"  
class="td11"> False Negatives  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-12-1-4"  
class="td11"> Correct  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-12-1-5"  
class="td11"> Total  </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-12-2-"><td  style="white-space:nowrap; text-align:left;" id="TBL-12-2-1"  
class="td11"> Dermofit      </td><td  style="white-space:nowrap; text-align:left;" id="TBL-12-2-2"  
class="td11"> 10                      </td><td  style="white-space:nowrap; text-align:left;" id="TBL-12-2-3"  
class="td11"> 8                          </td><td  style="white-space:nowrap; text-align:left;" id="TBL-12-2-4"  
class="td11"> 115        </td><td  style="white-space:nowrap; text-align:left;" id="TBL-12-2-5"  
class="td11"> 133     </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-12-3-"><td  style="white-space:nowrap; text-align:left;" id="TBL-12-3-1"  
class="td11"> Dermquest  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-12-3-2"  
class="td11"> 10                      </td><td  style="white-space:nowrap; text-align:left;" id="TBL-12-3-3"  
class="td11"> 4                          </td><td  style="white-space:nowrap; text-align:left;" id="TBL-12-3-4"  
class="td11"> 32          </td><td  style="white-space:nowrap; text-align:left;" id="TBL-12-3-5"  
class="td11"> 46       </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-12-4-"><td  style="white-space:nowrap; text-align:left;" id="TBL-12-4-1"  
class="td11"> PH2             </td><td  style="white-space:nowrap; text-align:left;" id="TBL-12-4-2"  
class="td11"> 13                      </td><td  style="white-space:nowrap; text-align:left;" id="TBL-12-4-3"  
class="td11"> 0                          </td><td  style="white-space:nowrap; text-align:left;" id="TBL-12-4-4"  
class="td11"> 29          </td><td  style="white-space:nowrap; text-align:left;" id="TBL-12-4-5"  
class="td11"> 42       </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-12-5-"><td colspan="5" style="white-space:nowrap; text-align:center;" id="TBL-12-5-1"  
class="td11">   <div class="multicolumn"  style="white-space:nowrap; text-align:center;"><div class="caption" 
><span class="id">Table 5.5: </span><span  
class="content">Results of TDS calculation</span></div><!--tex4ht:label?: x1-42001r5 -->                                                      </div>       <a 
 id="x1-42002"></a>
</td></tr><tr  
 style="vertical-align:baseline;" id="TBL-12-6-"><td  style="white-space:nowrap; text-align:left;" id="TBL-12-6-1"  
class="td11">         </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-12-7-"><td  style="white-space:nowrap; text-align:left;" id="TBL-12-7-1"  
class="td11">         </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-12-8-"><td  style="white-space:nowrap; text-align:left;" id="TBL-12-8-1"  
class="td11">         </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-12-9-"><td  style="white-space:nowrap; text-align:left;" id="TBL-12-9-1"  
class="td11">           </td><td  style="white-space:nowrap; text-align:left;" id="TBL-12-9-2"  
class="td11">              </td><td  style="white-space:nowrap; text-align:left;" id="TBL-12-9-3"  
class="td11">              </td><td  style="white-space:nowrap; text-align:left;" id="TBL-12-9-4"  
class="td11">        </td><td  style="white-space:nowrap; text-align:left;" id="TBL-12-9-5"  
class="td11"></td></tr>
   </table></div>
<a 
 id="x1-42003r6"></a>
   <!--l. 13--><div class="longtable"><table id="TBL-13" class="longtable" 
cellspacing="0" cellpadding="0" rules="groups" 
><colgroup id="TBL-13-1g"><col 
id="TBL-13-1"></colgroup><colgroup id="TBL-13-2g"><col 
id="TBL-13-2"></colgroup><colgroup id="TBL-13-3g"><col 
id="TBL-13-3"></colgroup><colgroup id="TBL-13-4g"><col 
id="TBL-13-4"></colgroup>
<tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-13-1-"><td  style="white-space:nowrap; text-align:left;" id="TBL-13-1-1"  
class="td11"> Source         </td><td  style="white-space:nowrap; text-align:left;" id="TBL-13-1-2"  
class="td11"> Malignagt  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-13-1-3"  
class="td11"> Malignant Correct  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-13-1-4"  
class="td11"> Total                   </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-13-2-"><td  style="white-space:nowrap; text-align:left;" id="TBL-13-2-1"  
class="td11"> Dermofit      </td><td  style="white-space:nowrap; text-align:left;" id="TBL-13-2-2"  
class="td11"> 16               </td><td  style="white-space:nowrap; text-align:left;" id="TBL-13-2-3"  
class="td11"> 8                              </td><td  style="white-space:nowrap; text-align:left;" id="TBL-13-2-4"  
class="td11"> 133                     </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-13-3-"><td  style="white-space:nowrap; text-align:left;" id="TBL-13-3-1"  
class="td11"> Dermquest  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-13-3-2"  
class="td11"> 16               </td><td  style="white-space:nowrap; text-align:left;" id="TBL-13-3-3"  
class="td11"> 12                            </td><td  style="white-space:nowrap; text-align:left;" id="TBL-13-3-4"  
class="td11"> 46                       </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-13-4-"><td  style="white-space:nowrap; text-align:left;" id="TBL-13-4-1"  
class="td11"> PH2             </td><td  style="white-space:nowrap; text-align:left;" id="TBL-13-4-2"  
class="td11"> 0                 </td><td  style="white-space:nowrap; text-align:left;" id="TBL-13-4-3"  
class="td11"> 0                              </td><td  style="white-space:nowrap; text-align:left;" id="TBL-13-4-4"  
class="td11"> 42                       </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-13-5-"><td colspan="4" style="white-space:nowrap; text-align:center;" id="TBL-13-5-1"  
class="td11"> <div class="multicolumn"  style="white-space:nowrap; text-align:center;"><div class="caption" 
><span class="id">Table 5.6: </span><span  
class="content">Correctly Diagnosed Malignant Melanoma Images</span></div><!--tex4ht:label?: x1-42003r6 -->               </div>  <a 
 id="x1-42004"></a>
</td></tr><tr  
 style="vertical-align:baseline;" id="TBL-13-6-"><td  style="white-space:nowrap; text-align:left;" id="TBL-13-6-1"  
class="td11">         </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-13-7-"><td  style="white-space:nowrap; text-align:left;" id="TBL-13-7-1"  
class="td11">         </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-13-8-"><td  style="white-space:nowrap; text-align:left;" id="TBL-13-8-1"  
class="td11">         </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-13-9-"><td  style="white-space:nowrap; text-align:left;" id="TBL-13-9-1"  
class="td11">           </td><td  style="white-space:nowrap; text-align:left;" id="TBL-13-9-2"  
class="td11">          </td><td  style="white-space:nowrap; text-align:left;" id="TBL-13-9-3"  
class="td11">                </td><td  style="white-space:nowrap; text-align:left;" id="TBL-13-9-4"  
class="td11"></td></tr>
                                                                  

                                                                  
   </table></div>
<!--l. 92--><p class="noindent" >
   <h3 class="sectionHead"><span class="titlemark">5.5    </span> <a 
 id="x1-430005.5"></a>Performance Evaluation</h3>
<!--l. 94--><p class="noindent" >Chapters 11.1, 11.2, maybe 11.3
                                                                  

                                                                  
   <h2 class="chapterHead"><span class="titlemark">Chapter 6</span><br /><a 
 id="x1-440006"></a>Machine Learning</h2>
   <h3 class="sectionHead"><span class="titlemark">6.1    </span> <a 
 id="x1-450006.1"></a>Section Title</h3>
<!--l. 2--><p class="noindent" >
   <h3 class="sectionHead"><span class="titlemark">6.2    </span> <a 
 id="x1-460006.2"></a>Results of Algorithm</h3>
<!--l. 4--><p class="noindent" >Performance Evaluation
<!--l. 6--><p class="indent" >   Chapters from book 11.1, 11.2, 11.3, 11.5, 11.6
                                                                  

                                                                  
   <h2 class="chapterHead"><span class="titlemark">Chapter 7</span><br /><a 
 id="x1-470007"></a>Implementaion of the Algorithm</h2>
   <h3 class="sectionHead"><span class="titlemark">7.1    </span> <a 
 id="x1-480007.1"></a>Section Title</h3>
                                                                  

                                                                  
   <h2 class="chapterHead"><span class="titlemark">Chapter 8</span><br /><a 
 id="x1-490008"></a>Requirements</h2>
<!--l. 1--><p class="noindent" >In section 2.2.1 categories of medical smart phone apps were defined. Apps in the same
categories might have a similar feature set and capabilities. An app in the <span 
class="ptmri7t-">Alert / First</span>
<span 
class="ptmri7t-">Response </span>category might have a database that stores important contacts in the users area and
a user interface that allows the user to quickly alert a contact in an emergency situation. An
app in the <span 
class="ptmri7t-">Learning / Educational / Reference </span>category might be modelled as a quiz app
which presents the user with a question and several possible answers to choose from.
Answers from several questions will can be evaluated and a score is presented to the user at
the end of a session. The app would be implemented with a database of questions and
weighted answers, as well as an interface that presents the questions to the user
sequentially.
<!--l. 3--><p class="indent" >   One of the goals of this project is to define requirements for an app that provides a risk
assessment of a lesion being benign or malignant. A high level description of the primary
function of the app is the following:
     <ul class="itemize1">
     <li class="itemize">The smart phone app allows the user to capture and analyse an image of a skin
     lesion and provide a risk assessment to the user of the lesion being a malignant
     melanoma.
     </li></ul>
<!--l. 10--><p class="indent" >   The user might also like to save the image and results in oder to be able to compare it with
other assessments in the future, or to review the assessment with a dermatologist. For
comparison it might be useful to save associated metadata, such as the date and location on
the body of the lesion. For convenience it might be nice to send the assessment and image
via email to a specialist for review. Secondary functionality can be described as
follows:
     <ul class="itemize1">
     <li class="itemize">The  app  allows  the  user  to  save  or  archive  the  image  and  corresponding
     assessment for future comparison and review.
     </li>
     <li class="itemize">The user can add, edit, and save metadata associated with the image of the lesion.
     </li>
     <li class="itemize">The user can browse archived images, assessments, and associated metadata.
     </li>
     <li class="itemize">The user can send a set of images with associated assessment and metadata via
     email.</li></ul>
<!--l. 20--><p class="indent" >   From this high level description some basic assumptions about the apps architecture can
already be made. The app will require access to a database that can store information about
an image, results of the analysis, and metadata. The app will require a user interface that
allows a user to browse and edit data associated with an image. The app requires access to the
smart phones camera api in order to capture images. Another consideration that will impact
design decisions is the investment already made in developing the image processing and
analysis algorithms. Choosing python as the basis for the numerical algorithms and
                                                                  

                                                                  
leveraging python based scientific computing libraries has implications because
python code is not easily portable to iOS or Android devices. In order to efficiently
utilise the algorithms as they are, and to continue to update and improve them,
the image processing and analysis algorithms should be implemented as online
services.
     <ul class="itemize1">
     <li class="itemize">The image processing and risk assessment algorithms will be implemented as
     online services.</li></ul>
<!--l. 27--><p class="indent" >   In order to formally elicit the requirements the hight level description will be broken
down into structured use cases. A set of requirements will be extracted from the use
cases.
   <h3 class="sectionHead"><span class="titlemark">8.1    </span> <a 
 id="x1-500008.1"></a>Use Cases</h3>
<!--l. 1--><p class="noindent" >In order to capture the formal use cases we will use a schema based on the one defined in
Requirement Engineering Fundamentals <span class="cite"> [<a 
href="#X9781937538774">8</a>]</span>.
   <div class="table">
                                                                  

                                                                  
<!--l. 4--><p class="indent" >   <a 
 id="x1-50001r1"></a><hr class="float"><div class="float" 
>
                                                                  

                                                                  
<div class="tabular"> <table id="TBL-14" class="tabular" 
cellspacing="0" cellpadding="0" rules="groups" 
><colgroup id="TBL-14-1g"><col 
id="TBL-14-1"></colgroup><colgroup id="TBL-14-2g"><col 
id="TBL-14-2"></colgroup><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-14-1-"><td  style="white-space:nowrap; text-align:left;" id="TBL-14-1-1"  
class="td11"> <span 
class="ptmb7t-">ID                              </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-14-1-2"  
class="td11"> <!--l. 7--><p class="noindent" >Unique designation of the use case                                          </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-14-2-"><td  style="white-space:nowrap; text-align:left;" id="TBL-14-2-1"  
class="td11"> <span 
class="ptmb7t-">Name                         </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-14-2-2"  
class="td11"> <!--l. 8--><p class="noindent" >Unique name of the use case                                                    </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-14-3-"><td  style="white-space:nowrap; text-align:left;" id="TBL-14-3-1"  
class="td11"> <span 
class="ptmb7t-">Priority                      </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-14-3-2"  
class="td11"> <!--l. 9--><p class="noindent" >Importance    of    the    use    case    according    to    applied
  prioritization technique                                                            </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-14-4-"><td  style="white-space:nowrap; text-align:left;" id="TBL-14-4-1"  
class="td11"> <span 
class="ptmb7t-">Description                </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-14-4-2"  
class="td11"> <!--l. 10--><p class="noindent" >Use case in user story form                                                      </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-14-5-"><td  style="white-space:nowrap; text-align:left;" id="TBL-14-5-1"  
class="td11"> <span 
class="ptmb7t-">Dependencies            </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-14-5-2"  
class="td11"> <!--l. 11--><p class="noindent" >dependencies                                                                            </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-14-6-"><td  style="white-space:nowrap; text-align:left;" id="TBL-14-6-1"  
class="td11"> <span 
class="ptmb7t-">Trigger event             </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-14-6-2"  
class="td11"> <!--l. 12--><p class="noindent" >Name of the event that triggers this use case                           </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-14-7-"><td  style="white-space:nowrap; text-align:left;" id="TBL-14-7-1"  
class="td11"> <span 
class="ptmb7t-">Actors                        </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-14-7-2"  
class="td11"> <!--l. 13--><p class="noindent" >List of all the actors involved in this use case                          </td></tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-14-8-"><td  style="white-space:nowrap; text-align:left;" id="TBL-14-8-1"  
class="td11"> <span 
class="ptmb7t-">Preconditions </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-14-8-2"  
class="td11"> <!--l. 14--><p class="noindent" >List of all necessary constraints that must be met before this
  use case can begin execution                                                   </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-14-9-"><td  style="white-space:nowrap; text-align:left;" id="TBL-14-9-1"  
class="td11"> <span 
class="ptmb7t-">Posconditions            </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-14-9-2"  
class="td11"> <!--l. 15--><p class="noindent" >List of all states the system can be in immediately after the
  execution of the main scenario                                                </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-14-10-"><td  style="white-space:nowrap; text-align:left;" id="TBL-14-10-1"  
class="td11"> <span 
class="ptmb7t-">Result                        </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-14-10-2"  
class="td11"> <!--l. 16--><p class="noindent" >Description of the results that are produced during the use
  case execution                                                                          </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-14-11-"><td  style="white-space:nowrap; text-align:left;" id="TBL-14-11-1"  
class="td11"> <span 
class="ptmb7t-">Main scenario           </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-14-11-2"  
class="td11"> <!--l. 17--><p class="noindent" >Sequnce of events that occur during the use case.                   </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-14-12-"><td  style="white-space:nowrap; text-align:left;" id="TBL-14-12-1"  
class="td11"> <span 
class="ptmb7t-">Alternate scenarios  </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-14-12-2"  
class="td11"> <!--l. 18--><p class="noindent" >Alternative sequence of events that might occur.                     </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-14-13-"><td  style="white-space:nowrap; text-align:left;" id="TBL-14-13-1"  
class="td11"> <span 
class="ptmb7t-">Comments                 </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-14-13-2"  
class="td11"> <!--l. 20--><p class="noindent" >Other infos                                                                               </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-14-14-"><td  style="white-space:nowrap; text-align:left;" id="TBL-14-14-1"  
class="td11">                </td></tr></table></div>
<br /><div class="caption" 
><span class="id">Table 8.1: </span><span  
class="content">Use Case Template</span></div><!--tex4ht:label?: x1-50001r1 -->
                                                                  

                                                                  
   </div><hr class="endfloat" />
   </div>
   <div class="table">
                                                                  

                                                                  
<!--l. 1--><p class="indent" >   <a 
 id="x1-50002r2"></a><hr class="float"><div class="float" 
>
                                                                  

                                                                  
<div class="tabular"> <table id="TBL-15" class="tabular" 
cellspacing="0" cellpadding="0" rules="groups" 
><colgroup id="TBL-15-1g"><col 
id="TBL-15-1"></colgroup><colgroup id="TBL-15-2g"><col 
id="TBL-15-2"></colgroup><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-15-1-"><td  style="white-space:nowrap; text-align:left;" id="TBL-15-1-1"  
class="td11"> <span 
class="ptmb7t-">ID                              </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-15-1-2"  
class="td11"> <!--l. 5--><p class="noindent" >UC-1                                                                                                      </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-15-2-"><td  style="white-space:nowrap; text-align:left;" id="TBL-15-2-1"  
class="td11"> <span 
class="ptmb7t-">Name                         </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-15-2-2"  
class="td11"> <!--l. 7--><p class="noindent" >Capture Image                                                                                       </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-15-3-"><td  style="white-space:nowrap; text-align:left;" id="TBL-15-3-1"  
class="td11"> <span 
class="ptmb7t-">Priority                      </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-15-3-2"  
class="td11"> <!--l. 9--><p class="noindent" >                                              </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-15-4-"><td  style="white-space:nowrap; text-align:left;" id="TBL-15-4-1"  
class="td11"> <span 
class="ptmb7t-">Description                </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-15-4-2"  
class="td11"> <!--l. 11--><p class="noindent" >As a user I can capture an image of the skin lesion that I would like
  to have analysed.                                                                                   </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-15-5-"><td  style="white-space:nowrap; text-align:left;" id="TBL-15-5-1"  
class="td11"> <span 
class="ptmb7t-">Dependencies            </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-15-5-2"  
class="td11"> <!--l. 13--><p class="noindent" >None                                                                                                      </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-15-6-"><td  style="white-space:nowrap; text-align:left;" id="TBL-15-6-1"  
class="td11"> <span 
class="ptmb7t-">Trigger event             </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-15-6-2"  
class="td11"> <!--l. 15--><p class="noindent" >The user activated the application and selected the image capture
  navigation item.                                                                                     </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-15-7-"><td  style="white-space:nowrap; text-align:left;" id="TBL-15-7-1"  
class="td11"> <span 
class="ptmb7t-">Preconditions            </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-15-7-2"  
class="td11"> <!--l. 17--><p class="noindent" >                                              </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-15-8-"><td  style="white-space:nowrap; text-align:left;" id="TBL-15-8-1"  
class="td11"> <span 
class="ptmb7t-">Postconditions           </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-15-8-2"  
class="td11"> <!--l. 19--><p class="noindent" >                                              </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-15-9-"><td  style="white-space:nowrap; text-align:left;" id="TBL-15-9-1"  
class="td11"> <span 
class="ptmb7t-">Result                        </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-15-9-2"  
class="td11"> <!--l. 21--><p class="noindent" >The  captured  image  is  saved  and  the  system  initiates  the  border
  calculation                                                                                             </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-15-10-"><td  style="white-space:nowrap; text-align:left;" id="TBL-15-10-1"  
class="td11"> <span 
class="ptmb7t-">Main scenario           </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-15-10-2"  
class="td11">     <dl class="description"><dt class="description">
 <span 
class="ptmb7t-">1.</span>  </dt><dd 
class="description">Point the camera at the skin lesion.
            </dd><dt class="description">
  <span 
class="ptmb7t-">2.</span>  </dt><dd 
class="description">Rotate and move the camera until the skin lesion is centered and
            optimally sized.
            </dd><dt class="description">
  <span 
class="ptmb7t-">3.</span>  </dt><dd 
class="description">The user touches the screen to capture the image.
            </dd><dt class="description">
  <span 
class="ptmb7t-">4.</span>  </dt><dd 
class="description">The user is notified ( beep ) that the image has been captured
            </dd><dt class="description">
  <span 
class="ptmb7t-">5.</span>  </dt><dd 
class="description">The user can repeat from the begining</dd></dl>
  <!--l. 33--><p class="noindent" >                                                                                                               </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-15-11-"><td  style="white-space:nowrap; text-align:left;" id="TBL-15-11-1"  
class="td11"> <span 
class="ptmb7t-">Alternate scenarios  </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-15-11-2"  
class="td11"> <!--l. 36--><p class="noindent" >None                                                                                                      </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-15-12-"><td  style="white-space:nowrap; text-align:left;" id="TBL-15-12-1"  
class="td11"> <span 
class="ptmb7t-">Comments                 </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-15-12-2"  
class="td11"> <!--l. 39--><p class="noindent" >It is important that a user can capture the image with just one hand.
  If a lesion is located on a users hand or arm, its not possible to use
  two hands. UI should account for this if possible.                                </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-15-13-"><td  style="white-space:nowrap; text-align:left;" id="TBL-15-13-1"  
class="td11">                </td></tr></table></div>
<br /><div class="caption" 
><span class="id">Table 8.2: </span><span  
class="content">Use Case 1</span></div><!--tex4ht:label?: x1-50002r2 -->
                                                                  

                                                                  
   </div><hr class="endfloat" />
   </div>
   <div class="table">
                                                                  

                                                                  
<!--l. 1--><p class="indent" >   <a 
 id="x1-50003r3"></a><hr class="float"><div class="float" 
>
                                                                  

                                                                  
<div class="tabular"> <table id="TBL-16" class="tabular" 
cellspacing="0" cellpadding="0" rules="groups" 
><colgroup id="TBL-16-1g"><col 
id="TBL-16-1"></colgroup><colgroup id="TBL-16-2g"><col 
id="TBL-16-2"></colgroup><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-16-1-"><td  style="white-space:nowrap; text-align:left;" id="TBL-16-1-1"  
class="td11"> <span 
class="ptmb7t-">ID                              </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-16-1-2"  
class="td11"> <!--l. 5--><p class="noindent" >UC-2                                                                                                      </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-16-2-"><td  style="white-space:nowrap; text-align:left;" id="TBL-16-2-1"  
class="td11"> <span 
class="ptmb7t-">Name                         </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-16-2-2"  
class="td11"> <!--l. 7--><p class="noindent" >Confirm calculation of skin lesions border                                          </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-16-3-"><td  style="white-space:nowrap; text-align:left;" id="TBL-16-3-1"  
class="td11"> <span 
class="ptmb7t-">Priority                      </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-16-3-2"  
class="td11"> <!--l. 9--><p class="noindent" >                                              </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-16-4-"><td  style="white-space:nowrap; text-align:left;" id="TBL-16-4-1"  
class="td11"> <span 
class="ptmb7t-">Description                </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-16-4-2"  
class="td11"> <!--l. 11--><p class="noindent" >As a user I want to confirm that the skin lesions borders have been
  properly calculated.                                                                               </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-16-5-"><td  style="white-space:nowrap; text-align:left;" id="TBL-16-5-1"  
class="td11"> <span 
class="ptmb7t-">Dependencies            </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-16-5-2"  
class="td11"> <!--l. 13--><p class="noindent" >UC-1                                                                                                      </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-16-6-"><td  style="white-space:nowrap; text-align:left;" id="TBL-16-6-1"  
class="td11"> <span 
class="ptmb7t-">Trigger event             </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-16-6-2"  
class="td11"> <!--l. 15--><p class="noindent" >The user selected the confirm border navigation item.                      </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-16-7-"><td  style="white-space:nowrap; text-align:left;" id="TBL-16-7-1"  
class="td11"> <span 
class="ptmb7t-">Preconditions            </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-16-7-2"  
class="td11"> <!--l. 17--><p class="noindent" >At least one image has been captured and border calculation could
  complete.                                                                                               </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-16-8-"><td  style="white-space:nowrap; text-align:left;" id="TBL-16-8-1"  
class="td11"> <span 
class="ptmb7t-">Postconditions           </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-16-8-2"  
class="td11"> <!--l. 19--><p class="noindent" >                                              </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-16-9-"><td  style="white-space:nowrap; text-align:left;" id="TBL-16-9-1"  
class="td11"> <span 
class="ptmb7t-">Result                        </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-16-9-2"  
class="td11"> <!--l. 21--><p class="noindent" >After positiv confirmation, the system initiates the risk assessment
  calculation  for  the  image.  If  the  image  can  not  be  positively
  confirmed, the user can recapture new images ( UC-1 )                       </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-16-10-"><td  style="white-space:nowrap; text-align:left;" id="TBL-16-10-1"  
class="td11"> <span 
class="ptmb7t-">Main scenario           </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-16-10-2"  
class="td11">
     <dl class="description"><dt class="description">
 <span 
class="ptmb7t-">1.</span>  </dt><dd 
class="description">The user is presented with a list of images.
            </dd><dt class="description">
  <span 
class="ptmb7t-">2.</span>  </dt><dd 
class="description">The following step is repeated for each image in the list.
            </dd><dt class="description">
  <span 
class="ptmb7t-">3.</span>  </dt><dd 
class="description">The user confirms that the border of the lesion has been precisely
            calculated.</dd></dl>
  <!--l. 31--><p class="noindent" >                                                                                                               </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-16-11-"><td  style="white-space:nowrap; text-align:left;" id="TBL-16-11-1"  
class="td11"> <span 
class="ptmb7t-">Alternate scenarios  </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-16-11-2"  
class="td11">
     <dl class="description"><dt class="description">
 <span 
class="ptmb7t-">A1.</span>  </dt><dd 
class="description">Border calculation for image has not completed.
            </dd><dt class="description">
  <span 
class="ptmb7t-">A1.3</span>  </dt><dd 
class="description">The user can refresh the image preview until the results of the
            border are visible.
            </dd><dt class="description">
  <span 
class="ptmb7t-">A1.4</span>  </dt><dd 
class="description">The  user  confirms  that  the  border  of  the  lesion  has  been
            precisely calculated.</dd></dl>
            <dl class="description"><dt class="description">
  <span 
class="ptmb7t-">A2</span>  </dt><dd 
class="description">Border calculation is not precise or has failed.
            </dd><dt class="description">
  <span 
class="ptmb7t-">A2.3</span>  </dt><dd 
class="description">The user confirms that the border of the lesion has not been
            precisely calculated.
            </dd><dt class="description">
  <span 
class="ptmb7t-">A2.4</span>  </dt><dd 
class="description">The image is deleted.</dd></dl>
  <!--l. 44--><p class="noindent" >                                                                                                               </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-16-12-"><td  style="white-space:nowrap; text-align:left;" id="TBL-16-12-1"  
class="td11"> <span 
class="ptmb7t-">hline Comments       </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-16-12-2"  
class="td11"> <!--l. 47--><p class="noindent" >                                              </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-16-13-"><td  style="white-space:nowrap; text-align:left;" id="TBL-16-13-1"  
class="td11">                </td></tr></table></div>
<br /><div class="caption" 
><span class="id">Table 8.3: </span><span  
class="content">Use Case 2</span></div><!--tex4ht:label?: x1-50003r3 -->
                                                                  

                                                                  
   </div><hr class="endfloat" />
   </div>
   <div class="table">
                                                                  

                                                                  
<!--l. 1--><p class="indent" >   <a 
 id="x1-50004r4"></a><hr class="float"><div class="float" 
>
                                                                  

                                                                  
<div class="tabular"> <table id="TBL-17" class="tabular" 
cellspacing="0" cellpadding="0" rules="groups" 
><colgroup id="TBL-17-1g"><col 
id="TBL-17-1"></colgroup><colgroup id="TBL-17-2g"><col 
id="TBL-17-2"></colgroup><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-17-1-"><td  style="white-space:nowrap; text-align:left;" id="TBL-17-1-1"  
class="td11"> <span 
class="ptmb7t-">ID                              </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-17-1-2"  
class="td11"> <!--l. 5--><p class="noindent" >UC-3                                                                                                      </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-17-2-"><td  style="white-space:nowrap; text-align:left;" id="TBL-17-2-1"  
class="td11"> <span 
class="ptmb7t-">Name                         </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-17-2-2"  
class="td11"> <!--l. 9--><p class="noindent" >View risk assessment                                                                            </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-17-3-"><td  style="white-space:nowrap; text-align:left;" id="TBL-17-3-1"  
class="td11"> <span 
class="ptmb7t-">Priority                      </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-17-3-2"  
class="td11"> <!--l. 14--><p class="noindent" >                                              </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-17-4-"><td  style="white-space:nowrap; text-align:left;" id="TBL-17-4-1"  
class="td11"> <span 
class="ptmb7t-">Description                </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-17-4-2"  
class="td11"> <!--l. 17--><p class="noindent" >As  a  user  I  want  to  view  the  results  of  the  risk  assessment
  calculation.                                                                                            </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-17-5-"><td  style="white-space:nowrap; text-align:left;" id="TBL-17-5-1"  
class="td11"> <span 
class="ptmb7t-">Dependencies            </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-17-5-2"  
class="td11"> <!--l. 21--><p class="noindent" >UC-2                                                                                                      </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-17-6-"><td  style="white-space:nowrap; text-align:left;" id="TBL-17-6-1"  
class="td11"> <span 
class="ptmb7t-">Trigger event             </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-17-6-2"  
class="td11"> <!--l. 25--><p class="noindent" >The user selected the risk assessment results navigation item.         </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-17-7-"><td  style="white-space:nowrap; text-align:left;" id="TBL-17-7-1"  
class="td11"> <span 
class="ptmb7t-">Preconditions            </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-17-7-2"  
class="td11"> <!--l. 29--><p class="noindent" >The system was able to complete the risk assessment calculation.      </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-17-8-"><td  style="white-space:nowrap; text-align:left;" id="TBL-17-8-1"  
class="td11"> <span 
class="ptmb7t-">Postconditions           </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-17-8-2"  
class="td11"> <!--l. 34--><p class="noindent" >                                              </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-17-9-"><td  style="white-space:nowrap; text-align:left;" id="TBL-17-9-1"  
class="td11"> <span 
class="ptmb7t-">Result                        </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-17-9-2"  
class="td11"> <!--l. 38--><p class="noindent" >                                              </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-17-10-"><td  style="white-space:nowrap; text-align:left;" id="TBL-17-10-1"  
class="td11"> <span 
class="ptmb7t-">Main scenario           </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-17-10-2"  
class="td11">     <dl class="description"><dt class="description">
 <span 
class="ptmb7t-">1.</span>  </dt><dd 
class="description">The user is presented with a list of images.
            </dd><dt class="description">
  <span 
class="ptmb7t-">2.</span>  </dt><dd 
class="description">The following step is repeated for each image in the list.
            </dd><dt class="description">
  <span 
class="ptmb7t-">3.</span>  </dt><dd 
class="description">The  user  can  select  and  view  and  image  and  corresponding
            results in detail.
            </dd></dl>
  <!--l. 50--><p class="noindent" >                                                                                                               </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-17-11-"><td  style="white-space:nowrap; text-align:left;" id="TBL-17-11-1"  
class="td11"> <span 
class="ptmb7t-">Alternate scenarios  </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-17-11-2"  
class="td11">
     <dl class="description"><dt class="description">
 <span 
class="ptmb7t-">A1.</span>  </dt><dd 
class="description">Risk assessment calculation for image has not completed.
            </dd><dt class="description">
  <span 
class="ptmb7t-">A1.3</span>  </dt><dd 
class="description">The user can refresh the results details until the results of a
            risk assessment is available.</dd></dl>
  <!--l. 57--><p class="noindent" >                                                                                                               </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-17-12-"><td  style="white-space:nowrap; text-align:left;" id="TBL-17-12-1"  
class="td11"> <span 
class="ptmb7t-">Comments                 </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-17-12-2"  
class="td11"> <!--l. 61--><p class="noindent" >                                              </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-17-13-"><td  style="white-space:nowrap; text-align:left;" id="TBL-17-13-1"  
class="td11">                </td></tr></table></div>
<br /><div class="caption" 
><span class="id">Table 8.4: </span><span  
class="content">Use Case 3</span></div><!--tex4ht:label?: x1-50004r4 -->
                                                                  

                                                                  
   </div><hr class="endfloat" />
   </div>
   <div class="table">
                                                                  

                                                                  
<!--l. 1--><p class="indent" >   <a 
 id="x1-50005r5"></a><hr class="float"><div class="float" 
>
                                                                  

                                                                  
<div class="tabular"> <table id="TBL-18" class="tabular" 
cellspacing="0" cellpadding="0" rules="groups" 
><colgroup id="TBL-18-1g"><col 
id="TBL-18-1"></colgroup><colgroup id="TBL-18-2g"><col 
id="TBL-18-2"></colgroup><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-18-1-"><td  style="white-space:nowrap; text-align:left;" id="TBL-18-1-1"  
class="td11"> <span 
class="ptmb7t-">ID                       </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-18-1-2"  
class="td11"> <!--l. 5--><p class="noindent" >UC-4                                                                                                      </td></tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-18-2-"><td  style="white-space:nowrap; text-align:left;" id="TBL-18-2-1"  
class="td11"> <span 
class="ptmb7t-">Name </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-18-2-2"  
class="td11"> <!--l. 7--><p class="noindent" >Save image and results</td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-18-3-"><td  style="white-space:nowrap; text-align:left;" id="TBL-18-3-1"  
class="td11"> <span 
class="ptmb7t-">Description        </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-18-3-2"  
class="td11"> <!--l. 9--><p class="noindent" >As  a  user  I  want  to  save  the  image  and  the  results  of  the  risk
  assessment.                                                                                            </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-18-4-"><td  style="white-space:nowrap; text-align:left;" id="TBL-18-4-1"  
class="td11"> <span 
class="ptmb7t-">Dependencies     </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-18-4-2"  
class="td11"> <!--l. 11--><p class="noindent" >UC-3                                                                                                      </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-18-5-"><td  style="white-space:nowrap; text-align:left;" id="TBL-18-5-1"  
class="td11"> <span 
class="ptmb7t-">Trigger               </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-18-5-2"  
class="td11"> <!--l. 13--><p class="noindent" >The user selects the save navigation item.                                         </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-18-6-"><td  style="white-space:nowrap; text-align:left;" id="TBL-18-6-1"  
class="td11"> <span 
class="ptmb7t-">Preconditions    </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-18-6-2"  
class="td11"> <!--l. 15--><p class="noindent" >The system was able to complete the risk assessment calculation.      </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-18-7-"><td  style="white-space:nowrap; text-align:left;" id="TBL-18-7-1"  
class="td11"> <span 
class="ptmb7t-">Normal Flow     </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-18-7-2"  
class="td11">
     <dl class="description"><dt class="description">
 <span 
class="ptmb7t-">1.</span>  </dt><dd 
class="description">The user is presented with a list of images.
            </dd><dt class="description">
  <span 
class="ptmb7t-">2.</span>  </dt><dd 
class="description">The can select one or more images with the corresponding risk
            assessment results.
            </dd><dt class="description">
  <span 
class="ptmb7t-">3.</span>  </dt><dd 
class="description">The user can add a title and comment.
            </dd><dt class="description">
  <span 
class="ptmb7t-">4.</span>  </dt><dd 
class="description">The user is presented with a confirmation that the package has
            been saved.</dd></dl>
  <!--l. 24--><p class="noindent" >                                                                                                               </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-18-8-"><td  style="white-space:nowrap; text-align:left;" id="TBL-18-8-1"  
class="td11"> <span 
class="ptmb7t-">Alternate Flow  </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-18-8-2"  
class="td11"> <!--l. 28--><p class="noindent" >                                              </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-18-9-"><td  style="white-space:nowrap; text-align:left;" id="TBL-18-9-1"  
class="td11"> <span 
class="ptmb7t-">Results                </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-18-9-2"  
class="td11"> <!--l. 31--><p class="noindent" >A  package  of  images  and  corresponding  risk  assessment  data  is
  stored in the archive with some metadata (title and comment).            </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-18-10-"><td  style="white-space:nowrap; text-align:left;" id="TBL-18-10-1"  
class="td11"> <span 
class="ptmb7t-">Comments          </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-18-10-2"  
class="td11"> <!--l. 34--><p class="noindent" >                                              </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-18-11-"><td  style="white-space:nowrap; text-align:left;" id="TBL-18-11-1"  
class="td11">             </td></tr></table></div>
<br /><div class="caption" 
><span class="id">Table 8.5: </span><span  
class="content">Use Case 4</span></div><!--tex4ht:label?: x1-50005r5 -->
                                                                  

                                                                  
   </div><hr class="endfloat" />
   </div>
   <div class="table">
                                                                  

                                                                  
<!--l. 1--><p class="indent" >   <a 
 id="x1-50006r6"></a><hr class="float"><div class="float" 
>
                                                                  

                                                                  
<div class="tabular"> <table id="TBL-19" class="tabular" 
cellspacing="0" cellpadding="0" rules="groups" 
><colgroup id="TBL-19-1g"><col 
id="TBL-19-1"></colgroup><colgroup id="TBL-19-2g"><col 
id="TBL-19-2"></colgroup><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-19-1-"><td  style="white-space:nowrap; text-align:left;" id="TBL-19-1-1"  
class="td11"> <span 
class="ptmb7t-">ID                       </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-19-1-2"  
class="td11"> <!--l. 5--><p class="noindent" >UC-5                                                                                                      </td></tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-19-2-"><td  style="white-space:nowrap; text-align:left;" id="TBL-19-2-1"  
class="td11"> <span 
class="ptmb7t-">Name </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-19-2-2"  
class="td11"> <!--l. 7--><p class="noindent" >View archived images and data.</td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-19-3-"><td  style="white-space:nowrap; text-align:left;" id="TBL-19-3-1"  
class="td11"> <span 
class="ptmb7t-">Description        </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-19-3-2"  
class="td11"> <!--l. 9--><p class="noindent" >As   a   user   I   want   to   view   previously   saved   images   and   the
  corresponding risk assessment data.                                                     </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-19-4-"><td  style="white-space:nowrap; text-align:left;" id="TBL-19-4-1"  
class="td11"> <span 
class="ptmb7t-">Dependencies     </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-19-4-2"  
class="td11"> <!--l. 11--><p class="noindent" >UC-4                                                                                                      </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-19-5-"><td  style="white-space:nowrap; text-align:left;" id="TBL-19-5-1"  
class="td11"> <span 
class="ptmb7t-">Trigger               </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-19-5-2"  
class="td11"> <!--l. 13--><p class="noindent" >The user selects the archive navigation item.                                    </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-19-6-"><td  style="white-space:nowrap; text-align:left;" id="TBL-19-6-1"  
class="td11"> <span 
class="ptmb7t-">Preconditions    </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-19-6-2"  
class="td11"> <!--l. 15--><p class="noindent" >The system was able to complete the risk assessment calculation.      </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-19-7-"><td  style="white-space:nowrap; text-align:left;" id="TBL-19-7-1"  
class="td11"> <span 
class="ptmb7t-">Normal Flow     </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-19-7-2"  
class="td11">
     <dl class="description"><dt class="description">
 <span 
class="ptmb7t-">1.</span>  </dt><dd 
class="description">The user is presented with a list of archived packages.
            </dd><dt class="description">
  <span 
class="ptmb7t-">2.</span>  </dt><dd 
class="description">The user can select an item in the list
            </dd><dt class="description">
  <span 
class="ptmb7t-">3.</span>  </dt><dd 
class="description">The  user  is  presented  with  the  images,  corresponding  risk
            assessment data and metadata for the selected item.</dd></dl>
  <!--l. 23--><p class="noindent" >                                                                                                               </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-19-8-"><td  style="white-space:nowrap; text-align:left;" id="TBL-19-8-1"  
class="td11"> <span 
class="ptmb7t-">Alternate Flow  </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-19-8-2"  
class="td11"> <!--l. 27--><p class="noindent" >                                              </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-19-9-"><td  style="white-space:nowrap; text-align:left;" id="TBL-19-9-1"  
class="td11"> <span 
class="ptmb7t-">Results                </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-19-9-2"  
class="td11"> <!--l. 30--><p class="noindent" >A  package  of  images  and  corresponding  risk  assessment  data  is
  stored in the archive with some metadata (title and comment).            </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-19-10-"><td  style="white-space:nowrap; text-align:left;" id="TBL-19-10-1"  
class="td11"> <span 
class="ptmb7t-">Comments          </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-19-10-2"  
class="td11"> <!--l. 33--><p class="noindent" >                                              </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-19-11-"><td  style="white-space:nowrap; text-align:left;" id="TBL-19-11-1"  
class="td11">             </td></tr></table></div>
<br /><div class="caption" 
><span class="id">Table 8.6: </span><span  
class="content">Use Case 5</span></div><!--tex4ht:label?: x1-50006r6 -->
                                                                  

                                                                  
   </div><hr class="endfloat" />
   </div>
   <div class="table">
                                                                  

                                                                  
<!--l. 1--><p class="indent" >   <a 
 id="x1-50007r7"></a><hr class="float"><div class="float" 
>
                                                                  

                                                                  
<div class="tabular"> <table id="TBL-20" class="tabular" 
cellspacing="0" cellpadding="0" rules="groups" 
><colgroup id="TBL-20-1g"><col 
id="TBL-20-1"></colgroup><colgroup id="TBL-20-2g"><col 
id="TBL-20-2"></colgroup><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-20-1-"><td  style="white-space:nowrap; text-align:left;" id="TBL-20-1-1"  
class="td11"> <span 
class="ptmb7t-">ID                       </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-20-1-2"  
class="td11"> <!--l. 5--><p class="noindent" >UC-6                                                                                                      </td></tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-20-2-"><td  style="white-space:nowrap; text-align:left;" id="TBL-20-2-1"  
class="td11"> <span 
class="ptmb7t-">Name </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-20-2-2"  
class="td11"> <!--l. 7--><p class="noindent" >Send results to dermatologist.</td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-20-3-"><td  style="white-space:nowrap; text-align:left;" id="TBL-20-3-1"  
class="td11"> <span 
class="ptmb7t-">Description        </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-20-3-2"  
class="td11"> <!--l. 9--><p class="noindent" >As a user I want to send a previously saved image, feature extraction
  data and assessment results to a dermatologist.                                    </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-20-4-"><td  style="white-space:nowrap; text-align:left;" id="TBL-20-4-1"  
class="td11"> <span 
class="ptmb7t-">Dependencies     </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-20-4-2"  
class="td11"> <!--l. 11--><p class="noindent" >UC-4                                                                                                      </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-20-5-"><td  style="white-space:nowrap; text-align:left;" id="TBL-20-5-1"  
class="td11"> <span 
class="ptmb7t-">Trigger               </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-20-5-2"  
class="td11"> <!--l. 13--><p class="noindent" >The user selects the archive navigation item.                                    </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-20-6-"><td  style="white-space:nowrap; text-align:left;" id="TBL-20-6-1"  
class="td11"> <span 
class="ptmb7t-">Preconditions    </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-20-6-2"  
class="td11"> <!--l. 15--><p class="noindent" >The system was able to complete the risk assessment calculation.      </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-20-7-"><td  style="white-space:nowrap; text-align:left;" id="TBL-20-7-1"  
class="td11"> <span 
class="ptmb7t-">Normal Flow     </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-20-7-2"  
class="td11">
     <dl class="description"><dt class="description">
 <span 
class="ptmb7t-">1.</span>  </dt><dd 
class="description">The user is presented with a list of archived packages.
            </dd><dt class="description">
  <span 
class="ptmb7t-">2.</span>  </dt><dd 
class="description">The user can select an item in the list
            </dd><dt class="description">
  <span 
class="ptmb7t-">3.</span>  </dt><dd 
class="description">The user can send the item as an email attachment.</dd></dl>
  <!--l. 23--><p class="noindent" >                                                                                                               </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-20-8-"><td  style="white-space:nowrap; text-align:left;" id="TBL-20-8-1"  
class="td11"> <span 
class="ptmb7t-">Alternate Flow  </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-20-8-2"  
class="td11"> <!--l. 27--><p class="noindent" >                                              </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-20-9-"><td  style="white-space:nowrap; text-align:left;" id="TBL-20-9-1"  
class="td11"> <span 
class="ptmb7t-">Results                </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-20-9-2"  
class="td11"> <!--l. 30--><p class="noindent" >                                              </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-20-10-"><td  style="white-space:nowrap; text-align:left;" id="TBL-20-10-1"  
class="td11"> <span 
class="ptmb7t-">Comments          </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-20-10-2"  
class="td11"> <!--l. 32--><p class="noindent" >                                              </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-20-11-"><td  style="white-space:nowrap; text-align:left;" id="TBL-20-11-1"  
class="td11">             </td></tr></table></div>
<br /><div class="caption" 
><span class="id">Table 8.7: </span><span  
class="content">Use Case 6</span></div><!--tex4ht:label?: x1-50007r7 -->
                                                                  

                                                                  
   </div><hr class="endfloat" />
   </div>
<!--l. 34--><p class="indent" >   <hr class="figure"><div class="figure" 
>
                                                                  

                                                                  
<a 
 id="x1-50008r1"></a>
                                                                  

                                                                  
<!--l. 36--><p class="noindent" ><img 
src="main4x.png" alt="PIC" class="graphics"><!--tex4ht:graphics  
name="main4x.png" src="assets/concept/UML.pdf"  
-->
<br /> <div class="caption" 
><span class="id">Figure 8.1: </span><span  
class="content">Use Case Diagram</span></div><!--tex4ht:label?: x1-50008r1 -->
                                                                  

                                                                  
<!--l. 39--><p class="indent" >   </div><hr class="endfigure">
   <h3 class="sectionHead"><span class="titlemark">8.2    </span> <a 
 id="x1-510008.2"></a>Prioritisation</h3>
<!--l. 1--><p class="noindent" >This project will employ a Single-Criterion Ad-hoc prioritisation classification as opposed to
an analytical approach such as the Wiegers prioritisation matrix. The rationale behind this
choice is that as a single person development project the determination of weights for benefit,
detriment, cost, and risk is an ad-hoc exercise. In a larger project with multiple developers
and active stakeholders the time and effort required for a prioritisation assessment according
to Wiegers would be advisable.
<!--l. 3--><p class="indent" >   The following are the prioritisation classes as defined in <span class="cite"> [<a 
href="#X9781937538774">8</a>]</span>:
     <ul class="itemize1">
     <li class="itemize"><span 
class="ptmb7t-">Mandatory</span>:   A   mandatory   requirement   is   a   requirement   that   must   be
     implemented at all costs or else the success of the system is threatened.
     </li>
     <li class="itemize"><span 
class="ptmb7t-">Optional</span>: An optional requirement is a requirement that does not necessarily
     need to be implemented. Neglecting a few requirements of this class does not
     threaten the success of the system.
     </li>
     <li class="itemize"><span 
class="ptmb7t-">Nice-to-have</span>: Nice-to-have requirements are requirements that do not influence
     the systems success if they are not implemented.
     </li></ul>
<!--l. 35--><p class="noindent" >
   <h3 class="sectionHead"><span class="titlemark">8.3    </span> <a 
 id="x1-520008.3"></a>Requirements</h3>
<!--l. 1--><p class="noindent" >
   <h3 class="sectionHead"><span class="titlemark">8.4    </span> <a 
 id="x1-530008.4"></a>Prioritized Requirements</h3>
<a 
 id="x1-53001r8"></a>
   <!--l. 5--><div class="longtable"> <table id="TBL-21" class="longtable" 
cellspacing="0" cellpadding="0" rules="groups" 
><colgroup id="TBL-21-1g"><col 
id="TBL-21-1"></colgroup><colgroup id="TBL-21-2g"><col 
id="TBL-21-2"></colgroup><colgroup id="TBL-21-3g"><col 
id="TBL-21-3"></colgroup><colgroup id="TBL-21-4g"><col 
id="TBL-21-4"></colgroup><colgroup id="TBL-21-5g"><col 
id="TBL-21-5"></colgroup><colgroup id="TBL-21-6g"><col 
id="TBL-21-6"></colgroup><colgroup id="TBL-21-7g"><col 
id="TBL-21-7"></colgroup>
                                                                  

                                                                  
<tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-21-1-"><td  style="white-space:nowrap; text-align:left;" id="TBL-21-1-1"  
class="td11"> ID                  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-21-1-2"  
class="td11"> Priority          </td><td  style="white-space:nowrap; text-align:left;" id="TBL-21-1-3"  
class="td11"> Name                                                                   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-21-1-4"  
class="td11"> Implemented  </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-21-2-"><td  style="white-space:nowrap; text-align:left;" id="TBL-21-2-1"  
class="td11"> REQ-NF-13  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-21-2-2"  
class="td11"> mandatory     </td><td  style="white-space:nowrap; text-align:left;" id="TBL-21-2-3"  
class="td11"> Extendability / Updatable                                   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-21-2-4"  
class="td11"> -                      </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-21-3-"><td  style="white-space:nowrap; text-align:left;" id="TBL-21-3-1"  
class="td11"> REQ-NF-14  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-21-3-2"  
class="td11"> mandatory     </td><td  style="white-space:nowrap; text-align:left;" id="TBL-21-3-3"  
class="td11"> Crossplatform Integration                                   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-21-3-4"  
class="td11"> -                      </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-21-4-"><td  style="white-space:nowrap; text-align:left;" id="TBL-21-4-1"  
class="td11"> REQ-F-1       </td><td  style="white-space:nowrap; text-align:left;" id="TBL-21-4-2"  
class="td11"> mandatory     </td><td  style="white-space:nowrap; text-align:left;" id="TBL-21-4-3"  
class="td11"> Preview Camera Input                                         </td><td  style="white-space:nowrap; text-align:left;" id="TBL-21-4-4"  
class="td11"> -                      </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-21-5-"><td  style="white-space:nowrap; text-align:left;" id="TBL-21-5-1"  
class="td11"> REQ-F-2       </td><td  style="white-space:nowrap; text-align:left;" id="TBL-21-5-2"  
class="td11"> mandatory     </td><td  style="white-space:nowrap; text-align:left;" id="TBL-21-5-3"  
class="td11"> Capture Camera Input                                         </td><td  style="white-space:nowrap; text-align:left;" id="TBL-21-5-4"  
class="td11"> -                      </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-21-6-"><td  style="white-space:nowrap; text-align:left;" id="TBL-21-6-1"  
class="td11"> REQ-F-3       </td><td  style="white-space:nowrap; text-align:left;" id="TBL-21-6-2"  
class="td11"> mandatory     </td><td  style="white-space:nowrap; text-align:left;" id="TBL-21-6-3"  
class="td11"> Border Extraction                                                </td><td  style="white-space:nowrap; text-align:left;" id="TBL-21-6-4"  
class="td11"> -                      </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-21-7-"><td  style="white-space:nowrap; text-align:left;" id="TBL-21-7-1"  
class="td11"> REQ-F-4       </td><td  style="white-space:nowrap; text-align:left;" id="TBL-21-7-2"  
class="td11"> mandatory     </td><td  style="white-space:nowrap; text-align:left;" id="TBL-21-7-3"  
class="td11"> Browse Images and Results                                </td><td  style="white-space:nowrap; text-align:left;" id="TBL-21-7-4"  
class="td11"> -                      </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-21-8-"><td  style="white-space:nowrap; text-align:left;" id="TBL-21-8-1"  
class="td11"> REQ-F-5       </td><td  style="white-space:nowrap; text-align:left;" id="TBL-21-8-2"  
class="td11"> mandatory     </td><td  style="white-space:nowrap; text-align:left;" id="TBL-21-8-3"  
class="td11"> Select Image To View in Detail                          </td><td  style="white-space:nowrap; text-align:left;" id="TBL-21-8-4"  
class="td11"> -                      </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-21-9-"><td  style="white-space:nowrap; text-align:left;" id="TBL-21-9-1"  
class="td11"> REQ-F-6       </td><td  style="white-space:nowrap; text-align:left;" id="TBL-21-9-2"  
class="td11"> mandatory     </td><td  style="white-space:nowrap; text-align:left;" id="TBL-21-9-3"  
class="td11"> Border Confirmation                                           </td><td  style="white-space:nowrap; text-align:left;" id="TBL-21-9-4"  
class="td11"> -                      </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-21-10-"><td  style="white-space:nowrap; text-align:left;" id="TBL-21-10-1"  
class="td11"> REQ-F-7       </td><td  style="white-space:nowrap; text-align:left;" id="TBL-21-10-2"  
class="td11"> mandatory     </td><td  style="white-space:nowrap; text-align:left;" id="TBL-21-10-3"  
class="td11"> Feature Extraction                                               </td><td  style="white-space:nowrap; text-align:left;" id="TBL-21-10-4"  
class="td11"> -                      </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-21-11-"><td  style="white-space:nowrap; text-align:left;" id="TBL-21-11-1"  
class="td11"> REQ-F-8       </td><td  style="white-space:nowrap; text-align:left;" id="TBL-21-11-2"  
class="td11"> mandatory     </td><td  style="white-space:nowrap; text-align:left;" id="TBL-21-11-3"  
class="td11"> Calculate Risk Assessment                                 </td><td  style="white-space:nowrap; text-align:left;" id="TBL-21-11-4"  
class="td11"> -                      </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-21-12-"><td  style="white-space:nowrap; text-align:left;" id="TBL-21-12-1"  
class="td11"> REQ-F-9       </td><td  style="white-space:nowrap; text-align:left;" id="TBL-21-12-2"  
class="td11"> optional         </td><td  style="white-space:nowrap; text-align:left;" id="TBL-21-12-3"  
class="td11"> Add/Save/Edit Metadata to Image and Results  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-21-12-4"  
class="td11"> -                      </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-21-13-"><td  style="white-space:nowrap; text-align:left;" id="TBL-21-13-1"  
class="td11"> REQ-NF-15  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-21-13-2"  
class="td11"> optional         </td><td  style="white-space:nowrap; text-align:left;" id="TBL-21-13-3"  
class="td11"> Asynchronous Image Processing                        </td><td  style="white-space:nowrap; text-align:left;" id="TBL-21-13-4"  
class="td11"> -                      </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-21-14-"><td  style="white-space:nowrap; text-align:left;" id="TBL-21-14-1"  
class="td11"> REQ-NF-16  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-21-14-2"  
class="td11"> optional         </td><td  style="white-space:nowrap; text-align:left;" id="TBL-21-14-3"  
class="td11"> Good user experience                                          </td><td  style="white-space:nowrap; text-align:left;" id="TBL-21-14-4"  
class="td11"> -                      </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-21-15-"><td  style="white-space:nowrap; text-align:left;" id="TBL-21-15-1"  
class="td11"> REQ-F-10     </td><td  style="white-space:nowrap; text-align:left;" id="TBL-21-15-2"  
class="td11"> nice-to-have  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-21-15-3"  
class="td11"> Save Image and Associated Data as Archive      </td><td  style="white-space:nowrap; text-align:left;" id="TBL-21-15-4"  
class="td11"> -                      </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-21-16-"><td  style="white-space:nowrap; text-align:left;" id="TBL-21-16-1"  
class="td11"> REQ-F-11     </td><td  style="white-space:nowrap; text-align:left;" id="TBL-21-16-2"  
class="td11"> nice-to-have  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-21-16-3"  
class="td11"> Browse Images and Results from Archive          </td><td  style="white-space:nowrap; text-align:left;" id="TBL-21-16-4"  
class="td11"> -                      </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-21-17-"><td  style="white-space:nowrap; text-align:left;" id="TBL-21-17-1"  
class="td11"> REQ-F-12     </td><td  style="white-space:nowrap; text-align:left;" id="TBL-21-17-2"  
class="td11"> nice-to-have  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-21-17-3"  
class="td11"> Send Image and Associated Data as Email         </td><td  style="white-space:nowrap; text-align:left;" id="TBL-21-17-4"  
class="td11"> -                      </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-21-18-"><td colspan="7" style="white-space:nowrap; text-align:center;" id="TBL-21-18-1"  
class="td11">              <div class="multicolumn"  style="white-space:nowrap; text-align:center;"><div class="caption" 
><span class="id">Table 8.8: </span><span  
class="content">Requirement in Detail</span></div><!--tex4ht:label?: x1-53001r8 -->                                                             </div>                                 <a 
 id="x1-53002"></a>
</td></tr><tr  
 style="vertical-align:baseline;" id="TBL-21-19-"><td  style="white-space:nowrap; text-align:left;" id="TBL-21-19-1"  
class="td11">          </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-21-20-"><td  style="white-space:nowrap; text-align:left;" id="TBL-21-20-1"  
class="td11">          </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-21-21-"><td  style="white-space:nowrap; text-align:left;" id="TBL-21-21-1"  
class="td11">          </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-21-22-"><td  style="white-space:nowrap; text-align:left;" id="TBL-21-22-1"  
class="td11">            </td><td  style="white-space:nowrap; text-align:left;" id="TBL-21-22-2"  
class="td11">            </td><td  style="white-space:nowrap; text-align:left;" id="TBL-21-22-3"  
class="td11">                                      </td><td  style="white-space:nowrap; text-align:left;" id="TBL-21-22-4"  
class="td11">            </td><td  style="white-space:nowrap; text-align:left;" id="TBL-21-22-5"  
class="td11"></td><td  style="white-space:nowrap; text-align:left;" id="TBL-21-22-6"  
class="td11"></td><td  style="white-space:nowrap; text-align:left;" id="TBL-21-22-7"  
class="td11"></td></tr>
   </table></div>
   <div class="table">
                                                                  

                                                                  
<!--l. 1--><p class="indent" >   <a 
 id="x1-53003r9"></a><hr class="float"><div class="float" 
>
                                                                  

                                                                  
<div class="tabular"><table id="TBL-22" class="tabular" 
cellspacing="0" cellpadding="0" rules="groups" 
><colgroup id="TBL-22-1g"><col 
id="TBL-22-1"></colgroup><colgroup id="TBL-22-2g"><col 
id="TBL-22-2"></colgroup><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-22-1-"><td  style="white-space:nowrap; text-align:left;" id="TBL-22-1-1"  
class="td11"> <span 
class="ptmb7t-">ID                          </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-22-1-2"  
class="td11"> <!--l. 6--><p class="noindent" >REQ-F-1                                                                                                </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-22-2-"><td  style="white-space:nowrap; text-align:left;" id="TBL-22-2-1"  
class="td11"> <span 
class="ptmb7t-">Name                     </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-22-2-2"  
class="td11"> <!--l. 9--><p class="noindent" >Preview Camera Input                                                                           </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-22-3-"><td  style="white-space:nowrap; text-align:left;" id="TBL-22-3-1"  
class="td11"> <span 
class="ptmb7t-">Description            </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-22-3-2"  
class="td11"> <!--l. 12--><p class="noindent" >The system will let the user view a preview of the cameras input in
  realtime                                                                                                 </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-22-4-"><td  style="white-space:nowrap; text-align:left;" id="TBL-22-4-1"  
class="td11"> <span 
class="ptmb7t-">Preconditions        </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-22-4-2"  
class="td11"> <!--l. 15--><p class="noindent" >None                                                                                                      </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-22-5-"><td  style="white-space:nowrap; text-align:left;" id="TBL-22-5-1"  
class="td11"> <span 
class="ptmb7t-">Acceptance Tests  </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-22-5-2"  
class="td11"> <!--l. 18--><p class="noindent" >                                              </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-22-6-"><td  style="white-space:nowrap; text-align:left;" id="TBL-22-6-1"  
class="td11"> <span 
class="ptmb7t-">Relations               </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-22-6-2"  
class="td11"> <!--l. 21--><p class="noindent" >UC-1                                                                                                      </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-22-7-"><td  style="white-space:nowrap; text-align:left;" id="TBL-22-7-1"  
class="td11"> <span 
class="ptmb7t-">Comments             </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-22-7-2"  
class="td11"> <!--l. 24--><p class="noindent" >                                              </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-22-8-"><td  style="white-space:nowrap; text-align:left;" id="TBL-22-8-1"  
class="td11">              </td></tr></table></div>
<br /><div class="caption" 
><span class="id">Table 8.9: </span><span  
class="content">Functional Requirement 1</span></div><!--tex4ht:label?: x1-53003r9 -->
                                                                  

                                                                  
   </div><hr class="endfloat" />
   </div>
   <div class="table">
                                                                  

                                                                  
<!--l. 1--><p class="indent" >   <a 
 id="x1-53004r10"></a><hr class="float"><div class="float" 
>
                                                                  

                                                                  
<div class="tabular"> <table id="TBL-23" class="tabular" 
cellspacing="0" cellpadding="0" rules="groups" 
><colgroup id="TBL-23-1g"><col 
id="TBL-23-1"></colgroup><colgroup id="TBL-23-2g"><col 
id="TBL-23-2"></colgroup><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-23-1-"><td  style="white-space:nowrap; text-align:left;" id="TBL-23-1-1"  
class="td11"> <span 
class="ptmb7t-">ID                          </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-23-1-2"  
class="td11"> <!--l. 6--><p class="noindent" >REQ-F-2                                                                                                </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-23-2-"><td  style="white-space:nowrap; text-align:left;" id="TBL-23-2-1"  
class="td11"> <span 
class="ptmb7t-">Name                     </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-23-2-2"  
class="td11"> <!--l. 9--><p class="noindent" >Capture Camera Input                                                                           </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-23-3-"><td  style="white-space:nowrap; text-align:left;" id="TBL-23-3-1"  
class="td11"> <span 
class="ptmb7t-">Description            </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-23-3-2"  
class="td11"> <!--l. 12--><p class="noindent" >The  system  will  let  the  user  capture  an  image  from  the  cameras
  input.                                                                                                     </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-23-4-"><td  style="white-space:nowrap; text-align:left;" id="TBL-23-4-1"  
class="td11"> <span 
class="ptmb7t-">Preconditions        </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-23-4-2"  
class="td11"> <!--l. 15--><p class="noindent" >None                                                                                                      </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-23-5-"><td  style="white-space:nowrap; text-align:left;" id="TBL-23-5-1"  
class="td11"> <span 
class="ptmb7t-">Acceptance Tests  </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-23-5-2"  
class="td11"> <!--l. 18--><p class="noindent" >                                              </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-23-6-"><td  style="white-space:nowrap; text-align:left;" id="TBL-23-6-1"  
class="td11"> <span 
class="ptmb7t-">Relations               </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-23-6-2"  
class="td11"> <!--l. 21--><p class="noindent" >UC-1                                                                                                      </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-23-7-"><td  style="white-space:nowrap; text-align:left;" id="TBL-23-7-1"  
class="td11"> <span 
class="ptmb7t-">Comments             </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-23-7-2"  
class="td11"> <!--l. 24--><p class="noindent" >                                              </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-23-8-"><td  style="white-space:nowrap; text-align:left;" id="TBL-23-8-1"  
class="td11">              </td></tr></table></div>
<br /><div class="caption" 
><span class="id">Table 8.10: </span><span  
class="content">Functional Requirement 2</span></div><!--tex4ht:label?: x1-53004r10 -->
                                                                  

                                                                  
   </div><hr class="endfloat" />
   </div>
   <div class="table">
                                                                  

                                                                  
<!--l. 1--><p class="indent" >   <a 
 id="x1-53005r11"></a><hr class="float"><div class="float" 
>
                                                                  

                                                                  
<div class="tabular"> <table id="TBL-24" class="tabular" 
cellspacing="0" cellpadding="0" rules="groups" 
><colgroup id="TBL-24-1g"><col 
id="TBL-24-1"></colgroup><colgroup id="TBL-24-2g"><col 
id="TBL-24-2"></colgroup><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-24-1-"><td  style="white-space:nowrap; text-align:left;" id="TBL-24-1-1"  
class="td11"> <span 
class="ptmb7t-">ID                          </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-24-1-2"  
class="td11"> <!--l. 6--><p class="noindent" >REQ-F-3                                                                                                </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-24-2-"><td  style="white-space:nowrap; text-align:left;" id="TBL-24-2-1"  
class="td11"> <span 
class="ptmb7t-">Name                     </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-24-2-2"  
class="td11"> <!--l. 9--><p class="noindent" >Border Extraction                                                                                  </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-24-3-"><td  style="white-space:nowrap; text-align:left;" id="TBL-24-3-1"  
class="td11"> <span 
class="ptmb7t-">Description            </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-24-3-2"  
class="td11"> <!--l. 12--><p class="noindent" >The  system  must  be  able  to  calculate  the  border  of  a  lesion  in  a
  captured image.                                                                                     </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-24-4-"><td  style="white-space:nowrap; text-align:left;" id="TBL-24-4-1"  
class="td11"> <span 
class="ptmb7t-">Preconditions        </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-24-4-2"  
class="td11"> <!--l. 15--><p class="noindent" >None                                                                                                      </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-24-5-"><td  style="white-space:nowrap; text-align:left;" id="TBL-24-5-1"  
class="td11"> <span 
class="ptmb7t-">Acceptance Tests  </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-24-5-2"  
class="td11"> <!--l. 18--><p class="noindent" >                                              </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-24-6-"><td  style="white-space:nowrap; text-align:left;" id="TBL-24-6-1"  
class="td11"> <span 
class="ptmb7t-">Relations               </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-24-6-2"  
class="td11"> <!--l. 21--><p class="noindent" >UC-2                                                                                                      </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-24-7-"><td  style="white-space:nowrap; text-align:left;" id="TBL-24-7-1"  
class="td11"> <span 
class="ptmb7t-">Comments             </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-24-7-2"  
class="td11"> <!--l. 24--><p class="noindent" >                                              </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-24-8-"><td  style="white-space:nowrap; text-align:left;" id="TBL-24-8-1"  
class="td11">              </td></tr></table></div>
<br /><div class="caption" 
><span class="id">Table 8.11: </span><span  
class="content">Functional Requirement 3</span></div><!--tex4ht:label?: x1-53005r11 -->
                                                                  

                                                                  
   </div><hr class="endfloat" />
   </div>
   <div class="table">
                                                                  

                                                                  
<!--l. 1--><p class="indent" >   <a 
 id="x1-53006r12"></a><hr class="float"><div class="float" 
>
                                                                  

                                                                  
<div class="tabular"> <table id="TBL-25" class="tabular" 
cellspacing="0" cellpadding="0" rules="groups" 
><colgroup id="TBL-25-1g"><col 
id="TBL-25-1"></colgroup><colgroup id="TBL-25-2g"><col 
id="TBL-25-2"></colgroup><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-25-1-"><td  style="white-space:nowrap; text-align:left;" id="TBL-25-1-1"  
class="td11"> <span 
class="ptmb7t-">ID                          </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-25-1-2"  
class="td11"> <!--l. 6--><p class="noindent" >REQ-F-4                                                                                                </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-25-2-"><td  style="white-space:nowrap; text-align:left;" id="TBL-25-2-1"  
class="td11"> <span 
class="ptmb7t-">Name                     </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-25-2-2"  
class="td11"> <!--l. 9--><p class="noindent" >Browse Images and Results                                                                  </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-25-3-"><td  style="white-space:nowrap; text-align:left;" id="TBL-25-3-1"  
class="td11"> <span 
class="ptmb7t-">Description            </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-25-3-2"  
class="td11"> <!--l. 12--><p class="noindent" >The system will let the user browse through a list of images. The list
  will display the status of the images.                                                    </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-25-4-"><td  style="white-space:nowrap; text-align:left;" id="TBL-25-4-1"  
class="td11"> <span 
class="ptmb7t-">Preconditions        </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-25-4-2"  
class="td11"> <!--l. 15--><p class="noindent" >None                                                                                                      </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-25-5-"><td  style="white-space:nowrap; text-align:left;" id="TBL-25-5-1"  
class="td11"> <span 
class="ptmb7t-">Acceptance Tests  </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-25-5-2"  
class="td11"> <!--l. 18--><p class="noindent" >                                              </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-25-6-"><td  style="white-space:nowrap; text-align:left;" id="TBL-25-6-1"  
class="td11"> <span 
class="ptmb7t-">Relations               </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-25-6-2"  
class="td11"> <!--l. 21--><p class="noindent" >                                              </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-25-7-"><td  style="white-space:nowrap; text-align:left;" id="TBL-25-7-1"  
class="td11"> <span 
class="ptmb7t-">Comments             </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-25-7-2"  
class="td11"> <!--l. 24--><p class="noindent" >                                              </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-25-8-"><td  style="white-space:nowrap; text-align:left;" id="TBL-25-8-1"  
class="td11">              </td></tr></table></div>
<br /><div class="caption" 
><span class="id">Table 8.12: </span><span  
class="content">Functional Requirement 4</span></div><!--tex4ht:label?: x1-53006r12 -->
                                                                  

                                                                  
   </div><hr class="endfloat" />
   </div>
   <div class="table">
                                                                  

                                                                  
<!--l. 1--><p class="indent" >   <a 
 id="x1-53007r13"></a><hr class="float"><div class="float" 
>
                                                                  

                                                                  
<div class="tabular"> <table id="TBL-26" class="tabular" 
cellspacing="0" cellpadding="0" rules="groups" 
><colgroup id="TBL-26-1g"><col 
id="TBL-26-1"></colgroup><colgroup id="TBL-26-2g"><col 
id="TBL-26-2"></colgroup><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-26-1-"><td  style="white-space:nowrap; text-align:left;" id="TBL-26-1-1"  
class="td11"> <span 
class="ptmb7t-">ID                          </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-26-1-2"  
class="td11"> <!--l. 6--><p class="noindent" >REQ-F-5                                                                                                </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-26-2-"><td  style="white-space:nowrap; text-align:left;" id="TBL-26-2-1"  
class="td11"> <span 
class="ptmb7t-">Name                     </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-26-2-2"  
class="td11"> <!--l. 9--><p class="noindent" >Select Image To View in Detail                                                            </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-26-3-"><td  style="white-space:nowrap; text-align:left;" id="TBL-26-3-1"  
class="td11"> <span 
class="ptmb7t-">Description            </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-26-3-2"  
class="td11"> <!--l. 12--><p class="noindent" >The system will let the user select and view an image as well as the
  results of completed processes.                                                             </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-26-4-"><td  style="white-space:nowrap; text-align:left;" id="TBL-26-4-1"  
class="td11"> <span 
class="ptmb7t-">Preconditions        </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-26-4-2"  
class="td11"> <!--l. 15--><p class="noindent" >None                                                                                                      </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-26-5-"><td  style="white-space:nowrap; text-align:left;" id="TBL-26-5-1"  
class="td11"> <span 
class="ptmb7t-">Acceptance Tests  </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-26-5-2"  
class="td11"> <!--l. 18--><p class="noindent" >                                              </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-26-6-"><td  style="white-space:nowrap; text-align:left;" id="TBL-26-6-1"  
class="td11"> <span 
class="ptmb7t-">Relations               </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-26-6-2"  
class="td11"> <!--l. 21--><p class="noindent" >                                              </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-26-7-"><td  style="white-space:nowrap; text-align:left;" id="TBL-26-7-1"  
class="td11"> <span 
class="ptmb7t-">Comments             </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-26-7-2"  
class="td11"> <!--l. 24--><p class="noindent" >                                              </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-26-8-"><td  style="white-space:nowrap; text-align:left;" id="TBL-26-8-1"  
class="td11">              </td></tr></table></div>
<br /><div class="caption" 
><span class="id">Table 8.13: </span><span  
class="content">Functional Requirement 5</span></div><!--tex4ht:label?: x1-53007r13 -->
                                                                  

                                                                  
   </div><hr class="endfloat" />
   </div>
   <div class="table">
                                                                  

                                                                  
<!--l. 1--><p class="indent" >   <a 
 id="x1-53008r14"></a><hr class="float"><div class="float" 
>
                                                                  

                                                                  
<div class="tabular"> <table id="TBL-27" class="tabular" 
cellspacing="0" cellpadding="0" rules="groups" 
><colgroup id="TBL-27-1g"><col 
id="TBL-27-1"></colgroup><colgroup id="TBL-27-2g"><col 
id="TBL-27-2"></colgroup><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-27-1-"><td  style="white-space:nowrap; text-align:left;" id="TBL-27-1-1"  
class="td11"> <span 
class="ptmb7t-">ID                          </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-27-1-2"  
class="td11"> <!--l. 6--><p class="noindent" >REQ-F-6                                                                                                </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-27-2-"><td  style="white-space:nowrap; text-align:left;" id="TBL-27-2-1"  
class="td11"> <span 
class="ptmb7t-">Name                     </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-27-2-2"  
class="td11"> <!--l. 9--><p class="noindent" >Border Confirmation                                                                             </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-27-3-"><td  style="white-space:nowrap; text-align:left;" id="TBL-27-3-1"  
class="td11"> <span 
class="ptmb7t-">Description            </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-27-3-2"  
class="td11"> <!--l. 12--><p class="noindent" >The system will let the user confirm that the border of a lesion hat
  been precisely calculated.                                                                     </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-27-4-"><td  style="white-space:nowrap; text-align:left;" id="TBL-27-4-1"  
class="td11"> <span 
class="ptmb7t-">Preconditions        </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-27-4-2"  
class="td11"> <!--l. 15--><p class="noindent" >                                              </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-27-5-"><td  style="white-space:nowrap; text-align:left;" id="TBL-27-5-1"  
class="td11"> <span 
class="ptmb7t-">Acceptance Tests  </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-27-5-2"  
class="td11"> <!--l. 18--><p class="noindent" >                                              </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-27-6-"><td  style="white-space:nowrap; text-align:left;" id="TBL-27-6-1"  
class="td11"> <span 
class="ptmb7t-">Relations               </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-27-6-2"  
class="td11"> <!--l. 21--><p class="noindent" >                                              </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-27-7-"><td  style="white-space:nowrap; text-align:left;" id="TBL-27-7-1"  
class="td11"> <span 
class="ptmb7t-">Comments             </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-27-7-2"  
class="td11"> <!--l. 24--><p class="noindent" >                                              </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-27-8-"><td  style="white-space:nowrap; text-align:left;" id="TBL-27-8-1"  
class="td11">              </td></tr></table></div>
<br /><div class="caption" 
><span class="id">Table 8.14: </span><span  
class="content">Functional Requirement 6</span></div><!--tex4ht:label?: x1-53008r14 -->
                                                                  

                                                                  
   </div><hr class="endfloat" />
   </div>
   <div class="table">
                                                                  

                                                                  
<!--l. 1--><p class="indent" >   <a 
 id="x1-53009r15"></a><hr class="float"><div class="float" 
>
                                                                  

                                                                  
<div class="tabular"> <table id="TBL-28" class="tabular" 
cellspacing="0" cellpadding="0" rules="groups" 
><colgroup id="TBL-28-1g"><col 
id="TBL-28-1"></colgroup><colgroup id="TBL-28-2g"><col 
id="TBL-28-2"></colgroup><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-28-1-"><td  style="white-space:nowrap; text-align:left;" id="TBL-28-1-1"  
class="td11"> <span 
class="ptmb7t-">ID                          </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-28-1-2"  
class="td11"> <!--l. 6--><p class="noindent" >REQ-F-7                                                                                                </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-28-2-"><td  style="white-space:nowrap; text-align:left;" id="TBL-28-2-1"  
class="td11"> <span 
class="ptmb7t-">Name                     </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-28-2-2"  
class="td11"> <!--l. 9--><p class="noindent" >Feature Extraction                                                                                 </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-28-3-"><td  style="white-space:nowrap; text-align:left;" id="TBL-28-3-1"  
class="td11"> <span 
class="ptmb7t-">Description            </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-28-3-2"  
class="td11"> <!--l. 12--><p class="noindent" >The  system  must  be  able  to  extract  relavent  features  from  the
  isolated lesion image.                                                                            </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-28-4-"><td  style="white-space:nowrap; text-align:left;" id="TBL-28-4-1"  
class="td11"> <span 
class="ptmb7t-">Preconditions        </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-28-4-2"  
class="td11"> <!--l. 15--><p class="noindent" >                                              </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-28-5-"><td  style="white-space:nowrap; text-align:left;" id="TBL-28-5-1"  
class="td11"> <span 
class="ptmb7t-">Acceptance Tests  </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-28-5-2"  
class="td11"> <!--l. 18--><p class="noindent" >                                              </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-28-6-"><td  style="white-space:nowrap; text-align:left;" id="TBL-28-6-1"  
class="td11"> <span 
class="ptmb7t-">Relations               </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-28-6-2"  
class="td11"> <!--l. 21--><p class="noindent" >                                              </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-28-7-"><td  style="white-space:nowrap; text-align:left;" id="TBL-28-7-1"  
class="td11"> <span 
class="ptmb7t-">Comments             </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-28-7-2"  
class="td11"> <!--l. 24--><p class="noindent" >                                              </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-28-8-"><td  style="white-space:nowrap; text-align:left;" id="TBL-28-8-1"  
class="td11">              </td></tr></table></div>
<br /><div class="caption" 
><span class="id">Table 8.15: </span><span  
class="content">Functional Requirement 7</span></div><!--tex4ht:label?: x1-53009r15 -->
                                                                  

                                                                  
   </div><hr class="endfloat" />
   </div>
   <div class="table">
                                                                  

                                                                  
<!--l. 1--><p class="indent" >   <a 
 id="x1-53010r16"></a><hr class="float"><div class="float" 
>
                                                                  

                                                                  
<div class="tabular"> <table id="TBL-29" class="tabular" 
cellspacing="0" cellpadding="0" rules="groups" 
><colgroup id="TBL-29-1g"><col 
id="TBL-29-1"></colgroup><colgroup id="TBL-29-2g"><col 
id="TBL-29-2"></colgroup><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-29-1-"><td  style="white-space:nowrap; text-align:left;" id="TBL-29-1-1"  
class="td11"> <span 
class="ptmb7t-">ID                          </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-29-1-2"  
class="td11"> <!--l. 6--><p class="noindent" >REQ-F-8                                                                                                </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-29-2-"><td  style="white-space:nowrap; text-align:left;" id="TBL-29-2-1"  
class="td11"> <span 
class="ptmb7t-">Name                     </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-29-2-2"  
class="td11"> <!--l. 9--><p class="noindent" >Calculate Risk Assessment                                                                   </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-29-3-"><td  style="white-space:nowrap; text-align:left;" id="TBL-29-3-1"  
class="td11"> <span 
class="ptmb7t-">Description            </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-29-3-2"  
class="td11"> <!--l. 12--><p class="noindent" >The system must be able to calculate the risk assessment of an lesion
  being malignant.                                                                                    </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-29-4-"><td  style="white-space:nowrap; text-align:left;" id="TBL-29-4-1"  
class="td11"> <span 
class="ptmb7t-">Preconditions        </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-29-4-2"  
class="td11"> <!--l. 15--><p class="noindent" >                                              </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-29-5-"><td  style="white-space:nowrap; text-align:left;" id="TBL-29-5-1"  
class="td11"> <span 
class="ptmb7t-">Acceptance Tests  </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-29-5-2"  
class="td11"> <!--l. 18--><p class="noindent" >                                              </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-29-6-"><td  style="white-space:nowrap; text-align:left;" id="TBL-29-6-1"  
class="td11"> <span 
class="ptmb7t-">Relations               </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-29-6-2"  
class="td11"> <!--l. 21--><p class="noindent" >                                              </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-29-7-"><td  style="white-space:nowrap; text-align:left;" id="TBL-29-7-1"  
class="td11"> <span 
class="ptmb7t-">Comments             </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-29-7-2"  
class="td11"> <!--l. 24--><p class="noindent" >                                              </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-29-8-"><td  style="white-space:nowrap; text-align:left;" id="TBL-29-8-1"  
class="td11">              </td></tr></table></div>
<br /><div class="caption" 
><span class="id">Table 8.16: </span><span  
class="content">Functional Requirement 8</span></div><!--tex4ht:label?: x1-53010r16 -->
                                                                  

                                                                  
   </div><hr class="endfloat" />
   </div>
   <div class="table">
                                                                  

                                                                  
<!--l. 1--><p class="indent" >   <a 
 id="x1-53011r17"></a><hr class="float"><div class="float" 
>
                                                                  

                                                                  
<div class="tabular"> <table id="TBL-30" class="tabular" 
cellspacing="0" cellpadding="0" rules="groups" 
><colgroup id="TBL-30-1g"><col 
id="TBL-30-1"></colgroup><colgroup id="TBL-30-2g"><col 
id="TBL-30-2"></colgroup><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-30-1-"><td  style="white-space:nowrap; text-align:left;" id="TBL-30-1-1"  
class="td11"> <span 
class="ptmb7t-">ID                          </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-30-1-2"  
class="td11"> <!--l. 6--><p class="noindent" >REQ-F-9                                                                                                </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-30-2-"><td  style="white-space:nowrap; text-align:left;" id="TBL-30-2-1"  
class="td11"> <span 
class="ptmb7t-">Name                     </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-30-2-2"  
class="td11"> <!--l. 9--><p class="noindent" >Add/Save/Edit Metadata to Image and Results                                     </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-30-3-"><td  style="white-space:nowrap; text-align:left;" id="TBL-30-3-1"  
class="td11"> <span 
class="ptmb7t-">Description            </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-30-3-2"  
class="td11"> <!--l. 12--><p class="noindent" >The system will allow the user to add or edit metadata associated
  with the captured image.                                                                       </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-30-4-"><td  style="white-space:nowrap; text-align:left;" id="TBL-30-4-1"  
class="td11"> <span 
class="ptmb7t-">Preconditions        </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-30-4-2"  
class="td11"> <!--l. 15--><p class="noindent" >                                              </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-30-5-"><td  style="white-space:nowrap; text-align:left;" id="TBL-30-5-1"  
class="td11"> <span 
class="ptmb7t-">Acceptance Tests  </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-30-5-2"  
class="td11"> <!--l. 18--><p class="noindent" >                                              </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-30-6-"><td  style="white-space:nowrap; text-align:left;" id="TBL-30-6-1"  
class="td11"> <span 
class="ptmb7t-">Relations               </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-30-6-2"  
class="td11"> <!--l. 21--><p class="noindent" >                                              </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-30-7-"><td  style="white-space:nowrap; text-align:left;" id="TBL-30-7-1"  
class="td11"> <span 
class="ptmb7t-">Comments             </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-30-7-2"  
class="td11"> <!--l. 24--><p class="noindent" >The metadata associated might include the date when the image was
  captures  as  well  as  the  location  on  the  body  where  the  lesion  is
  located. The metadata will have the form of a text input field where
  the user can enter any text. It could be extended, if necessary, with
  structured data fields.
  <!--l. 26--><p class="noindent" >                                                                                                               </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-30-8-"><td  style="white-space:nowrap; text-align:left;" id="TBL-30-8-1"  
class="td11">              </td></tr></table></div>
<br /><div class="caption" 
><span class="id">Table 8.17: </span><span  
class="content">Functional Requirement 9</span></div><!--tex4ht:label?: x1-53011r17 -->
                                                                  

                                                                  
   </div><hr class="endfloat" />
   </div>
   <div class="table">
                                                                  

                                                                  
<!--l. 1--><p class="indent" >   <a 
 id="x1-53012r18"></a><hr class="float"><div class="float" 
>
                                                                  

                                                                  
<div class="tabular"> <table id="TBL-31" class="tabular" 
cellspacing="0" cellpadding="0" rules="groups" 
><colgroup id="TBL-31-1g"><col 
id="TBL-31-1"></colgroup><colgroup id="TBL-31-2g"><col 
id="TBL-31-2"></colgroup><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-31-1-"><td  style="white-space:nowrap; text-align:left;" id="TBL-31-1-1"  
class="td11"> <span 
class="ptmb7t-">ID                          </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-31-1-2"  
class="td11"> <!--l. 6--><p class="noindent" >REQ-F-10                                                                                              </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-31-2-"><td  style="white-space:nowrap; text-align:left;" id="TBL-31-2-1"  
class="td11"> <span 
class="ptmb7t-">Name                     </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-31-2-2"  
class="td11"> <!--l. 9--><p class="noindent" >Save Image and Associated Data as Archive.                                       </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-31-3-"><td  style="white-space:nowrap; text-align:left;" id="TBL-31-3-1"  
class="td11"> <span 
class="ptmb7t-">Description            </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-31-3-2"  
class="td11"> <!--l. 12--><p class="noindent" >The system will allow the user to save images and associated data
  for reassessment and comparison in the future.                                    </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-31-4-"><td  style="white-space:nowrap; text-align:left;" id="TBL-31-4-1"  
class="td11"> <span 
class="ptmb7t-">Preconditions        </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-31-4-2"  
class="td11"> <!--l. 15--><p class="noindent" >                                              </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-31-5-"><td  style="white-space:nowrap; text-align:left;" id="TBL-31-5-1"  
class="td11"> <span 
class="ptmb7t-">Acceptance Tests  </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-31-5-2"  
class="td11"> <!--l. 18--><p class="noindent" >                                              </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-31-6-"><td  style="white-space:nowrap; text-align:left;" id="TBL-31-6-1"  
class="td11"> <span 
class="ptmb7t-">Relations               </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-31-6-2"  
class="td11"> <!--l. 21--><p class="noindent" >                                              </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-31-7-"><td  style="white-space:nowrap; text-align:left;" id="TBL-31-7-1"  
class="td11"> <span 
class="ptmb7t-">Comments             </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-31-7-2"  
class="td11"> <!--l. 25--><p class="noindent" >Storage on a mobile device is a limited resource. Depending on the
  development strategy chosen, Web App vs Native, the application
  might not have access to its own data store. It would be useful to
  offload data to a cloud or web based storage location.
  <!--l. 27--><p class="noindent" >                                                                                                               </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-31-8-"><td  style="white-space:nowrap; text-align:left;" id="TBL-31-8-1"  
class="td11">              </td></tr></table></div>
<br /><div class="caption" 
><span class="id">Table 8.18: </span><span  
class="content">Functional Requirement 10</span></div><!--tex4ht:label?: x1-53012r18 -->
                                                                  

                                                                  
   </div><hr class="endfloat" />
   </div>
   <div class="table">
                                                                  

                                                                  
<!--l. 1--><p class="indent" >   <a 
 id="x1-53013r19"></a><hr class="float"><div class="float" 
>
                                                                  

                                                                  
<div class="tabular"> <table id="TBL-32" class="tabular" 
cellspacing="0" cellpadding="0" rules="groups" 
><colgroup id="TBL-32-1g"><col 
id="TBL-32-1"></colgroup><colgroup id="TBL-32-2g"><col 
id="TBL-32-2"></colgroup><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-32-1-"><td  style="white-space:nowrap; text-align:left;" id="TBL-32-1-1"  
class="td11"> <span 
class="ptmb7t-">ID                          </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-32-1-2"  
class="td11"> <!--l. 6--><p class="noindent" >REQ-F-11                                                                                              </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-32-2-"><td  style="white-space:nowrap; text-align:left;" id="TBL-32-2-1"  
class="td11"> <span 
class="ptmb7t-">Name                     </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-32-2-2"  
class="td11"> <!--l. 9--><p class="noindent" >Browse Images and Results from Archive.                                           </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-32-3-"><td  style="white-space:nowrap; text-align:left;" id="TBL-32-3-1"  
class="td11"> <span 
class="ptmb7t-">Description            </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-32-3-2"  
class="td11"> <!--l. 12--><p class="noindent" >The sytem will allow the user to browse previously saved images
  and results from the archive.                                                                 </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-32-4-"><td  style="white-space:nowrap; text-align:left;" id="TBL-32-4-1"  
class="td11"> <span 
class="ptmb7t-">Preconditions        </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-32-4-2"  
class="td11"> <!--l. 15--><p class="noindent" >                                              </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-32-5-"><td  style="white-space:nowrap; text-align:left;" id="TBL-32-5-1"  
class="td11"> <span 
class="ptmb7t-">Acceptance Tests  </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-32-5-2"  
class="td11"> <!--l. 18--><p class="noindent" >                                              </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-32-6-"><td  style="white-space:nowrap; text-align:left;" id="TBL-32-6-1"  
class="td11"> <span 
class="ptmb7t-">Relations               </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-32-6-2"  
class="td11"> <!--l. 21--><p class="noindent" >                                              </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-32-7-"><td  style="white-space:nowrap; text-align:left;" id="TBL-32-7-1"  
class="td11"> <span 
class="ptmb7t-">Comments             </span></td><td  style="white-space:wrap; text-align:left;" id="TBL-32-7-2"  
class="td11"> <!--l. 24--><p class="noindent" >                                              </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-32-8-"><td  style="white-space:nowrap; text-align:left;" id="TBL-32-8-1"  
class="td11">              </td></tr></table></div>
<br /><div class="caption" 
><span class="id">Table 8.19: </span><span  
class="content">Functional Requirement 11</span></div><!--tex4ht:label?: x1-53013r19 -->
                                                                  

                                                                  
   </div><hr class="endfloat" />
   </div>
                                                                  

                                                                  
   <h2 class="chapterHead"><span class="titlemark">Chapter 9</span><br /><a 
 id="x1-540009"></a>Architecture Design</h2>
<!--l. 1--><p class="noindent" >In section 2.2.1 categories of medical smart phone apps were defined. Apps in the same
categories might have a similar feature set and capabilities. An app in the <span 
class="ptmri7t-">Alert / First</span>
<span 
class="ptmri7t-">Response </span>category might have a database that stores important contacts in the users area and
a user interface that allows the user to quickly alert a contact in an emergency situation. An
app in the <span 
class="ptmri7t-">Learning / Educational / Reference </span>category might be modelled as a quiz app
which presents the user with a question and several possible answers to choose from.
Answers from several questions will can be evaluated and a score is presented to the user at
the end of a session. The app would be implemented with a database of questions and
weighted answers, as well as an interface that presents the questions to the user
sequentially.
<!--l. 3--><p class="indent" >   One of the goals of this project is to define requirements for an app that provides a risk
assessment of a lesion being benign or malignant. A high level description of the primary
function of the app is the following:
     <ul class="itemize1">
     <li class="itemize">The smart phone app allows the user to capture and analyse an image of a skin
     lesion and provide a risk assessment to the user of the lesion being a malignant
     melanoma.
     </li></ul>
<!--l. 10--><p class="indent" >   The user might also like to save the image and results in oder to be able to compare it with
other assessments in the future, or to review the assessment with a dermatologist. For
comparison it might be useful to save associated metadata, such as the date and location on
the body of the lesion. For convenience it might be nice to send the assessment and image
via email to a specialist for review. Secondary functionality can be described as
follows:
     <ul class="itemize1">
     <li class="itemize">The  app  allows  the  user  to  save  or  archive  the  image  and  corresponding
     assessment for future comparison and review.
     </li>
     <li class="itemize">The user can add, edit, and save metadata associated with the image of the lesion.
     </li>
     <li class="itemize">The user can browse archived images, assessments, and associated metadata.
     </li>
     <li class="itemize">The user can send a set of images with associated assessment and metadata via
     email.</li></ul>
<!--l. 20--><p class="indent" >   From this high level description some basic assumptions about the apps architecture can
already be made. The app will require access to a database that can store information about
an image, results of the analysis, and metadata. The app will require a user interface that
allows a user to browse and edit data associated with an image. The app requires access to the
smart phones camera api in order to capture images. Another consideration that will impact
design decisions is the investment already made in developing the image processing and
analysis algorithms. Choosing python as the basis for the numerical algorithms and
                                                                  

                                                                  
leveraging python based scientific computing libraries has implications because
python code is not easily portable to iOS or Android devices. In order to efficiently
utilise the algorithms as they are, and to continue to update and improve them,
the image processing and analysis algorithms should be implemented as online
services.
     <ul class="itemize1">
     <li class="itemize">The image processing and risk assessment algorithms will be implemented as
     online services.</li></ul>
<!--l. 27--><p class="indent" >   In order to formally elicit the requirements the hight level description will be broken
down into structured use cases. A set of requirements will be extracted from the use
cases.
   <h3 class="sectionHead"><span class="titlemark">9.1    </span> <a 
 id="x1-550009.1"></a>User Interface</h3>
<!--l. 1--><p class="noindent" ><hr class="figure"><div class="figure" 
>
                                                                  

                                                                  
<a 
 id="x1-55001r1"></a>
                                                                  

                                                                  
<!--l. 3--><p class="noindent" ><img 
src="main5x.png" alt="PIC" class="graphics"><!--tex4ht:graphics  
name="main5x.png" src="assets/GUI/image_capture.pdf"  
-->
<br /> <div class="caption" 
><span class="id">Figure 9.1: </span><span  
class="content">Image Capture View</span></div><!--tex4ht:label?: x1-55001r1 -->
                                                                  

                                                                  
<!--l. 6--><p class="noindent" ></div><hr class="endfigure">
<!--l. 8--><p class="indent" >   <hr class="figure"><div class="figure" 
>
                                                                  

                                                                  
<a 
 id="x1-55002r2"></a>
                                                                  

                                                                  
<!--l. 10--><p class="noindent" ><img 
src="main6x.png" alt="PIC" class="graphics"><!--tex4ht:graphics  
name="main6x.png" src="assets/GUI/image_list_view.pdf"  
-->
<br /> <div class="caption" 
><span class="id">Figure 9.2: </span><span  
class="content">Image List View</span></div><!--tex4ht:label?: x1-55002r2 -->
                                                                  

                                                                  
<!--l. 13--><p class="indent" >   </div><hr class="endfigure">
<!--l. 15--><p class="indent" >   <hr class="figure"><div class="figure" 
>
                                                                  

                                                                  
<a 
 id="x1-55003r3"></a>
                                                                  

                                                                  
<!--l. 17--><p class="noindent" ><img 
src="main7x.png" alt="PIC" class="graphics"><!--tex4ht:graphics  
name="main7x.png" src="assets/GUI/border_confirm.pdf"  
-->
<br /> <div class="caption" 
><span class="id">Figure 9.3: </span><span  
class="content">Border Confirm View</span></div><!--tex4ht:label?: x1-55003r3 -->
                                                                  

                                                                  
<!--l. 20--><p class="indent" >   </div><hr class="endfigure">
<!--l. 22--><p class="indent" >   <hr class="figure"><div class="figure" 
>
                                                                  

                                                                  
<a 
 id="x1-55004r4"></a>
                                                                  

                                                                  
<!--l. 24--><p class="noindent" ><img 
src="main8x.png" alt="PIC" class="graphics"><!--tex4ht:graphics  
name="main8x.png" src="assets/GUI/image_detail_view.pdf"  
-->
<br /> <div class="caption" 
><span class="id">Figure 9.4: </span><span  
class="content">Image Detail View</span></div><!--tex4ht:label?: x1-55004r4 -->
                                                                  

                                                                  
<!--l. 27--><p class="indent" >   </div><hr class="endfigure">
<!--l. 29--><p class="indent" >   <hr class="figure"><div class="figure" 
>
                                                                  

                                                                  
<a 
 id="x1-55005r5"></a>
                                                                  

                                                                  
<!--l. 31--><p class="noindent" ><img 
src="main9x.png" alt="PIC" class="graphics"><!--tex4ht:graphics  
name="main9x.png" src="assets/GUI/archive_view.pdf"  
-->
<br /> <div class="caption" 
><span class="id">Figure 9.5: </span><span  
class="content">Archive View</span></div><!--tex4ht:label?: x1-55005r5 -->
                                                                  

                                                                  
<!--l. 34--><p class="indent" >   </div><hr class="endfigure">
<!--l. 36--><p class="indent" >   <hr class="figure"><div class="figure" 
>
                                                                  

                                                                  
<a 
 id="x1-55006r6"></a>
                                                                  

                                                                  
<!--l. 38--><p class="noindent" ><img 
src="main10x.png" alt="PIC" class="graphics"><!--tex4ht:graphics  
name="main10x.png" src="assets/GUI/archive_detail_view.pdf"  
-->
<br /> <div class="caption" 
><span class="id">Figure 9.6: </span><span  
class="content">Archive Detail View</span></div><!--tex4ht:label?: x1-55006r6 -->
                                                                  

                                                                  
<!--l. 41--><p class="indent" >   </div><hr class="endfigure">
   <h3 class="sectionHead"><span class="titlemark">9.2    </span> <a 
 id="x1-560009.2"></a>Data Structure</h3>
<!--l. 1--><p class="noindent" >
   <h4 class="subsectionHead"><span class="titlemark">9.2.1    </span> <a 
 id="x1-570009.2.1"></a>Server Data Structure</h4>
<!--l. 4--><p class="noindent" ><hr class="figure"><div class="figure" 
>
                                                                  

                                                                  
<a 
 id="x1-57001r7"></a>
                                                                  

                                                                  
<!--l. 6--><p class="noindent" ><img 
src="main11x.png" alt="PIC" class="graphics"><!--tex4ht:graphics  
name="main11x.png" src="assets/data/server_data.pdf"  
-->
<br /> <div class="caption" 
><span class="id">Figure 9.7: </span><span  
class="content">Serverside Data Structure</span></div><!--tex4ht:label?: x1-57001r7 -->
                                                                  

                                                                  
<!--l. 9--><p class="noindent" ></div><hr class="endfigure">
   <h4 class="subsectionHead"><span class="titlemark">9.2.2    </span> <a 
 id="x1-580009.2.2"></a>Client Data Structure</h4>
<!--l. 37--><p class="noindent" >
   <h3 class="sectionHead"><span class="titlemark">9.3    </span> <a 
 id="x1-590009.3"></a>Software Architecture</h3>
<!--l. 1--><p class="noindent" >
   <h4 class="subsectionHead"><span class="titlemark">9.3.1    </span> <a 
 id="x1-600009.3.1"></a>MVC</h4>
<!--l. 2--><p class="noindent" >Since the 1970s the Model View Controller ( MVC ) pattern is the standard architectural
design pattern for applications that present the user with a graphical user interface. It was
developed out of a need for modularity, to encapsulate responsibility of specific concepts to
separate program modules, or Separation of Concerns. MVC identifies three main
components that program code should be grouped into, namely<span class="cite"> [<a 
href="#Xwalther_2016">12</a>]</span>:
     <ul class="itemize1">
     <li class="itemize"><span 
class="ptmb7t-">Model</span>:  The  representation  of  some  object  of  knowledge,  encapsulates  code
     managing the associated data and behaviour ( business-logic ).
     </li>
     <li class="itemize"><span 
class="ptmb7t-">View</span>:  The  visual  representation  of  the  model.  The  view  can  feature  or  hide
     aspects of the model and thus act as a presentation filter. The view observe the
     model for changes and update the presentation accordingly.
     </li>
     <li class="itemize"><span 
class="ptmb7t-">Controller</span>: The controller allows the user to interact with the model. It allows
     the user to trigger behaviours implemented in the Model.
     </li></ul>
<!--l. 12--><p class="indent" >   In the classic MVC pattern the model does not know about the view or the controller.
And the controller does not effect the view. Instead, both the view and controller monitor the
model using an observer mechanism and synchronise themselves when updates to the model
occur.
<!--l. 14--><p class="indent" >   <hr class="figure"><div class="figure" 
>
                                                                  

                                                                  
<a 
 id="x1-60001r8"></a>
                                                                  

                                                                  
<!--l. 16--><p class="noindent" ><img 
src="main12x.png" alt="PIC" class="graphics"><!--tex4ht:graphics  
name="main12x.png" src="assets/concept/mvc_1.pdf"  
-->
<br /> <div class="caption" 
><span class="id">Figure 9.8: </span><span  
class="content">Classic MVC</span></div><!--tex4ht:label?: x1-60001r8 -->
                                                                  

                                                                  
<!--l. 19--><p class="indent" >   </div><hr class="endfigure">
   <h4 class="subsectionHead"><span class="titlemark">9.3.2    </span> <a 
 id="x1-610009.3.2"></a>Modern MVC</h4>
<!--l. 23--><p class="noindent" >Modern MVC has evolved from being a software design pattern which handles components
of an application to an architectural design pattern that defines the structure of an application
itself. It has many similarities to the Layer Architecture. The responsibilities of each layer
are slightly different to the typical presentation, business, and persistence layer
definitions.
<!--l. 25--><p class="indent" >   Most modern web frameworks such as Ruby on Rails, Symfony or the IOS environment
refer to themselves as MVC based frameworks. The modern MVC concept has changed
slightly. The component definitions are the same, but some responsibilities have shifted.
Modern MVC strictly separates the model from the view. All modern frameworks state that
the view should have as little logic as possible. Any logic implemented in the view should
only be relevant to presentation. The view components should not directly reference the
model components<span class="cite"> [<a 
href="#Xapple_MVC">4</a>]</span><span class="cite"> [<a 
href="#Xsymfony_MVC">1</a>]</span>.
<!--l. 27--><p class="indent" >   <hr class="figure"><div class="figure" 
>
                                                                  

                                                                  
<a 
 id="x1-61001r9"></a>
                                                                  

                                                                  
<!--l. 29--><p class="noindent" ><img 
src="main13x.png" alt="PIC" class="graphics"><!--tex4ht:graphics  
name="main13x.png" src="assets/concept/mvc_2.pdf"  
-->
<br /> <div class="caption" 
><span class="id">Figure 9.9: </span><span  
class="content">Modern MVC vs 3-Tier Layered Architecture</span></div><!--tex4ht:label?: x1-61001r9 -->
                                                                  

                                                                  
<!--l. 32--><p class="indent" >   </div><hr class="endfigure">
<!--l. 34--><p class="indent" >   This division of responsibility has the added benefit of increased testability. GUIs are
difficult to test, by removing as much logic as possible from the user interface there is less
necessity to test it. The controller and model components can more easily be tested in
isolation using normal unit tests<span class="cite"> [<a 
href="#Xmvp_testing">6</a>]</span>.
   <h4 class="subsectionHead"><span class="titlemark">9.3.3    </span> <a 
 id="x1-620009.3.3"></a>MVC Derivatives</h4>
<!--l. 38--><p class="noindent" >Many MVC derivatives exist. The main differences are where the division of responsibility is
made and how it is labeled. MVVM defines a view model instead of a controller. The view
model acts as a facade around the model and introduces a data binder element that is
responsible for keeping the view and view model synchronised. The MVT, calls the view a
template and the controller a view. The slight difference is that the template is basically a
static file, with no logic, and placeholders for the data. The Django web framework uses this
model, but there is little difference to the other MVC derivatives such as MVP ( model
view presenter ). The AngularJS web framework attempts to end the discussion
of which design to follow by labelling itself a MVW ( Model View Whatever )
framework<span class="cite"> [<a 
href="#Xmvw">7</a>]</span>.
<!--l. 41--><p class="indent" >   <hr class="figure"><div class="figure" 
>
                                                                  

                                                                  
<a 
 id="x1-62001r10"></a>
                                                                  

                                                                  
<!--l. 43--><p class="noindent" ><img 
src="main14x.png" alt="PIC" class="graphics"><!--tex4ht:graphics  
name="main14x.png" src="assets/concept/mvc_3.pdf"  
-->
<br /> <div class="caption" 
><span class="id">Figure 9.10: </span><span  
class="content">MVC Derivatives in relation to 3-Tier Layer</span></div><!--tex4ht:label?: x1-62001r10 -->
                                                                  

                                                                  
<!--l. 46--><p class="indent" >   </div><hr class="endfigure">
   <h4 class="subsectionHead"><span class="titlemark">9.3.4    </span> <a 
 id="x1-630009.3.4"></a>MVC and Smart Phone Applications</h4>
<!--l. 50--><p class="noindent" >Although most frameworks and environments targeted toward mobile application
development use concepts from MVC, it can be difficult to define strict devision of
responsibility, especially in conjunction with services provided from an online server. Often
the responsibilities of the controller are reimplemented server side, some model management
might occur in the app. Server and application code are developed using different languages
and often most likely different developers. One solution is is to develop the app as a thin
client, where it basically becomes the view component of MVC and the controllers and
model are implemented on the server. Taken to the extreme, the app runs in a standard web
browser and server provides the view components that emulate a native mobile user
interface. This is referred to as a web app. Any logic in the view is implemented using
javascript. Hardware support is limited to what the mobile browser provides access to. In
order to extend hardware support a hybrid approach can be used in which the app
implements a custom browser view which is extended with native capabilities. Here the
division of responsibilities as defined by MVC become fuzzy. A fully native app
working in conjunction with a web server will not conform well to the definitions of
MVC.
<!--l. 52--><p class="noindent" >
   <h4 class="subsectionHead"><span class="titlemark">9.3.5    </span> <a 
 id="x1-640009.3.5"></a>Considerations</h4>
<!--l. 54--><p class="noindent" >From the prioritised requirements defined above two important issues have an impact on
architectural design decisions. Cross platform integration and extendability. The image
processing and risk assessment algorithms are a complex combination of existing python
based libraries and custom code. The rational behind choosing python as the basis
is explained in detail in previous chapters. The disadvantage of choosing python
for the basis of a mobile application is that is it not easily deployable on mobile
hardware. Regardless of the decision to use python, the complexity of these algorithms
would make it difficult and costly to implement in a cross platform manner in any
language.
<!--l. 56--><p class="indent" >   The solution is to offload the image processing and risk assessment algorithms to an
online server running a python environment. The mobile application can interface with the
online server in such a way that the process is transparent to the user.
<!--l. 58--><p class="indent" >   The requirement for extendability and maintenance ( updatability ) becomes much easier
as well. Updating the complex algorithms in multiple languages on multiple platforms and
deploying updates to all existing users via the iTunes and Android shop platforms is not
necessary. Instead only the server code needs to be updated. In the best case the phone-side
app will not have to be updated at all.
<!--l. 60--><p class="indent" >   Still the question remains, what architecture design pattern best covers the requirements
of a mobile app with online server integration.
                                                                  

                                                                  
<!--l. 62--><p class="noindent" >
   <h4 class="subsectionHead"><span class="titlemark">9.3.6    </span> <a 
 id="x1-650009.3.6"></a>VIPER</h4>
<!--l. 64--><p class="noindent" >VIPER is a new software architecture pattern which extends MVC with some addition
concepts that make it more adaptable to mobile applications, especially when they are
extended with online server based services. The classic controller is split into a presenter and
a controller, the model component is split into a central data manager communicating with
many services and entities<span class="cite"> [<a 
href="#Xviper">10</a>]</span>.
<!--l. 66--><p class="indent" >   <hr class="figure"><div class="figure" 
>
                                                                  

                                                                  
<a 
 id="x1-65001r11"></a>
                                                                  

                                                                  
<!--l. 68--><p class="noindent" ><img 
src="main15x.png" alt="PIC" class="graphics"><!--tex4ht:graphics  
name="main15x.png" src="assets/concept/viper.pdf"  
-->
<br /> <div class="caption" 
><span class="id">Figure 9.11: </span><span  
class="content">VIPER Overview</span></div><!--tex4ht:label?: x1-65001r11 -->
                                                                  

                                                                  
<!--l. 71--><p class="indent" >   </div><hr class="endfigure">
     <ul class="itemize1">
     <li class="itemize"><span 
class="ptmb7t-">View</span>: The view corresponds to the view as defined in modern MVC definitions,
     it is a slim component with as little logic as possible. It presents the current state
     of the models and provides widgets with which the user can interact.
     </li>
     <li class="itemize"><span 
class="ptmb7t-">Presenter</span>: The presenter passes data to the view and handles events from the
     view. The presenter might perform some basic validation, in the case of a user
     sign-up scenario, for example, the presenter might validate that a users email is
     indeed formatted as a correct email, it will not validate if the email has already
     been used by someone else.
     </li>
     <li class="itemize"><span 
class="ptmb7t-">Interactor</span>: Business logic is handled by the interactor. Most a what the model
     component in MVC was responsible for is handled here. The interactor however
     does not know anything about data storage, databases, or persistence. It does not
     know if data is local or accessible via a network.
     </li>
     <li class="itemize"><span 
class="ptmb7t-">Data Manager</span>: To the Interactor the data manager looks like a database, with the
     difference that the it knows how to notify the interactor when data is available.
     The  data  manager  will  receive  requests  from  the  interactor,  check  its  local
     cache, perform external service requests if necessary, then pass data back to the
     interactor once available.
     </li>
     <li class="itemize"><span 
class="ptmb7t-">Service</span>: Services are encapsulated processes that can be online or local. The
     service knows how to fetch or store data, it might be a local sqlite database, or it
     can encapsulate the communication to an online database via a REST-API.
     </li>
     <li class="itemize"><span 
class="ptmb7t-">Entity</span>: The representation of the actual data. As the entity get passed through the
     system it might be in the form of a database entry, a json object, or data object.
     </li>
     <li class="itemize"><span 
class="ptmb7t-">Wireframe / Router</span>: The wireframe initialises all the other classes and handles
     the  transitions  to  other  views  in  the  app.  The  wireframe  handles  the  current
     state of the app and might implement a history allowing the user to transition
     back to a previous view with the associated other components and data.
     </li></ul>
   <h3 class="sectionHead"><span class="titlemark">9.4    </span> <a 
 id="x1-660009.4"></a>Mobile Development Strategies</h3>
                                                                  

                                                                  
<!--l. 1--><p class="noindent" >
   <h4 class="subsectionHead"><span class="titlemark">9.4.1    </span> <a 
 id="x1-670009.4.1"></a>Pure Native vs Hybrid Native vs Hybrid vs Web Apps</h4>
<!--l. 3--><p class="noindent" >The mobile app market is segmented into several platforms. Each platform has its own
framework, API, and language specifications and requirements. Android apps are written in
java and access the Android apis, iOS apps in Objective-C or Swift and interface
with the iOS frameworks. Android and iOS cover about 94% of the worldwide
mobile market <span class="cite"> [<a 
href="#Xmobile_market">2</a>]</span>. A developer must de decide which platforms are priorities, and
how might programming effort be consolidated across multiple platforms. Several
strategies exist, and there are many tool kits and frameworks that can help accelerate
development.
     <ul class="itemize1">
     <li class="itemize"><span 
class="ptmb7t-">Web Apps</span>: The simplest development strategy is to develop an HTML based
     web page that is disguised to appear and behave like a mobile app. The web app
     runs in a normal browser, is deployed from a standard web server. Model mobile
     web  browsers  offer  javascript  APIs  that  can  access  various  other  hardware
     components of the smart phone such as the compass, GPS/geolocation services,
     accelerometer, and the camera. Other services will remain inaccessible.
     </li>
     <li class="itemize"><span 
class="ptmb7t-">Hybrid</span>: A similar strategy is to develop using javascript and html, but to package
     these elements into a hollow native app that is little else than a native view
     component with an embedded web browser. The web browser url is locked to
     the internal html files and appears to the user as a mobile app. though the user
     interface might slightly different that a pure native app. The advantage of a hybrid
     strategy is that the app can be distributed via the standard app stores increasing
     its  marketability.  It  can  also  be  extended  with  native  components  that  might
     otherwise not be accessible to to a web app such as internal file storage and native
     data storage mechanisms.
     </li>
     <li class="itemize"><span 
class="ptmb7t-">Pure Native</span>: The developer uses the development environment as provided by
     the phone manufacturer and has full access to all of the native hardware APIs,
     development kits and tools. The performance and responsiveness of a pure native
     app is much better compared to web and hybrid solutions. The user interface is
     build with the standard UI tools allowing a better user experience because the
     user is presented with familiar UI elements.
     </li>
     <li class="itemize"><span 
class="ptmb7t-">Hybrid  Native</span>:  Recently  several  cross  platform  application  frameworks  and
     emerged that allow the developer in a single language that can be compiled across
     several platforms. Qt and Juce are examples of application frameworks that allow
     cross platform development in C++, Xamarin uses C#.
     </li></ul>
<!--l. 17--><p class="indent" >   The criteria to compare these strategies are the following:
                                                                  

                                                                  
     <ul class="itemize1">
     <li class="itemize"><span 
class="ptmb7t-">Development Effort </span>: Judging the development effort is subjective. It depends
     greatly  on  the  experience  of  the  developers  involved.  An  expert  Objective-C
     developer  with  years  of  experience  developing  IOS  applications  will  have  no
     problem  developing  a  native  IOS  app,  but  might  be  stumped  when  it  comes
     to hybrid development. For this project we will assume Javascript and HTML
     development requires the least amount of effort and thus give high scores to Web
     Apps and Hybrid development.
     </li>
     <li class="itemize"><span 
class="ptmb7t-">Code Portability</span>: How much of the code developed can be reused on each target
     platform without any extra effort.
     </li>
     <li class="itemize"><span 
class="ptmb7t-">Camera Access</span>: Does a strategy allow access to all the devices camera,? is the
     camera view customisable with guidelines and information that can help the user
     take a high quality picture?
     </li>
     <li class="itemize"><span 
class="ptmb7t-">Look and Feel</span>: Does a strategy offer pure native UI elements that conform with
     user expectations for a particular device?
     </li>
     <li class="itemize"><span 
class="ptmb7t-">Deployment</span>: What effort is required to deploy the application to a device?
     </li>
     <li class="itemize"><span 
class="ptmb7t-">Performance</span>: What is the performance impact of a chosen strategy?
     </li></ul>
<!--l. 36--><p class="indent" >   For comparison we rank each criteria per strategy either 2 = benefit, 1 = no benefit, 0 =
negative benefit.
<!--l. 38--><p class="indent" >   <hr class="figure"><div class="figure" 
>
                                                                  

                                                                  
<a 
 id="x1-67001r12"></a>
                                                                  

                                                                  
<!--l. 40--><p class="noindent" ><img 
src="main16x.png" alt="PIC" class="graphics"><!--tex4ht:graphics  
name="main16x.png" src="assets/concept/native_vs_hybrid.pdf"  
-->
<br /> <div class="caption" 
><span class="id">Figure 9.12: </span><span  
class="content">Mobile Development Strategies Comparison</span></div><!--tex4ht:label?: x1-67001r12 -->
                                                                  

                                                                  
<!--l. 43--><p class="indent" >   </div><hr class="endfigure">
                                                                  

                                                                  
   <h2 class="chapterHead"><span class="titlemark">Chapter 10</span><br /><a 
 id="x1-6800010"></a>Testing</h2>
   <h3 class="sectionHead"><span class="titlemark">10.1    </span> <a 
 id="x1-6900010.1"></a>Section Title</h3>
                                                                  

                                                                  
   <h2 class="chapterHead"><span class="titlemark">Chapter 11</span><br /><a 
 id="x1-7000011"></a>Application Implementation</h2>
   <h3 class="sectionHead"><span class="titlemark">11.1    </span> <a 
 id="x1-7100011.1"></a>Language and Libraries</h3>
<!--l. 3--><p class="noindent" >
   <h4 class="subsectionHead"><span class="titlemark">11.1.1    </span> <a 
 id="x1-7200011.1.1"></a>Server</h4>
<!--l. 6--><p class="noindent" >
   <h4 class="subsectionHead"><span class="titlemark">11.1.2    </span> <a 
 id="x1-7300011.1.2"></a>Mobile Client</h4>
                                                                  

                                                                  
   <h2 class="chapterHead"><span class="titlemark">Chapter 12</span><br /><a 
 id="x1-7400012"></a>Conclusions</h2>
   <h3 class="sectionHead"><span class="titlemark">12.1    </span> <a 
 id="x1-7500012.1"></a>Section Title</h3>
                                                                  

                                                                  
   <h2 class="likechapterHead"><a 
 id="x1-7600012.1"></a>Bibliography</h2>
    <div class="thebibliography">
    <p class="bibitem" ><span class="biblabel">
  [1]<span class="bibsp">   </span></span><a 
 id="Xsymfony_MVC"></a>Symfony Book: Chapter 2 - Exploring Symfonys Code, The MVC Pattern,
    2015. [Online; accessed 2016-8-27], <a 
href="http://symfony.com/legacy/doc/book/1_0/en/02-Exploring-Symfony-s-Code#chapter_02_the_mvc_pattern" >link</a>.
    </p>
    <p class="bibitem" ><span class="biblabel">
  [2]<span class="bibsp">   </span></span><a 
 id="Xmobile_market"></a>Mobile/Tablet  Operating  System  Market  Share,  2016.    [Online;  accessed
    2016-8-28], <a 
href="https://www.netmarketshare.com/operating-system-market-share.aspx?qprid=8&qpcustomd=1" >link</a>.
    </p>
    <p class="bibitem" ><span class="biblabel">
  [3]<span class="bibsp">   </span></span><a 
 id="XFernandez_Alcon_2009"></a>Jose Fernandez Alcon, Calina Ciuhu, Warner ten Kate, Adrienne Heinrich,
    Natallia  Uzunbajakava,  Gertruud  Krekels,  Denny  Siem,  and  Gerard  de Haan.
    Automatic Imaging System With Decision Support for Inspection of Pigmented
    Skin Lesions and Melanoma Diagnosis. <span 
class="ptmri7t-">IEEE</span>, 3(1):1425, feb 2009.
    </p>
    <p class="bibitem" ><span class="biblabel">
  [4]<span class="bibsp">   </span></span><a 
 id="Xapple_MVC"></a>Apple. Model-View-Controller, 2015. [Online; accessed 2016-8-27], <a 
href="https://developer.apple.com/library/ios/documentation/General/Conceptual/DevPedia-CocoaCore/MVC.html" >link</a>.
    </p>
    <p class="bibitem" ><span class="biblabel">
  [5]<span class="bibsp">   </span></span><a 
 id="XBrewer_2013"></a>Ann Chang Brewer, Dawnielle C. Endly, Jill Henley, Mahsa Amir, Blake P.
    Sampson, Jacqueline F. Moreau, and Robert P. Dellavalle.  Mobile Applications
    in Dermatology. <span 
class="ptmri7t-">JAMA Dermatol</span>, 149(11):1300, nov 2013.
    </p>
    <p class="bibitem" ><span class="biblabel">
  [6]<span class="bibsp">   </span></span><a 
 id="Xmvp_testing"></a>Martin Fowler.  GUI Architectures, Humble View, 2006.  [Online; accessed
    2016-8-28], <a 
href="http://martinfowler.com/eaaDev/uiArchs.html#HumbleView" >link</a>.
    </p>
    <p class="bibitem" ><span class="biblabel">
  [7]<span class="bibsp">   </span></span><a 
 id="Xmvw"></a>Igor Minar.  MVC vs MVVM vs MVP, 2012.  [Online; accessed 2016-8-28],
    <a 
href="https://plus.google.com/+IgorMinar/posts/DRUAkZmXjNV" >link</a>.
                                                                  

                                                                  
    </p>
    <p class="bibitem" ><span class="biblabel">
  [8]<span class="bibsp">   </span></span><a 
 id="X9781937538774"></a>Klaus  Pohl  and  Chris  Rupp.   <span 
class="ptmri7t-">Requirements  Engineering  Fundamentals:  A</span>
    <span 
class="ptmri7t-">Study Guide for the Certified Professional for Requirements Engineering Exam -</span>
    <span 
class="ptmri7t-">Foundation Level - IREB compliant</span>. Rocky Nook, 2015.
    </p>
    <p class="bibitem" ><span class="biblabel">
  [9]<span class="bibsp">   </span></span><a 
 id="XPremaladha_2014"></a>J. Premaladha  and  K.S.  Ravichandr.    Asymmetry  Analysis  of  Malignant
    Melanoma  Using  Image  Processing:  A  Survey.    <span 
class="ptmri7t-">J.  of  Artificial  Intelligence</span>,
    7(2):4553, feb 2014.
    </p>
    <p class="bibitem" ><span class="biblabel">
 [10]<span class="bibsp">   </span></span><a 
 id="Xviper"></a>Ryan Quan. Brigades Experience Using an MVC Alternative, 2014. [Online;
    accessed 2016-8-28], <a 
href="https://medium.com/brigade-engineering/brigades-experience-using-an-mvc-alternative-36ef1601a41f#.yw4bp1y48" >link</a>.
    </p>
    <p class="bibitem" ><span class="biblabel">
 [11]<span class="bibsp">   </span></span><a 
 id="XSiddiq_2015"></a>Sophia.M   Mallikarjun   Mundas Vidya.R   Siddiq Iqbal,   Divyashree.J.A.
    Implementation  of  Stolzs  Algorithm  for  Melanoma  Detection.    <span 
class="ptmri7t-">International</span>
    <span 
class="ptmri7t-">Advanced Research Journal in Science, Engineering and Technology IARJSET</span>,
    2(6), jun 2015.
    </p>
    <p class="bibitem" ><span class="biblabel">
 [12]<span class="bibsp">   </span></span><a 
 id="Xwalther_2016"></a>Stephen  Walther.      The  Evolution  of  MVC,  2016.      [Online;  accessed
    2016-8-27], <a 
href="http://stephenwalther.com/archive/2008/08/24/the-evolution-of-mvc" >link</a>.
    </p>
    <p class="bibitem" ><span class="biblabel">
 [13]<span class="bibsp">   </span></span><a 
 id="XWeigert_2012"></a>Ulrike Weigert, Walter H.C. Burgdorf, and Wilhelm Stolz.  ABCD Rule.  In
    <span 
class="ptmri7t-">Atlas of Dermoscopy</span>, page 116. Informa Healthcare, aug 2012.
</p>
    </div>
                                                                  

                                                                  
   <h2 class="chapterHead"><span class="titlemark">Chapter 13</span><br /><a 
 id="x1-7700013"></a>Appendix</h2>
   <h3 class="sectionHead"><span class="titlemark">13.1    </span> <a 
 id="x1-7800013.1"></a>Optimizations</h3>
<!--l. 3--><p class="noindent" >
   <h4 class="subsectionHead"><span class="titlemark">13.1.1    </span> <a 
 id="x1-7900013.1.1"></a>Border Extraction</h4>
<!--l. 5--><p class="noindent" >
   <h4 class="subsectionHead"><span class="titlemark">13.1.2    </span> <a 
 id="x1-8000013.1.2"></a>SFA Threshold</h4>
<!--l. 7--><p class="noindent" >
   <h4 class="subsectionHead"><span class="titlemark">13.1.3    </span> <a 
 id="x1-8100013.1.3"></a>TDS Evaluation</h4>
<a 
 id="x1-81001r1"></a>
   <!--l. 3--><div class="longtable"> <table id="TBL-33" class="longtable" 
cellspacing="0" cellpadding="0" rules="groups" 
><colgroup id="TBL-33-1g"><col 
id="TBL-33-1"></colgroup><colgroup id="TBL-33-2g"><col 
id="TBL-33-2"></colgroup><colgroup id="TBL-33-3g"><col 
id="TBL-33-3"></colgroup><colgroup id="TBL-33-4g"><col 
id="TBL-33-4"></colgroup><colgroup id="TBL-33-5g"><col 
id="TBL-33-5"></colgroup><colgroup id="TBL-33-6g"><col 
id="TBL-33-6"></colgroup><colgroup id="TBL-33-7g"><col 
id="TBL-33-7"></colgroup>
<tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-33-1-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-1-1"  
class="td11"> Name           </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-1-2"  
class="td11"> Source      </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-1-3"  
class="td11"> Category                      </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-1-4"  
class="td11"> Asymmetry  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-1-5"  
class="td11"> Border  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-1-6"  
class="td11"> Color  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-1-7"  
class="td11"> TDS  </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-33-2-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-2-1"  
class="td11"> B1052.png  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-2-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-2-3"  
class="td11"> Malignant Melanoma  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-2-4"  
class="td11"> 2                   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-2-5"  
class="td11"> 4            </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-2-6"  
class="td11"> 3.0       </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-2-7"  
class="td11"> 4.50   </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-3-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-3-1"  
class="td11"> B287.png    </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-3-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-3-3"  
class="td11"> Malignant Melanoma  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-3-4"  
class="td11"> 2                   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-3-5"  
class="td11"> 5            </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-3-6"  
class="td11"> 2.0       </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-3-7"  
class="td11"> 4.10   </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-4-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-4-1"  
class="td11"> B302.png    </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-4-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-4-3"  
class="td11"> Malignant Melanoma  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-4-4"  
class="td11"> 0                   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-4-5"  
class="td11"> 3            </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-4-6"  
class="td11"> 2.0       </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-4-7"  
class="td11"> 1.30   </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-5-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-5-1"  
class="td11"> B314.png    </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-5-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-5-3"  
class="td11"> Malignant Melanoma  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-5-4"  
class="td11"> 2                   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-5-5"  
class="td11"> 6            </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-5-6"  
class="td11"> 2.0       </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-5-7"  
class="td11"> 4.20   </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-6-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-6-1"  
class="td11"> B65.png      </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-6-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-6-3"  
class="td11"> Malignant Melanoma  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-6-4"  
class="td11"> 2                   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-6-5"  
class="td11"> 4            </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-6-6"  
class="td11"> 3.0       </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-6-7"  
class="td11"> 4.50   </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-7-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-7-1"  
class="td11"> C158.png    </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-7-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-7-3"  
class="td11"> Malignant Melanoma  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-7-4"  
class="td11"> 0                   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-7-5"  
class="td11"> 2            </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-7-6"  
class="td11"> 3.0       </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-7-7"  
class="td11"> 1.70   </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-8-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-8-1"  
class="td11"> C201.png    </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-8-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-8-3"  
class="td11"> Malignant Melanoma  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-8-4"  
class="td11"> 2                   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-8-5"  
class="td11"> 4            </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-8-6"  
class="td11"> 3.0       </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-8-7"  
class="td11"> 4.50   </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-9-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-9-1"  
class="td11"> C263a.png   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-9-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-9-3"  
class="td11"> Malignant Melanoma  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-9-4"  
class="td11"> 2                   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-9-5"  
class="td11"> 4            </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-9-6"  
class="td11"> 3.0       </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-9-7"  
class="td11"> 4.50   </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-10-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-10-1"  
class="td11"> C311b.png   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-10-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-10-3"  
class="td11"> Malignant Melanoma  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-10-4"  
class="td11"> 2                   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-10-5"  
class="td11"> 8            </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-10-6"  
class="td11"> 3.0       </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-10-7"  
class="td11"> 4.90   </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-11-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-11-1"  
class="td11"> C359.png    </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-11-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-11-3"  
class="td11"> Malignant Melanoma  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-11-4"  
class="td11"> 1                   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-11-5"  
class="td11"> 3            </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-11-6"  
class="td11"> 3.0       </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-11-7"  
class="td11"> 3.10   </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-12-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-12-1"  
class="td11"> D143.png    </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-12-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-12-3"  
class="td11"> Malignant Melanoma  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-12-4"  
class="td11"> 0                   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-12-5"  
class="td11"> 1            </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-12-6"  
class="td11"> 3.0       </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-12-7"  
class="td11"> 1.60   </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-13-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-13-1"  
class="td11"> D39.png      </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-13-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-13-3"  
class="td11"> Malignant Melanoma  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-13-4"  
class="td11"> 2                   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-13-5"  
class="td11"> 3            </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-13-6"  
class="td11"> 3.0       </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-13-7"  
class="td11"> 4.40   </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-14-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-14-1"  
class="td11"> D630.png    </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-14-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-14-3"  
class="td11"> Malignant Melanoma  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-14-4"  
class="td11"> 0                   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-14-5"  
class="td11"> 2            </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-14-6"  
class="td11"> 1.0       </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-14-7"  
class="td11"> 0.70   </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-15-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-15-1"  
class="td11"> D678.png    </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-15-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-15-3"  
class="td11"> Malignant Melanoma  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-15-4"  
class="td11"> 0                   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-15-5"  
class="td11"> 0            </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-15-6"  
class="td11"> 3.0       </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-15-7"  
class="td11"> 1.50   </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-16-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-16-1"  
class="td11"> T233a.png   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-16-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-16-3"  
class="td11"> Malignant Melanoma  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-16-4"  
class="td11"> 1                   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-16-5"  
class="td11"> 8            </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-16-6"  
class="td11"> 2.0       </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-16-7"  
class="td11"> 3.10   </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-17-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-17-1"  
class="td11"> T86b.png     </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-17-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-17-3"  
class="td11"> Malignant Melanoma  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-17-4"  
class="td11"> 1                   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-17-5"  
class="td11"> 3            </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-17-6"  
class="td11"> 3.0       </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-17-7"  
class="td11"> 3.10   </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-18-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-18-1"  
class="td11"> A121a.png  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-18-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-18-3"  
class="td11"> Melanocytic Nevus      </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-18-4"  
class="td11"> 0                   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-18-5"  
class="td11"> 3            </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-18-6"  
class="td11"> 3.0       </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-18-7"  
class="td11"> 1.80   </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-19-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-19-1"  
class="td11"> A21b.png    </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-19-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-19-3"  
class="td11"> Melanocytic Nevus      </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-19-4"  
class="td11"> 0                   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-19-5"  
class="td11"> 2            </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-19-6"  
class="td11"> 2.0       </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-19-7"  
class="td11"> 1.20   </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-20-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-20-1"  
class="td11"> A2b.png      </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-20-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-20-3"  
class="td11"> Melanocytic Nevus      </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-20-4"  
class="td11"> 1                   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-20-5"  
class="td11"> 2            </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-20-6"  
class="td11"> 2.0       </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-20-7"  
class="td11"> 2.50   </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-21-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-21-1"  
class="td11">           </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-21-2"  
class="td11">         </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-21-3"  
class="td11">                   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-21-4"  
class="td11">           </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-21-5"  
class="td11">        </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-21-6"  
class="td11">       </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-21-7"  
class="td11"></td></tr>
<tr  
 style="vertical-align:baseline;" id="TBL-33-22-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-22-1"  
class="td11"> A8c.png      </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-22-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-22-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-22-4"  
class="td11"> 2  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-22-5"  
class="td11"> 4  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-22-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-22-7"  
class="td11"> 4.00  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-23-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-23-1"  
class="td11"> A8d.png      </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-23-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-23-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-23-4"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-23-5"  
class="td11"> 2  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-23-6"  
class="td11"> 1.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-23-7"  
class="td11"> 2.00  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-24-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-24-1"  
class="td11"> A8e.png      </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-24-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-24-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-24-4"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-24-5"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-24-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-24-7"  
class="td11"> 1.10  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-25-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-25-1"  
class="td11"> B125c.png   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-25-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-25-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-25-4"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-25-5"  
class="td11"> 2  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-25-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-25-7"  
class="td11"> 2.50  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-26-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-26-1"  
class="td11"> B157.png    </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-26-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-26-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-26-4"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-26-5"  
class="td11"> 2  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-26-6"  
class="td11"> 3.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-26-7"  
class="td11"> 3.00  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-27-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-27-1"  
class="td11"> B17a.png     </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-27-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-27-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-27-4"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-27-5"  
class="td11"> 2  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-27-6"  
class="td11"> 3.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-27-7"  
class="td11"> 3.00  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-28-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-28-1"  
class="td11"> B17b.png     </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-28-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-28-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-28-4"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-28-5"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-28-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-28-7"  
class="td11"> 2.40  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-29-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-29-1"  
class="td11"> B17c.png     </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-29-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-29-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-29-4"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-29-5"  
class="td11"> 2  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-29-6"  
class="td11"> 1.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-29-7"  
class="td11"> 2.00  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-30-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-30-1"  
class="td11"> B17f.png     </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-30-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-30-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-30-4"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-30-5"  
class="td11"> 3  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-30-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-30-7"  
class="td11"> 2.60  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-31-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-31-1"  
class="td11"> B197d.png  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-31-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-31-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-31-4"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-31-5"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-31-6"  
class="td11"> 1.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-31-7"  
class="td11"> 1.80  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-32-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-32-1"  
class="td11"> B202b.png   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-32-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-32-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-32-4"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-32-5"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-32-6"  
class="td11"> 3.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-32-7"  
class="td11"> 2.80  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-33-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-33-1"  
class="td11"> B293b.png   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-33-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-33-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-33-4"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-33-5"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-33-6"  
class="td11"> 1.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-33-7"  
class="td11"> 0.60  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-34-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-34-1"  
class="td11"> B293d.png  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-34-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-34-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-34-4"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-34-5"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-34-6"  
class="td11"> 1.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-34-7"  
class="td11"> 0.60  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-35-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-35-1"  
class="td11"> B293e.png   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-35-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-35-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-35-4"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-35-5"  
class="td11"> 2  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-35-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-35-7"  
class="td11"> 1.20  </td>
                                                                  

                                                                  
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-36-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-36-1"  
class="td11"> B311c.png   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-36-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-36-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-36-4"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-36-5"  
class="td11"> 4  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-36-6"  
class="td11"> 1.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-36-7"  
class="td11"> 2.20  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-37-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-37-1"  
class="td11"> B350a.png   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-37-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-37-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-37-4"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-37-5"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-37-6"  
class="td11"> 1.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-37-7"  
class="td11"> 0.50  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-38-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-38-1"  
class="td11"> B355b.png   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-38-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-38-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-38-4"  
class="td11"> 2  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-38-5"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-38-6"  
class="td11"> 1.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-38-7"  
class="td11"> 3.10  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-39-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-39-1"  
class="td11"> B356.png    </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-39-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-39-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-39-4"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-39-5"  
class="td11"> 2  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-39-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-39-7"  
class="td11"> 2.50  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-40-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-40-1"  
class="td11"> B361a.png   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-40-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-40-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-40-4"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-40-5"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-40-6"  
class="td11"> 1.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-40-7"  
class="td11"> 0.60  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-41-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-41-1"  
class="td11"> B379a.png   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-41-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-41-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-41-4"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-41-5"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-41-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-41-7"  
class="td11"> 1.00  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-42-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-42-1"  
class="td11">         </td></tr>
<tr  
 style="vertical-align:baseline;" id="TBL-33-43-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-43-1"  
class="td11"> B379b.png  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-43-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-43-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-43-4"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-43-5"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-43-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-43-7"  
class="td11"> 2.40  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-44-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-44-1"  
class="td11"> B447a.png  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-44-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-44-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-44-4"  
class="td11"> 2  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-44-5"  
class="td11"> 8  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-44-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-44-7"  
class="td11"> 4.40  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-45-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-45-1"  
class="td11"> B447b.png  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-45-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-45-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-45-4"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-45-5"  
class="td11"> 3  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-45-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-45-7"  
class="td11"> 2.60  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-46-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-46-1"  
class="td11"> B472b.png  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-46-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-46-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-46-4"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-46-5"  
class="td11"> 2  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-46-6"  
class="td11"> 1.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-46-7"  
class="td11"> 0.70  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-47-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-47-1"  
class="td11"> B508.png    </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-47-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-47-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-47-4"  
class="td11"> 2  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-47-5"  
class="td11"> 5  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-47-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-47-7"  
class="td11"> 4.10  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-48-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-48-1"  
class="td11"> B522b.png  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-48-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-48-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-48-4"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-48-5"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-48-6"  
class="td11"> 1.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-48-7"  
class="td11"> 0.50  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-49-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-49-1"  
class="td11"> B52a.png    </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-49-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-49-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-49-4"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-49-5"  
class="td11"> 2  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-49-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-49-7"  
class="td11"> 2.50  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-50-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-50-1"  
class="td11"> B52c.png    </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-50-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-50-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-50-4"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-50-5"  
class="td11"> 4  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-50-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-50-7"  
class="td11"> 1.40  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-51-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-51-1"  
class="td11"> B543.png    </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-51-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-51-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-51-4"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-51-5"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-51-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-51-7"  
class="td11"> 1.00  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-52-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-52-1"  
class="td11"> B549c.png  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-52-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-52-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-52-4"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-52-5"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-52-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-52-7"  
class="td11"> 2.40  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-53-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-53-1"  
class="td11"> B574.png    </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-53-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-53-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-53-4"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-53-5"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-53-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-53-7"  
class="td11"> 2.30  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-54-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-54-1"  
class="td11"> B598a.png  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-54-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-54-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-54-4"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-54-5"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-54-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-54-7"  
class="td11"> 2.40  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-55-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-55-1"  
class="td11"> B612b.png  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-55-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-55-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-55-4"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-55-5"  
class="td11"> 2  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-55-6"  
class="td11"> 1.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-55-7"  
class="td11"> 2.00  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-56-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-56-1"  
class="td11"> B654c.png  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-56-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-56-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-56-4"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-56-5"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-56-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-56-7"  
class="td11"> 1.10  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-57-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-57-1"  
class="td11"> B66c.png    </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-57-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-57-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-57-4"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-57-5"  
class="td11"> 3  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-57-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-57-7"  
class="td11"> 1.30  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-58-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-58-1"  
class="td11"> B676a.png  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-58-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-58-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-58-4"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-58-5"  
class="td11"> 3  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-58-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-58-7"  
class="td11"> 1.30  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-59-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-59-1"  
class="td11"> B676b.png  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-59-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-59-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-59-4"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-59-5"  
class="td11"> 4  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-59-6"  
class="td11"> 3.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-59-7"  
class="td11"> 3.20  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-60-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-60-1"  
class="td11"> B69a.png    </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-60-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-60-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-60-4"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-60-5"  
class="td11"> 2  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-60-6"  
class="td11"> 3.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-60-7"  
class="td11"> 3.00  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-61-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-61-1"  
class="td11"> B69b.png    </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-61-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-61-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-61-4"  
class="td11"> 2  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-61-5"  
class="td11"> 2  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-61-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-61-7"  
class="td11"> 3.80  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-62-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-62-1"  
class="td11"> B89e.png    </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-62-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-62-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-62-4"  
class="td11"> 2  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-62-5"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-62-6"  
class="td11"> 1.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-62-7"  
class="td11"> 3.20  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-63-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-63-1"  
class="td11">         </td></tr>
<tr  
 style="vertical-align:baseline;" id="TBL-33-64-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-64-1"  
class="td11"> B91a.png     </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-64-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-64-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-64-4"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-64-5"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-64-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-64-7"  
class="td11"> 1.00  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-65-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-65-1"  
class="td11"> B91b.png     </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-65-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-65-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-65-4"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-65-5"  
class="td11"> 6  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-65-6"  
class="td11"> 3.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-65-7"  
class="td11"> 3.40  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-66-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-66-1"  
class="td11"> B91c.png     </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-66-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-66-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-66-4"  
class="td11"> 2  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-66-5"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-66-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-66-7"  
class="td11"> 3.60  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-67-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-67-1"  
class="td11"> D144.png    </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-67-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-67-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-67-4"  
class="td11"> 2  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-67-5"  
class="td11"> 3  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-67-6"  
class="td11"> 3.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-67-7"  
class="td11"> 4.40  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-68-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-68-1"  
class="td11"> D176b.png  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-68-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-68-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-68-4"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-68-5"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-68-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-68-7"  
class="td11"> 1.00  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-69-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-69-1"  
class="td11"> D239a.png  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-69-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-69-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-69-4"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-69-5"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-69-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-69-7"  
class="td11"> 2.40  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-70-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-70-1"  
class="td11"> D239b.png  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-70-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-70-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-70-4"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-70-5"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-70-6"  
class="td11"> 1.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-70-7"  
class="td11"> 0.50  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-71-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-71-1"  
class="td11"> D271a.png  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-71-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-71-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-71-4"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-71-5"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-71-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-71-7"  
class="td11"> 2.40  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-72-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-72-1"  
class="td11"> D291b.png  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-72-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-72-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-72-4"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-72-5"  
class="td11"> 2  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-72-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-72-7"  
class="td11"> 1.20  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-73-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-73-1"  
class="td11"> D339.png    </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-73-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-73-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-73-4"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-73-5"  
class="td11"> 2  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-73-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-73-7"  
class="td11"> 2.50  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-74-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-74-1"  
class="td11"> D374.png    </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-74-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-74-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-74-4"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-74-5"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-74-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-74-7"  
class="td11"> 1.00  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-75-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-75-1"  
class="td11"> D384.png    </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-75-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-75-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-75-4"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-75-5"  
class="td11"> 7  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-75-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-75-7"  
class="td11"> 1.70  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-76-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-76-1"  
class="td11"> D395.png    </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-76-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-76-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-76-4"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-76-5"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-76-6"  
class="td11"> 3.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-76-7"  
class="td11"> 1.50  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-77-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-77-1"  
class="td11"> D404.png    </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-77-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-77-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-77-4"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-77-5"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-77-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-77-7"  
class="td11"> 1.00  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-78-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-78-1"  
class="td11"> D426.png    </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-78-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-78-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-78-4"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-78-5"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-78-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-78-7"  
class="td11"> 1.00  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-79-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-79-1"  
class="td11"> D427b.png  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-79-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-79-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-79-4"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-79-5"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-79-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-79-7"  
class="td11"> 1.10  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-80-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-80-1"  
class="td11"> D492.png    </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-80-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-80-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-80-4"  
class="td11"> 2  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-80-5"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-80-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-80-7"  
class="td11"> 3.70  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-81-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-81-1"  
class="td11"> D526b.png  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-81-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-81-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-81-4"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-81-5"  
class="td11"> 2  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-81-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-81-7"  
class="td11"> 1.20  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-82-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-82-1"  
class="td11"> D567b.png  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-82-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-82-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-82-4"  
class="td11"> 2  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-82-5"  
class="td11"> 2  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-82-6"  
class="td11"> 1.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-82-7"  
class="td11"> 3.30  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-83-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-83-1"  
class="td11"> D626.png    </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-83-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-83-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-83-4"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-83-5"  
class="td11"> 2  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-83-6"  
class="td11"> 3.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-83-7"  
class="td11"> 1.70  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-84-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-84-1"  
class="td11">         </td></tr>
<tr  
 style="vertical-align:baseline;" id="TBL-33-85-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-85-1"  
class="td11"> D715.png    </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-85-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-85-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-85-4"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-85-5"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-85-6"  
class="td11"> 1.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-85-7"  
class="td11"> 0.50  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-86-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-86-1"  
class="td11"> D722.png    </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-86-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-86-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-86-4"  
class="td11"> 2  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-86-5"  
class="td11"> 6  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-86-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-86-7"  
class="td11"> 4.20  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-87-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-87-1"  
class="td11"> D723a.png   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-87-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-87-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-87-4"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-87-5"  
class="td11"> 2  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-87-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-87-7"  
class="td11"> 2.50  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-88-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-88-1"  
class="td11"> D726d.png  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-88-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-88-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-88-4"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-88-5"  
class="td11"> 7  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-88-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-88-7"  
class="td11"> 1.70  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-89-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-89-1"  
class="td11"> D726e.png   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-89-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-89-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-89-4"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-89-5"  
class="td11"> 3  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-89-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-89-7"  
class="td11"> 2.60  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-90-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-90-1"  
class="td11"> P103a.png   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-90-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-90-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-90-4"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-90-5"  
class="td11"> 3  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-90-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-90-7"  
class="td11"> 1.30  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-91-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-91-1"  
class="td11"> P126b.png   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-91-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-91-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-91-4"  
class="td11"> 2  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-91-5"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-91-6"  
class="td11"> 1.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-91-7"  
class="td11"> 3.20  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-92-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-92-1"  
class="td11"> P144.png     </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-92-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-92-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-92-4"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-92-5"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-92-6"  
class="td11"> 1.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-92-7"  
class="td11"> 0.60  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-93-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-93-1"  
class="td11"> P18.png       </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-93-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-93-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-93-4"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-93-5"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-93-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-93-7"  
class="td11"> 2.40  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-94-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-94-1"  
class="td11"> P196.png     </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-94-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-94-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-94-4"  
class="td11"> 2  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-94-5"  
class="td11"> 3  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-94-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-94-7"  
class="td11"> 3.90  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-95-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-95-1"  
class="td11"> P199.png     </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-95-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-95-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-95-4"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-95-5"  
class="td11"> 2  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-95-6"  
class="td11"> 1.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-95-7"  
class="td11"> 2.00  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-96-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-96-1"  
class="td11"> P2.png         </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-96-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-96-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-96-4"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-96-5"  
class="td11"> 3  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-96-6"  
class="td11"> 1.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-96-7"  
class="td11"> 0.80  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-97-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-97-1"  
class="td11"> P237b.png   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-97-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-97-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-97-4"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-97-5"  
class="td11"> 6  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-97-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-97-7"  
class="td11"> 2.90  </td>
                                                                  

                                                                  
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-98-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-98-1"  
class="td11"> P256a.png   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-98-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-98-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-98-4"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-98-5"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-98-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-98-7"  
class="td11"> 1.00  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-99-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-99-1"  
class="td11"> P271f.png    </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-99-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-99-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-99-4"  
class="td11"> 2  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-99-5"  
class="td11"> 2  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-99-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-99-7"  
class="td11"> 3.80  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-100-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-100-1"  
class="td11"> P277b.png   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-100-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-100-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-100-4"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-100-5"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-100-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-100-7"  
class="td11"> 2.40  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-101-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-101-1"  
class="td11"> P291.png     </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-101-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-101-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-101-4"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-101-5"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-101-6"  
class="td11"> 3.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-101-7"  
class="td11"> 1.50  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-102-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-102-1"  
class="td11"> P304a.png   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-102-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-102-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-102-4"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-102-5"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-102-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-102-7"  
class="td11"> 2.30  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-103-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-103-1"  
class="td11"> P306a.png   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-103-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-103-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-103-4"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-103-5"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-103-6"  
class="td11"> 3.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-103-7"  
class="td11"> 2.80  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-104-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-104-1"  
class="td11"> P306c.png   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-104-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-104-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-104-4"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-104-5"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-104-6"  
class="td11"> 3.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-104-7"  
class="td11"> 1.50  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-105-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-105-1"  
class="td11">         </td></tr>
<tr  
 style="vertical-align:baseline;" id="TBL-33-106-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-106-1"  
class="td11"> P337a.png   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-106-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-106-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-106-4"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-106-5"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-106-6"  
class="td11"> 3.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-106-7"  
class="td11"> 1.50  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-107-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-107-1"  
class="td11"> P337b.png   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-107-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-107-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-107-4"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-107-5"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-107-6"  
class="td11"> 3.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-107-7"  
class="td11"> 1.60  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-108-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-108-1"  
class="td11"> P337d.png  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-108-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-108-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-108-4"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-108-5"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-108-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-108-7"  
class="td11"> 1.00  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-109-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-109-1"  
class="td11"> P337e.png   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-109-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-109-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-109-4"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-109-5"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-109-6"  
class="td11"> 1.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-109-7"  
class="td11"> 1.90  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-110-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-110-1"  
class="td11"> P354a.png   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-110-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-110-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-110-4"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-110-5"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-110-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-110-7"  
class="td11"> 1.10  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-111-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-111-1"  
class="td11"> P359b.png   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-111-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-111-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-111-4"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-111-5"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-111-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-111-7"  
class="td11"> 1.10  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-112-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-112-1"  
class="td11"> P365d.png  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-112-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-112-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-112-4"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-112-5"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-112-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-112-7"  
class="td11"> 1.10  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-113-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-113-1"  
class="td11"> P365e.png   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-113-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-113-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-113-4"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-113-5"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-113-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-113-7"  
class="td11"> 2.40  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-114-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-114-1"  
class="td11"> P376b.png   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-114-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-114-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-114-4"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-114-5"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-114-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-114-7"  
class="td11"> 2.40  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-115-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-115-1"  
class="td11"> P376d.png  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-115-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-115-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-115-4"  
class="td11"> 2  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-115-5"  
class="td11"> 5  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-115-6"  
class="td11"> 1.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-115-7"  
class="td11"> 3.60  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-116-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-116-1"  
class="td11"> P382a.png   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-116-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-116-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-116-4"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-116-5"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-116-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-116-7"  
class="td11"> 1.10  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-117-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-117-1"  
class="td11"> P384b.png   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-117-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-117-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-117-4"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-117-5"  
class="td11"> 2  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-117-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-117-7"  
class="td11"> 2.50  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-118-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-118-1"  
class="td11"> P384c.png   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-118-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-118-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-118-4"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-118-5"  
class="td11"> 7  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-118-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-118-7"  
class="td11"> 3.00  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-119-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-119-1"  
class="td11"> P392.png    </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-119-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-119-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-119-4"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-119-5"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-119-6"  
class="td11"> 3.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-119-7"  
class="td11"> 1.60  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-120-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-120-1"  
class="td11"> P399.png    </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-120-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-120-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-120-4"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-120-5"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-120-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-120-7"  
class="td11"> 2.40  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-121-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-121-1"  
class="td11"> P404a.png   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-121-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-121-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-121-4"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-121-5"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-121-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-121-7"  
class="td11"> 2.30  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-122-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-122-1"  
class="td11"> P404c.png   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-122-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-122-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-122-4"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-122-5"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-122-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-122-7"  
class="td11"> 1.00  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-123-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-123-1"  
class="td11"> P407b.png   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-123-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-123-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-123-4"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-123-5"  
class="td11"> 2  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-123-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-123-7"  
class="td11"> 1.20  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-124-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-124-1"  
class="td11"> P407c.png   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-124-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-124-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-124-4"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-124-5"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-124-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-124-7"  
class="td11"> 1.10  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-125-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-125-1"  
class="td11"> P432.png    </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-125-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-125-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-125-4"  
class="td11"> 2  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-125-5"  
class="td11"> 4  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-125-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-125-7"  
class="td11"> 4.00  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-126-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-126-1"  
class="td11">         </td></tr>
<tr  
 style="vertical-align:baseline;" id="TBL-33-127-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-127-1"  
class="td11"> P435b.png  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-127-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-127-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-127-4"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-127-5"  
class="td11"> 3  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-127-6"  
class="td11"> 3.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-127-7"  
class="td11"> 1.80  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-128-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-128-1"  
class="td11"> P454a.png  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-128-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-128-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-128-4"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-128-5"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-128-6"  
class="td11"> 3.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-128-7"  
class="td11"> 2.90  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-129-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-129-1"  
class="td11"> P454b.png  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-129-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-129-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-129-4"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-129-5"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-129-6"  
class="td11"> 1.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-129-7"  
class="td11"> 0.50  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-130-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-130-1"  
class="td11"> P45a.png    </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-130-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-130-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-130-4"  
class="td11"> 2  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-130-5"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-130-6"  
class="td11"> 3.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-130-7"  
class="td11"> 4.20  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-131-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-131-1"  
class="td11"> P45b.png    </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-131-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-131-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-131-4"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-131-5"  
class="td11"> 5  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-131-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-131-7"  
class="td11"> 2.80  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-132-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-132-1"  
class="td11"> P49.png      </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-132-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-132-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-132-4"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-132-5"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-132-6"  
class="td11"> 3.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-132-7"  
class="td11"> 1.50  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-133-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-133-1"  
class="td11"> P505c.png  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-133-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-133-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-133-4"  
class="td11"> 2  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-133-5"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-133-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-133-7"  
class="td11"> 3.70  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-134-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-134-1"  
class="td11"> P505e.png  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-134-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-134-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-134-4"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-134-5"  
class="td11"> 7  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-134-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-134-7"  
class="td11"> 3.00  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-135-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-135-1"  
class="td11"> P509c.png  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-135-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-135-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-135-4"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-135-5"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-135-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-135-7"  
class="td11"> 2.40  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-136-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-136-1"  
class="td11"> P53b.png    </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-136-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-136-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-136-4"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-136-5"  
class="td11"> 6  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-136-6"  
class="td11"> 1.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-136-7"  
class="td11"> 1.10  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-137-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-137-1"  
class="td11"> P56b.png    </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-137-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-137-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-137-4"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-137-5"  
class="td11"> 2  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-137-6"  
class="td11"> 3.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-137-7"  
class="td11"> 1.70  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-138-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-138-1"  
class="td11"> P58.png      </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-138-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-138-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-138-4"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-138-5"  
class="td11"> 3  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-138-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-138-7"  
class="td11"> 1.30  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-139-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-139-1"  
class="td11"> P63.png      </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-139-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-139-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-139-4"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-139-5"  
class="td11"> 6  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-139-6"  
class="td11"> 1.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-139-7"  
class="td11"> 2.40  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-140-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-140-1"  
class="td11"> P88b.png    </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-140-2"  
class="td11"> Dermofit  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-140-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-140-4"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-140-5"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-140-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-33-140-7"  
class="td11"> 1.00  </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-33-141-"><td colspan="6" style="white-space:nowrap; text-align:left;" id="TBL-33-141-1"  
class="td11"></td>     <div class="multicolumn"  style="white-space:nowrap; text-align:center;"><div class="caption" 
><span class="id">Table 13.1: </span><span  
class="content">Results of TDS calculation for Dermfit</span></div><!--tex4ht:label?: x1-81001r1 -->                                </div>            <a 
 id="x1-81002"></a>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-142-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-142-1"  
class="td11">         </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-143-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-143-1"  
class="td11">         </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-144-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-144-1"  
class="td11">         </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-33-145-"><td  style="white-space:nowrap; text-align:left;" id="TBL-33-145-1"  
class="td11">         </td></tr>
   </table></div>
<a 
 id="x1-81003r2"></a>
   <!--l. 143--><div class="longtable"><table id="TBL-34" class="longtable" 
cellspacing="0" cellpadding="0" rules="groups" 
><colgroup id="TBL-34-1g"><col 
id="TBL-34-1"></colgroup><colgroup id="TBL-34-2g"><col 
id="TBL-34-2"></colgroup><colgroup id="TBL-34-3g"><col 
id="TBL-34-3"></colgroup><colgroup id="TBL-34-4g"><col 
id="TBL-34-4"></colgroup><colgroup id="TBL-34-5g"><col 
id="TBL-34-5"></colgroup><colgroup id="TBL-34-6g"><col 
id="TBL-34-6"></colgroup><colgroup id="TBL-34-7g"><col 
id="TBL-34-7"></colgroup>
<tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-34-1-"><td  style="white-space:nowrap; text-align:left;" id="TBL-34-1-1"  
class="td11"> Name                  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-1-2"  
class="td11"> Source          </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-1-3"  
class="td11"> Category                      </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-1-4"  
class="td11"> Asymmetry  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-1-5"  
class="td11"> Border  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-1-6"  
class="td11"> Color  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-1-7"  
class="td11"> TDS  </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-34-2-"><td  style="white-space:nowrap; text-align:left;" id="TBL-34-2-1"  
class="td11"> 012383HB.jpeg  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-2-2"  
class="td11"> DermQuest  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-2-3"  
class="td11"> Benign Keratosis         </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-2-4"  
class="td11"> 2                   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-2-5"  
class="td11"> 5            </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-2-6"  
class="td11"> 3.0       </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-2-7"  
class="td11"> 4.60   </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-34-3-"><td  style="white-space:nowrap; text-align:left;" id="TBL-34-3-1"  
class="td11"> 012824HB.JPG   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-3-2"  
class="td11"> DermQuest  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-3-3"  
class="td11"> Benign Keratosis         </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-3-4"  
class="td11"> 0                   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-3-5"  
class="td11"> 2            </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-3-6"  
class="td11"> 3.0       </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-3-7"  
class="td11"> 1.70   </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-34-4-"><td  style="white-space:nowrap; text-align:left;" id="TBL-34-4-1"  
class="td11"> 019462HB.JPG   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-4-2"  
class="td11"> DermQuest  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-4-3"  
class="td11"> Malignant Melanoma  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-4-4"  
class="td11"> 2                   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-4-5"  
class="td11"> 4            </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-4-6"  
class="td11"> 3.0       </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-4-7"  
class="td11"> 4.50   </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-34-5-"><td  style="white-space:nowrap; text-align:left;" id="TBL-34-5-1"  
class="td11"> 019475HB.JPG   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-5-2"  
class="td11"> DermQuest  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-5-3"  
class="td11"> Malignant Melanoma  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-5-4"  
class="td11"> 1                   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-5-5"  
class="td11"> 2            </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-5-6"  
class="td11"> 3.0       </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-5-7"  
class="td11"> 3.00   </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-34-6-"><td  style="white-space:nowrap; text-align:left;" id="TBL-34-6-1"  
class="td11"> 019523HB.JPG   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-6-2"  
class="td11"> DermQuest  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-6-3"  
class="td11"> Malignant Melanoma  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-6-4"  
class="td11"> 2                   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-6-5"  
class="td11"> 2            </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-6-6"  
class="td11"> 6.0       </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-6-7"  
class="td11"> 5.80   </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-34-7-"><td  style="white-space:nowrap; text-align:left;" id="TBL-34-7-1"  
class="td11"> 019563HB.JPG   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-7-2"  
class="td11"> DermQuest  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-7-3"  
class="td11"> Malignant Melanoma  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-7-4"  
class="td11"> 2                   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-7-5"  
class="td11"> 1            </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-7-6"  
class="td11"> 4.0       </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-7-7"  
class="td11"> 4.70   </td>
                                                                  

                                                                  
</tr><tr  
 style="vertical-align:baseline;" id="TBL-34-8-"><td  style="white-space:nowrap; text-align:left;" id="TBL-34-8-1"  
class="td11"> 019578HB.JPG   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-8-2"  
class="td11"> DermQuest  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-8-3"  
class="td11"> Malignant Melanoma  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-8-4"  
class="td11"> 2                   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-8-5"  
class="td11"> 2            </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-8-6"  
class="td11"> 2.0       </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-8-7"  
class="td11"> 3.80   </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-34-9-"><td  style="white-space:nowrap; text-align:left;" id="TBL-34-9-1"  
class="td11"> 019681HB.JPG   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-9-2"  
class="td11"> DermQuest  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-9-3"  
class="td11"> Malignant Melanoma  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-9-4"  
class="td11"> 1                   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-9-5"  
class="td11"> 4            </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-9-6"  
class="td11"> 3.0       </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-9-7"  
class="td11"> 3.20   </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-34-10-"><td  style="white-space:nowrap; text-align:left;" id="TBL-34-10-1"  
class="td11"> 019682HB.JPG   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-10-2"  
class="td11"> DermQuest  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-10-3"  
class="td11"> Malignant Melanoma  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-10-4"  
class="td11"> 1                   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-10-5"  
class="td11"> 5            </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-10-6"  
class="td11"> 3.0       </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-10-7"  
class="td11"> 3.30   </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-34-11-"><td  style="white-space:nowrap; text-align:left;" id="TBL-34-11-1"  
class="td11"> 019725HB.JPG   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-11-2"  
class="td11"> DermQuest  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-11-3"  
class="td11"> Malignant Melanoma  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-11-4"  
class="td11"> 0                   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-11-5"  
class="td11"> 2            </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-11-6"  
class="td11"> 4.0       </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-11-7"  
class="td11"> 2.20   </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-34-12-"><td  style="white-space:nowrap; text-align:left;" id="TBL-34-12-1"  
class="td11"> 019736HB.JPG   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-12-2"  
class="td11"> DermQuest  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-12-3"  
class="td11"> Malignant Melanoma  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-12-4"  
class="td11"> 1                   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-12-5"  
class="td11"> 1            </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-12-6"  
class="td11"> 3.0       </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-12-7"  
class="td11"> 2.90   </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-34-13-"><td  style="white-space:nowrap; text-align:left;" id="TBL-34-13-1"  
class="td11"> 020192HB.JPG   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-13-2"  
class="td11"> DermQuest  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-13-3"  
class="td11"> Malignant Melanoma  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-13-4"  
class="td11"> 1                   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-13-5"  
class="td11"> 5            </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-13-6"  
class="td11"> 4.0       </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-13-7"  
class="td11"> 3.80   </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-34-14-"><td  style="white-space:nowrap; text-align:left;" id="TBL-34-14-1"  
class="td11"> 020250HB.JPG   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-14-2"  
class="td11"> DermQuest  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-14-3"  
class="td11"> Malignant Melanoma  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-14-4"  
class="td11"> 2                   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-14-5"  
class="td11"> 3            </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-14-6"  
class="td11"> 3.0       </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-14-7"  
class="td11"> 4.40   </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-34-15-"><td  style="white-space:nowrap; text-align:left;" id="TBL-34-15-1"  
class="td11"> 020266HB.JPG   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-15-2"  
class="td11"> DermQuest  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-15-3"  
class="td11"> Malignant Melanoma  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-15-4"  
class="td11"> 1                   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-15-5"  
class="td11"> 0            </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-15-6"  
class="td11"> 3.0       </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-15-7"  
class="td11"> 2.80   </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-34-16-"><td  style="white-space:nowrap; text-align:left;" id="TBL-34-16-1"  
class="td11"> 020268HB.JPG   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-16-2"  
class="td11"> DermQuest  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-16-3"  
class="td11"> Malignant Melanoma  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-16-4"  
class="td11"> 1                   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-16-5"  
class="td11"> 1            </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-16-6"  
class="td11"> 4.0       </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-16-7"  
class="td11"> 3.40   </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-34-17-"><td  style="white-space:nowrap; text-align:left;" id="TBL-34-17-1"  
class="td11"> 020302HB.JPG   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-17-2"  
class="td11"> DermQuest  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-17-3"  
class="td11"> Malignant Melanoma  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-17-4"  
class="td11"> 2                   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-17-5"  
class="td11"> 8            </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-17-6"  
class="td11"> 4.0       </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-17-7"  
class="td11"> 5.40   </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-34-18-"><td  style="white-space:nowrap; text-align:left;" id="TBL-34-18-1"  
class="td11"> 020319HB.JPG   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-18-2"  
class="td11"> DermQuest  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-18-3"  
class="td11"> Malignant Melanoma  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-18-4"  
class="td11"> 1                   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-18-5"  
class="td11"> 2            </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-18-6"  
class="td11"> 5.0       </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-18-7"  
class="td11"> 4.00   </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-34-19-"><td  style="white-space:nowrap; text-align:left;" id="TBL-34-19-1"  
class="td11"> 044936HB.JPG   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-19-2"  
class="td11"> DermQuest  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-19-3"  
class="td11"> Malignant Melanoma  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-19-4"  
class="td11"> 2                   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-19-5"  
class="td11"> 3            </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-19-6"  
class="td11"> 4.0       </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-19-7"  
class="td11"> 4.90   </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-34-20-"><td  style="white-space:nowrap; text-align:left;" id="TBL-34-20-1"  
class="td11"> 005613HB.jpeg  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-20-2"  
class="td11"> DermQuest  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-20-3"  
class="td11"> Melanocytic Nevus      </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-20-4"  
class="td11"> 0                   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-20-5"  
class="td11"> 3            </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-20-6"  
class="td11"> 3.0       </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-20-7"  
class="td11"> 1.80   </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-34-21-"><td  style="white-space:nowrap; text-align:left;" id="TBL-34-21-1"  
class="td11">              </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-21-2"  
class="td11">           </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-21-3"  
class="td11">                   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-21-4"  
class="td11">           </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-21-5"  
class="td11">        </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-21-6"  
class="td11">       </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-21-7"  
class="td11"></td></tr>
<tr  
 style="vertical-align:baseline;" id="TBL-34-22-"><td  style="white-space:nowrap; text-align:left;" id="TBL-34-22-1"  
class="td11"> 005728HB.jpeg  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-22-2"  
class="td11"> DermQuest  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-22-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-22-4"  
class="td11"> 2  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-22-5"  
class="td11"> 3  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-22-6"  
class="td11"> 4.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-22-7"  
class="td11"> 4.90  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-34-23-"><td  style="white-space:nowrap; text-align:left;" id="TBL-34-23-1"  
class="td11"> 005859HB.jpeg  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-23-2"  
class="td11"> DermQuest  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-23-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-23-4"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-23-5"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-23-6"  
class="td11"> 3.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-23-7"  
class="td11"> 1.50  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-34-24-"><td  style="white-space:nowrap; text-align:left;" id="TBL-34-24-1"  
class="td11"> 005900HB.jpeg  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-24-2"  
class="td11"> DermQuest  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-24-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-24-4"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-24-5"  
class="td11"> 3  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-24-6"  
class="td11"> 5.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-24-7"  
class="td11"> 2.80  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-34-25-"><td  style="white-space:nowrap; text-align:left;" id="TBL-34-25-1"  
class="td11"> 006027HB.jpeg  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-25-2"  
class="td11"> DermQuest  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-25-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-25-4"  
class="td11"> 2  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-25-5"  
class="td11"> 8  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-25-6"  
class="td11"> 3.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-25-7"  
class="td11"> 4.90  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-34-26-"><td  style="white-space:nowrap; text-align:left;" id="TBL-34-26-1"  
class="td11"> 006074HB.jpeg  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-26-2"  
class="td11"> DermQuest  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-26-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-26-4"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-26-5"  
class="td11"> 6  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-26-6"  
class="td11"> 3.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-26-7"  
class="td11"> 3.40  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-34-27-"><td  style="white-space:nowrap; text-align:left;" id="TBL-34-27-1"  
class="td11"> 006095HB.jpeg  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-27-2"  
class="td11"> DermQuest  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-27-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-27-4"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-27-5"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-27-6"  
class="td11"> 4.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-27-7"  
class="td11"> 2.10  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-34-28-"><td  style="white-space:nowrap; text-align:left;" id="TBL-34-28-1"  
class="td11"> 010769HB.jpeg  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-28-2"  
class="td11"> DermQuest  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-28-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-28-4"  
class="td11"> 2  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-28-5"  
class="td11"> 6  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-28-6"  
class="td11"> 3.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-28-7"  
class="td11"> 4.70  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-34-29-"><td  style="white-space:nowrap; text-align:left;" id="TBL-34-29-1"  
class="td11"> 010992VB.jpeg  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-29-2"  
class="td11"> DermQuest  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-29-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-29-4"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-29-5"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-29-6"  
class="td11"> 3.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-29-7"  
class="td11"> 1.50  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-34-30-"><td  style="white-space:nowrap; text-align:left;" id="TBL-34-30-1"  
class="td11"> 011031HB.jpeg  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-30-2"  
class="td11"> DermQuest  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-30-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-30-4"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-30-5"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-30-6"  
class="td11"> 4.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-30-7"  
class="td11"> 2.00  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-34-31-"><td  style="white-space:nowrap; text-align:left;" id="TBL-34-31-1"  
class="td11"> 011040VB.jpeg  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-31-2"  
class="td11"> DermQuest  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-31-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-31-4"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-31-5"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-31-6"  
class="td11"> 3.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-31-7"  
class="td11"> 1.50  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-34-32-"><td  style="white-space:nowrap; text-align:left;" id="TBL-34-32-1"  
class="td11"> 011201HB.jpeg  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-32-2"  
class="td11"> DermQuest  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-32-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-32-4"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-32-5"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-32-6"  
class="td11"> 3.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-32-7"  
class="td11"> 2.80  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-34-33-"><td  style="white-space:nowrap; text-align:left;" id="TBL-34-33-1"  
class="td11"> 011548HB.jpeg  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-33-2"  
class="td11"> DermQuest  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-33-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-33-4"  
class="td11"> 2  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-33-5"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-33-6"  
class="td11"> 3.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-33-7"  
class="td11"> 4.20  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-34-34-"><td  style="white-space:nowrap; text-align:left;" id="TBL-34-34-1"  
class="td11"> 011697HB.jpeg  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-34-2"  
class="td11"> DermQuest  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-34-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-34-4"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-34-5"  
class="td11"> 4  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-34-6"  
class="td11"> 4.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-34-7"  
class="td11"> 3.70  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-34-35-"><td  style="white-space:nowrap; text-align:left;" id="TBL-34-35-1"  
class="td11"> 011697HB.JPG   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-35-2"  
class="td11"> DermQuest  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-35-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-35-4"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-35-5"  
class="td11"> 4  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-35-6"  
class="td11"> 4.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-35-7"  
class="td11"> 3.70  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-34-36-"><td  style="white-space:nowrap; text-align:left;" id="TBL-34-36-1"  
class="td11"> 011936HB.jpeg  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-36-2"  
class="td11"> DermQuest  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-36-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-36-4"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-36-5"  
class="td11"> 6  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-36-6"  
class="td11"> 3.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-36-7"  
class="td11"> 3.40  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-34-37-"><td  style="white-space:nowrap; text-align:left;" id="TBL-34-37-1"  
class="td11"> 011936HB.JPG   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-37-2"  
class="td11"> DermQuest  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-37-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-37-4"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-37-5"  
class="td11"> 6  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-37-6"  
class="td11"> 3.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-37-7"  
class="td11"> 3.40  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-34-38-"><td  style="white-space:nowrap; text-align:left;" id="TBL-34-38-1"  
class="td11"> 021733HB.jpeg  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-38-2"  
class="td11"> DermQuest  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-38-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-38-4"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-38-5"  
class="td11"> 3  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-38-6"  
class="td11"> 1.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-38-7"  
class="td11"> 2.10  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-34-39-"><td  style="white-space:nowrap; text-align:left;" id="TBL-34-39-1"  
class="td11"> 021835HB.jpeg  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-39-2"  
class="td11"> DermQuest  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-39-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-39-4"  
class="td11"> 2  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-39-5"  
class="td11"> 2  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-39-6"  
class="td11"> 4.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-39-7"  
class="td11"> 4.80  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-34-40-"><td  style="white-space:nowrap; text-align:left;" id="TBL-34-40-1"  
class="td11"> 021837HB.jpeg  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-40-2"  
class="td11"> DermQuest  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-40-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-40-4"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-40-5"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-40-6"  
class="td11"> 4.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-40-7"  
class="td11"> 3.30  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-34-41-"><td  style="white-space:nowrap; text-align:left;" id="TBL-34-41-1"  
class="td11"> 021848HB.jpeg  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-41-2"  
class="td11"> DermQuest  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-41-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-41-4"  
class="td11"> 2  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-41-5"  
class="td11"> 7  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-41-6"  
class="td11"> 3.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-41-7"  
class="td11"> 4.80  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-34-42-"><td  style="white-space:nowrap; text-align:left;" id="TBL-34-42-1"  
class="td11">             </td></tr>
<tr  
 style="vertical-align:baseline;" id="TBL-34-43-"><td  style="white-space:nowrap; text-align:left;" id="TBL-34-43-1"  
class="td11"> 021852HB.jpeg  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-43-2"  
class="td11"> DermQuest  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-43-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-43-4"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-43-5"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-43-6"  
class="td11"> 3.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-43-7"  
class="td11"> 1.50  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-34-44-"><td  style="white-space:nowrap; text-align:left;" id="TBL-34-44-1"  
class="td11"> 021869HB.jpeg  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-44-2"  
class="td11"> DermQuest  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-44-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-44-4"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-44-5"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-44-6"  
class="td11"> 4.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-44-7"  
class="td11"> 3.30  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-34-45-"><td  style="white-space:nowrap; text-align:left;" id="TBL-34-45-1"  
class="td11"> 021878HB.jpeg  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-45-2"  
class="td11"> DermQuest  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-45-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-45-4"  
class="td11"> 2  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-45-5"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-45-6"  
class="td11"> 3.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-45-7"  
class="td11"> 4.20  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-34-46-"><td  style="white-space:nowrap; text-align:left;" id="TBL-34-46-1"  
class="td11"> 021902HB.jpeg  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-46-2"  
class="td11"> DermQuest  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-46-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-46-4"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-46-5"  
class="td11"> 4  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-46-6"  
class="td11"> 3.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-46-7"  
class="td11"> 1.90  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-34-47-"><td  style="white-space:nowrap; text-align:left;" id="TBL-34-47-1"  
class="td11"> 045720HB.jpeg  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-47-2"  
class="td11"> DermQuest  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-47-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-47-4"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-47-5"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-47-6"  
class="td11"> 3.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-47-7"  
class="td11"> 1.60  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-34-48-"><td  style="white-space:nowrap; text-align:left;" id="TBL-34-48-1"  
class="td11"> 046342HB.jpeg  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-48-2"  
class="td11"> DermQuest  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-48-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-48-4"  
class="td11"> 2  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-48-5"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-48-6"  
class="td11"> 3.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-48-7"  
class="td11"> 4.20  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-34-49-"><td  style="white-space:nowrap; text-align:left;" id="TBL-34-49-1"  
class="td11"> 046343HB.JPG   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-49-2"  
class="td11"> DermQuest  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-49-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-49-4"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-49-5"  
class="td11"> 6  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-49-6"  
class="td11"> 4.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-34-49-7"  
class="td11"> 3.90  </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-34-50-"><td colspan="6" style="white-space:nowrap; text-align:left;" id="TBL-34-50-1"  
class="td11"></td>        <div class="multicolumn"  style="white-space:nowrap; text-align:center;"><div class="caption" 
><span class="id">Table 13.2: </span><span  
class="content">Results of TDS calculation for DermQuest</span></div><!--tex4ht:label?: x1-81003r2 -->                          </div>                  <a 
 id="x1-81004"></a>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-34-51-"><td  style="white-space:nowrap; text-align:left;" id="TBL-34-51-1"  
class="td11">             </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-34-52-"><td  style="white-space:nowrap; text-align:left;" id="TBL-34-52-1"  
class="td11">             </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-34-53-"><td  style="white-space:nowrap; text-align:left;" id="TBL-34-53-1"  
class="td11">             </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-34-54-"><td  style="white-space:nowrap; text-align:left;" id="TBL-34-54-1"  
class="td11">             </td></tr>
   </table></div>
<a 
 id="x1-81005r3"></a>
   <!--l. 196--><div class="longtable"><table id="TBL-35" class="longtable" 
cellspacing="0" cellpadding="0" rules="groups" 
><colgroup id="TBL-35-1g"><col 
id="TBL-35-1"></colgroup><colgroup id="TBL-35-2g"><col 
id="TBL-35-2"></colgroup><colgroup id="TBL-35-3g"><col 
id="TBL-35-3"></colgroup><colgroup id="TBL-35-4g"><col 
id="TBL-35-4"></colgroup><colgroup id="TBL-35-5g"><col 
id="TBL-35-5"></colgroup><colgroup id="TBL-35-6g"><col 
id="TBL-35-6"></colgroup><colgroup id="TBL-35-7g"><col 
id="TBL-35-7"></colgroup>
<tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-35-1-"><td  style="white-space:nowrap; text-align:left;" id="TBL-35-1-1"  
class="td11"> Name               </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-1-2"  
class="td11"> Source          </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-1-3"  
class="td11"> Category                   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-1-4"  
class="td11"> Asymmetry  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-1-5"  
class="td11"> Border  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-1-6"  
class="td11"> Color  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-1-7"  
class="td11"> TDS  </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-35-2-"><td  style="white-space:nowrap; text-align:left;" id="TBL-35-2-1"  
class="td11"> IMD015.bmp  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-2-2"  
class="td11"> PH2Dataset  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-2-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-2-4"  
class="td11"> 1                   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-2-5"  
class="td11"> 5            </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-2-6"  
class="td11"> 2.0       </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-2-7"  
class="td11"> 2.80   </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-35-3-"><td  style="white-space:nowrap; text-align:left;" id="TBL-35-3-1"  
class="td11"> IMD016.bmp  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-3-2"  
class="td11"> PH2Dataset  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-3-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-3-4"  
class="td11"> 1                   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-3-5"  
class="td11"> 2            </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-3-6"  
class="td11"> 2.0       </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-3-7"  
class="td11"> 2.50   </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-35-4-"><td  style="white-space:nowrap; text-align:left;" id="TBL-35-4-1"  
class="td11"> IMD018.bmp  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-4-2"  
class="td11"> PH2Dataset  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-4-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-4-4"  
class="td11"> 1                   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-4-5"  
class="td11"> 1            </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-4-6"  
class="td11"> 2.0       </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-4-7"  
class="td11"> 2.40   </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-35-5-"><td  style="white-space:nowrap; text-align:left;" id="TBL-35-5-1"  
class="td11"> IMD020.bmp  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-5-2"  
class="td11"> PH2Dataset  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-5-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-5-4"  
class="td11"> 0                   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-5-5"  
class="td11"> 1            </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-5-6"  
class="td11"> 2.0       </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-5-7"  
class="td11"> 1.10   </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-35-6-"><td  style="white-space:nowrap; text-align:left;" id="TBL-35-6-1"  
class="td11"> IMD027.bmp  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-6-2"  
class="td11"> PH2Dataset  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-6-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-6-4"  
class="td11"> 2                   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-6-5"  
class="td11"> 7            </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-6-6"  
class="td11"> 2.0       </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-6-7"  
class="td11"> 4.30   </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-35-7-"><td  style="white-space:nowrap; text-align:left;" id="TBL-35-7-1"  
class="td11"> IMD038.bmp  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-7-2"  
class="td11"> PH2Dataset  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-7-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-7-4"  
class="td11"> 1                   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-7-5"  
class="td11"> 2            </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-7-6"  
class="td11"> 3.0       </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-7-7"  
class="td11"> 3.00   </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-35-8-"><td  style="white-space:nowrap; text-align:left;" id="TBL-35-8-1"  
class="td11"> IMD039.bmp  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-8-2"  
class="td11"> PH2Dataset  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-8-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-8-4"  
class="td11"> 1                   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-8-5"  
class="td11"> 3            </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-8-6"  
class="td11"> 2.0       </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-8-7"  
class="td11"> 2.60   </td>
                                                                  

                                                                  
</tr><tr  
 style="vertical-align:baseline;" id="TBL-35-9-"><td  style="white-space:nowrap; text-align:left;" id="TBL-35-9-1"  
class="td11"> IMD043.bmp  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-9-2"  
class="td11"> PH2Dataset  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-9-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-9-4"  
class="td11"> 2                   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-9-5"  
class="td11"> 7            </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-9-6"  
class="td11"> 3.0       </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-9-7"  
class="td11"> 4.80   </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-35-10-"><td  style="white-space:nowrap; text-align:left;" id="TBL-35-10-1"  
class="td11"> IMD045.bmp  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-10-2"  
class="td11"> PH2Dataset  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-10-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-10-4"  
class="td11"> 1                   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-10-5"  
class="td11"> 1            </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-10-6"  
class="td11"> 2.0       </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-10-7"  
class="td11"> 2.40   </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-35-11-"><td  style="white-space:nowrap; text-align:left;" id="TBL-35-11-1"  
class="td11"> IMD050.bmp  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-11-2"  
class="td11"> PH2Dataset  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-11-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-11-4"  
class="td11"> 1                   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-11-5"  
class="td11"> 6            </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-11-6"  
class="td11"> 2.0       </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-11-7"  
class="td11"> 2.90   </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-35-12-"><td  style="white-space:nowrap; text-align:left;" id="TBL-35-12-1"  
class="td11"> IMD078.bmp  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-12-2"  
class="td11"> PH2Dataset  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-12-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-12-4"  
class="td11"> 2                   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-12-5"  
class="td11"> 8            </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-12-6"  
class="td11"> 3.0       </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-12-7"  
class="td11"> 4.90   </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-35-13-"><td  style="white-space:nowrap; text-align:left;" id="TBL-35-13-1"  
class="td11"> IMD103.bmp  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-13-2"  
class="td11"> PH2Dataset  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-13-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-13-4"  
class="td11"> 1                   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-13-5"  
class="td11"> 5            </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-13-6"  
class="td11"> 2.0       </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-13-7"  
class="td11"> 2.80   </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-35-14-"><td  style="white-space:nowrap; text-align:left;" id="TBL-35-14-1"  
class="td11"> IMD105.bmp  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-14-2"  
class="td11"> PH2Dataset  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-14-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-14-4"  
class="td11"> 1                   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-14-5"  
class="td11"> 4            </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-14-6"  
class="td11"> 2.0       </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-14-7"  
class="td11"> 2.70   </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-35-15-"><td  style="white-space:nowrap; text-align:left;" id="TBL-35-15-1"  
class="td11"> IMD107.bmp  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-15-2"  
class="td11"> PH2Dataset  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-15-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-15-4"  
class="td11"> 2                   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-15-5"  
class="td11"> 3            </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-15-6"  
class="td11"> 2.0       </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-15-7"  
class="td11"> 3.90   </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-35-16-"><td  style="white-space:nowrap; text-align:left;" id="TBL-35-16-1"  
class="td11"> IMD132.bmp  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-16-2"  
class="td11"> PH2Dataset  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-16-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-16-4"  
class="td11"> 2                   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-16-5"  
class="td11"> 5            </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-16-6"  
class="td11"> 3.0       </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-16-7"  
class="td11"> 4.60   </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-35-17-"><td  style="white-space:nowrap; text-align:left;" id="TBL-35-17-1"  
class="td11"> IMD133.bmp  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-17-2"  
class="td11"> PH2Dataset  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-17-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-17-4"  
class="td11"> 1                   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-17-5"  
class="td11"> 2            </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-17-6"  
class="td11"> 2.0       </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-17-7"  
class="td11"> 2.50   </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-35-18-"><td  style="white-space:nowrap; text-align:left;" id="TBL-35-18-1"  
class="td11"> IMD134.bmp  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-18-2"  
class="td11"> PH2Dataset  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-18-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-18-4"  
class="td11"> 2                   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-18-5"  
class="td11"> 4            </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-18-6"  
class="td11"> 2.0       </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-18-7"  
class="td11"> 4.00   </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-35-19-"><td  style="white-space:nowrap; text-align:left;" id="TBL-35-19-1"  
class="td11"> IMD137.bmp  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-19-2"  
class="td11"> PH2Dataset  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-19-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-19-4"  
class="td11"> 0                   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-19-5"  
class="td11"> 5            </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-19-6"  
class="td11"> 2.0       </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-19-7"  
class="td11"> 1.50   </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-35-20-"><td  style="white-space:nowrap; text-align:left;" id="TBL-35-20-1"  
class="td11"> IMD139.bmp  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-20-2"  
class="td11"> PH2Dataset  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-20-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-20-4"  
class="td11"> 1                   </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-20-5"  
class="td11"> 3            </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-20-6"  
class="td11"> 2.0       </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-20-7"  
class="td11"> 2.60   </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-35-21-"><td  style="white-space:nowrap; text-align:left;" id="TBL-35-21-1"  
class="td11">             </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-21-2"  
class="td11">           </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-21-3"  
class="td11">                 </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-21-4"  
class="td11">           </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-21-5"  
class="td11">        </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-21-6"  
class="td11">       </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-21-7"  
class="td11"></td></tr>
<tr  
 style="vertical-align:baseline;" id="TBL-35-22-"><td  style="white-space:nowrap; text-align:left;" id="TBL-35-22-1"  
class="td11"> IMD140.bmp  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-22-2"  
class="td11"> PH2Dataset  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-22-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-22-4"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-22-5"  
class="td11"> 5  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-22-6"  
class="td11"> 3.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-22-7"  
class="td11"> 3.30  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-35-23-"><td  style="white-space:nowrap; text-align:left;" id="TBL-35-23-1"  
class="td11"> IMD142.bmp  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-23-2"  
class="td11"> PH2Dataset  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-23-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-23-4"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-23-5"  
class="td11"> 5  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-23-6"  
class="td11"> 3.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-23-7"  
class="td11"> 3.30  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-35-24-"><td  style="white-space:nowrap; text-align:left;" id="TBL-35-24-1"  
class="td11"> IMD143.bmp  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-24-2"  
class="td11"> PH2Dataset  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-24-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-24-4"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-24-5"  
class="td11"> 2  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-24-6"  
class="td11"> 3.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-24-7"  
class="td11"> 3.00  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-35-25-"><td  style="white-space:nowrap; text-align:left;" id="TBL-35-25-1"  
class="td11"> IMD144.bmp  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-25-2"  
class="td11"> PH2Dataset  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-25-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-25-4"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-25-5"  
class="td11"> 2  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-25-6"  
class="td11"> 3.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-25-7"  
class="td11"> 3.00  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-35-26-"><td  style="white-space:nowrap; text-align:left;" id="TBL-35-26-1"  
class="td11"> IMD156.bmp  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-26-2"  
class="td11"> PH2Dataset  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-26-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-26-4"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-26-5"  
class="td11"> 3  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-26-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-26-7"  
class="td11"> 2.60  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-35-27-"><td  style="white-space:nowrap; text-align:left;" id="TBL-35-27-1"  
class="td11"> IMD171.bmp  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-27-2"  
class="td11"> PH2Dataset  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-27-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-27-4"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-27-5"  
class="td11"> 4  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-27-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-27-7"  
class="td11"> 2.70  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-35-28-"><td  style="white-space:nowrap; text-align:left;" id="TBL-35-28-1"  
class="td11"> IMD173.bmp  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-28-2"  
class="td11"> PH2Dataset  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-28-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-28-4"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-28-5"  
class="td11"> 7  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-28-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-28-7"  
class="td11"> 1.70  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-35-29-"><td  style="white-space:nowrap; text-align:left;" id="TBL-35-29-1"  
class="td11"> IMD204.bmp  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-29-2"  
class="td11"> PH2Dataset  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-29-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-29-4"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-29-5"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-29-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-29-7"  
class="td11"> 1.10  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-35-30-"><td  style="white-space:nowrap; text-align:left;" id="TBL-35-30-1"  
class="td11"> IMD243.bmp  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-30-2"  
class="td11"> PH2Dataset  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-30-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-30-4"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-30-5"  
class="td11"> 8  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-30-6"  
class="td11"> 3.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-30-7"  
class="td11"> 3.60  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-35-31-"><td  style="white-space:nowrap; text-align:left;" id="TBL-35-31-1"  
class="td11"> IMD256.bmp  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-31-2"  
class="td11"> PH2Dataset  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-31-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-31-4"  
class="td11"> 2  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-31-5"  
class="td11"> 7  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-31-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-31-7"  
class="td11"> 4.30  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-35-32-"><td  style="white-space:nowrap; text-align:left;" id="TBL-35-32-1"  
class="td11"> IMD280.bmp  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-32-2"  
class="td11"> PH2Dataset  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-32-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-32-4"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-32-5"  
class="td11"> 2  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-32-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-32-7"  
class="td11"> 2.50  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-35-33-"><td  style="white-space:nowrap; text-align:left;" id="TBL-35-33-1"  
class="td11"> IMD328.bmp  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-33-2"  
class="td11"> PH2Dataset  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-33-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-33-4"  
class="td11"> 2  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-33-5"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-33-6"  
class="td11"> 3.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-33-7"  
class="td11"> 4.20  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-35-34-"><td  style="white-space:nowrap; text-align:left;" id="TBL-35-34-1"  
class="td11"> IMD331.bmp  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-34-2"  
class="td11"> PH2Dataset  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-34-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-34-4"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-34-5"  
class="td11"> 5  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-34-6"  
class="td11"> 3.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-34-7"  
class="td11"> 3.30  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-35-35-"><td  style="white-space:nowrap; text-align:left;" id="TBL-35-35-1"  
class="td11"> IMD356.bmp  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-35-2"  
class="td11"> PH2Dataset  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-35-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-35-4"  
class="td11"> 2  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-35-5"  
class="td11"> 2  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-35-6"  
class="td11"> 3.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-35-7"  
class="td11"> 4.30  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-35-36-"><td  style="white-space:nowrap; text-align:left;" id="TBL-35-36-1"  
class="td11"> IMD360.bmp  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-36-2"  
class="td11"> PH2Dataset  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-36-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-36-4"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-36-5"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-36-6"  
class="td11"> 3.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-36-7"  
class="td11"> 2.90  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-35-37-"><td  style="white-space:nowrap; text-align:left;" id="TBL-35-37-1"  
class="td11"> IMD369.bmp  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-37-2"  
class="td11"> PH2Dataset  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-37-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-37-4"  
class="td11"> 2  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-37-5"  
class="td11"> 5  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-37-6"  
class="td11"> 3.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-37-7"  
class="td11"> 4.60  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-35-38-"><td  style="white-space:nowrap; text-align:left;" id="TBL-35-38-1"  
class="td11"> IMD380.bmp  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-38-2"  
class="td11"> PH2Dataset  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-38-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-38-4"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-38-5"  
class="td11"> 3  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-38-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-38-7"  
class="td11"> 2.60  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-35-39-"><td  style="white-space:nowrap; text-align:left;" id="TBL-35-39-1"  
class="td11"> IMD382.bmp  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-39-2"  
class="td11"> PH2Dataset  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-39-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-39-4"  
class="td11"> 2  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-39-5"  
class="td11"> 4  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-39-6"  
class="td11"> 4.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-39-7"  
class="td11"> 5.00  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-35-40-"><td  style="white-space:nowrap; text-align:left;" id="TBL-35-40-1"  
class="td11"> IMD383.bmp  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-40-2"  
class="td11"> PH2Dataset  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-40-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-40-4"  
class="td11"> 0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-40-5"  
class="td11"> 3  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-40-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-40-7"  
class="td11"> 1.30  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-35-41-"><td  style="white-space:nowrap; text-align:left;" id="TBL-35-41-1"  
class="td11"> IMD384.bmp  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-41-2"  
class="td11"> PH2Dataset  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-41-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-41-4"  
class="td11"> 2  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-41-5"  
class="td11"> 5  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-41-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-41-7"  
class="td11"> 4.10  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-35-42-"><td  style="white-space:nowrap; text-align:left;" id="TBL-35-42-1"  
class="td11">           </td></tr>
<tr  
 style="vertical-align:baseline;" id="TBL-35-43-"><td  style="white-space:nowrap; text-align:left;" id="TBL-35-43-1"  
class="td11"> IMD392.bmp  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-43-2"  
class="td11"> PH2Dataset  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-43-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-43-4"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-43-5"  
class="td11"> 6  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-43-6"  
class="td11"> 2.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-43-7"  
class="td11"> 2.90  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-35-44-"><td  style="white-space:nowrap; text-align:left;" id="TBL-35-44-1"  
class="td11"> IMD430.bmp  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-44-2"  
class="td11"> PH2Dataset  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-44-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-44-4"  
class="td11"> 1  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-44-5"  
class="td11"> 2  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-44-6"  
class="td11"> 3.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-44-7"  
class="td11"> 3.00  </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-35-45-"><td  style="white-space:nowrap; text-align:left;" id="TBL-35-45-1"  
class="td11"> IMD433.bmp  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-45-2"  
class="td11"> PH2Dataset  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-45-3"  
class="td11"> Melanocytic Nevus  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-45-4"  
class="td11"> 2  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-45-5"  
class="td11"> 4  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-45-6"  
class="td11"> 3.0  </td><td  style="white-space:nowrap; text-align:left;" id="TBL-35-45-7"  
class="td11"> 4.50  </td>
</tr><tr 
class="hline"><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td><td><hr></td></tr><tr  
 style="vertical-align:baseline;" id="TBL-35-46-"><td colspan="6" style="white-space:nowrap; text-align:left;" id="TBL-35-46-1"  
class="td11"></td>       <div class="multicolumn"  style="white-space:nowrap; text-align:center;"><div class="caption" 
><span class="id">Table 13.3: </span><span  
class="content">Results of TDS calculation for PH2Dataset</span></div><!--tex4ht:label?: x1-81005r3 -->                          </div>                 <a 
 id="x1-81006"></a>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-35-47-"><td  style="white-space:nowrap; text-align:left;" id="TBL-35-47-1"  
class="td11">           </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-35-48-"><td  style="white-space:nowrap; text-align:left;" id="TBL-35-48-1"  
class="td11">           </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-35-49-"><td  style="white-space:nowrap; text-align:left;" id="TBL-35-49-1"  
class="td11">           </td>
</tr><tr  
 style="vertical-align:baseline;" id="TBL-35-50-"><td  style="white-space:nowrap; text-align:left;" id="TBL-35-50-1"  
class="td11">           </td></tr>
   </table></div>
    
</body></html> 

                                                                  


